EP48

DICIEMBRE 2006
CATALOGO N. 48
Catlogo Farmacopea Europea 2006

Sustancias Qumicas de Referencia Spectra Infrarrojos de Referencia Preparados Biolgicos de Referencia
Catlogo de Publicaciones EP
5th Edition European Pharmacopoeia Pharmeurope 18.3 Phaemeurope Bio 2005.1 List Standard Terms 2004 (Book) Proceedings of EDQM Conferences
European Pharmacopoeia Reagents Conductivity Standards pH Buffer Solutions Analytical Volumetric Solutions Inorganic Spectroscopy Standards Standards and Calibrators Electrode Care and Maintenance
Catalogue
Catalogue
Chemical Reference Substances Infrared Reference Spectra Biological Reference Preparations
List No. 48
December 2006
European Pharmacopoeia - Catalogue, December 2006
Catalogue
of the sub-batches 1a, 1b, 1c, will be gradually replaced with 1.1, 1.2, 1.3, etc.) However, all necessary precautions are taken in order to guarantee that the quality and the specications of the sub-batches do not differ from one to another. Since CRSs and BRPs are ofcially certied by the European Pharmacopoeia Commission, which adopts the reports establishing their suitability for the intended use, it should be noted that neither certicates of analysis nor data not relevant to the use of the products as dened by the Ph. Eur. monograph are provided with the reference standard. In the same way, no expiry date is indicated because the reference standards comply with the requirements of the corresponding monograph and are monitored regularly. The Information column of the catalogue indicates an ofcial date on which the batch is no longer valid as a CRS/BRP for all batches that have just been replaced. Hence batch 1 valid until 30 June 2006 means that batch 1 is no longer ofcial as of 1 July 2006. Where no drying conditions are stated, the substance is to be used as received. For the CRS with an assigned content, the stated content is expressed on an as is basis. The reference standards database on our website is now updated daily with information on availability. Other information available includes details on the origin, assigned value and batch validity. A batch validity statement (BVS) for the reference standards is now available. It enables the user of a reference standard to print a validity statement directly from the reference standards database on the EDQM website (http://crs.pheur.org/). This tool will help users to assure the traceability of validity dates and leaets
provided with the previous batch. An example of a BVS is included on pages xx and xxi of this catalogue. For reference standards supplied in sealed glass ampoules the following technique is suitable for opening the ampoule: tap the ampoule gently to collect the material at the lower end; score the ampoule with a le; heat a glass rod to white heat and apply rmly to the le mark; if a crack is not produced, deepen and extend the le mark, reheat the glass rod and apply again. Toxic substances. The potential toxicity of certain reference standards is such that special precautions are needed during use to avoid contact. Such substances should be manipulated in a glove box, otherwise protective gloves, eye protection and a mask should be worn. Biological preparations and blood products. These preparations should be regarded as potentially hazardous to health and should be used and disposed of according to your own Laboratory safety practices. Safety Data Sheets Safety data sheets are available on the website or on request. Information provided by the Ph. Eur. on the safety data sheets is compiled from information provided in the usual way by suppliers or manufacturers of the products and has not been independently veried by Ph. Eur. staff. The accuracy of such information cannot therefore be guaranteed.
V. LEAFLET
In specic cases, an explanatory leaet is sent with the product. See the relevant column in the list starting on page 1 (where nothing is stated, no leaet is needed for the given product). Leaets are also available on the website.
European Pharmacopoeia - Catalogue, December 2006
vii
Catalogue No. 48-2006/4 Batch Monograph Leaflet Storage
6 December 2006
Reference Standard
Order Code Y0000055 Y0000116 Y0000500 Y0000354 Y0000427 A0040000 Y0000359 n/a 1 1 1 1 1 1 Yes +5C +5C +5C +5C +5C +5C +5C +5C 1 2 n/a 1 1 n/a 20 mg 10 mg 1 1 1 0871 0871 a a 1585 1585 2089 2089 2089 0871 0871
Acamprosate calcium - reference spectrum Acamprosate impurity A Acarbose Acarbose for identification Acarbose for peak identification Acebutolol hydrochloride Acebutolol impurity B
Extra charges l a a a a a a
Y0000127 Acebutolol impurity C Y0000128 Acebutolol impurity I
Information Unit Sale Quantity Unit n/a 1 50 mg 1 3-aminopropane-1-sulphonic acid 100.1 mg 1 100.1 mg per vial of CHNO 10 mg 1 40 mg 1 50 mg 1 10 mg 1 N-[3-acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino] propoxy]phenyl]acetamide (diacetolol) 20 mg 1 N-(3-acetyl-4-hydroxyphenyl)butanamide 0.004 mg 1 N-[3-acetyl-4-[(2RS)-3-(ethylamino)-2-hydroxypropoxy]phenyl] butanamide 1281 benzyl[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetate 1281 [[[[[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetyl] 1281 oxy]acetyl]oxy]acetic acid Batch 1 is valid until 30 April 2006 5-chloro-6-methyl-1,2,3-oxathiazin-4(3)-one 2,2-dioxide +5C +5C l a a
Y0000056 Aceclofenac - reference spectrum Y0000085 Aceclofenac impurity F Y0000086 Aceclofenac impurity H
90.9% CHNOS; N,N'-diacetyl-L-cystine N,-diacetyl-L-cysteine
Yes
A0050000 A0070000 A0070020 A0100000 Y0000002 A0150000 A0152000 A0153000 Y0000565 Y0000642 A0200000 A0208000 A0202000 Y0000693 A0220000 A0221000
Acenocoumarol Acesulfame potassium Acesulfame potassium impurity B Acetazolamide Acetylcholine chloride Acetylcysteine Acetylcysteine impurity C Acetylcysteine impurity D -Acetyldigoxin -Acetyldigoxin for peak identification Acetylsalicylic acid N-Acetyltryptophan N-Acetyltyrosine Acholeplasma laidlawii BRP Aciclovir Aciclovir impurity A
1 2 2 1 1 2 5 4 1 1 3 1 1 1 2 5
20 mg 50 mg 10 mg 100 mg 50 mg 50 mg 10 mg 10 mg 30 mg 10 mg 100 mg 125 mg 200 mg 1 ml 75 mg 15 mg
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
2-[(2-amino-6-oxo-1,6-dihydro-9-purin-9-yl)methoxy]ethyl acetate 99.7% CHO ; Batch 1 is valid until 28 February 2007 1 1 1 1 1 1 1 Batch 1 is valid until 28 February 2007
0698,0699 1282 1282 0454 1485,1971 0967 0967 0967 2168 2168 0309 1383 1384 20607 0968 0968
Yes
+5C +5C +5C +5C -20C +5C +5C +5C +5C +5C +5C +5C +5C -80C +5C +5C
a a a a c a a a f f a a a d a a 1385 +5C g 2043 Yes +5C a 0800,1486 +5C a 1486 +5C a 1586 +5C a 0254,0285,0732 +5C g 0614,0752 +5C a For extra charges please see 2.2
A0225000 Acitretin Y0000360 Acriflavinium monochloride A0230000 Adenine A0230200 Adenosine Y0000110 Adipic acid A0300000 Adrenaline tartrate A0325000 Alanine Council of Europe, all rights reserved 2006
2 2 2 1 1 3 2
100 mg 1 mg 50 mg 50 mg 50 mg 200 mg 50 mg
Catalogue No. 48-2006/4 Batch +5C +5C -20C +5C +5C +5C +5C +5C +5C 0576 0576 +5C +5C 1 1 4 n/a 2 n/a 1 1 1 2 2 2 2 10 mg 10 mg 1 1 99.9% CHNO 5-amino-1H-pyrazole-4-carboxamide ; Batch 1 is valid until 28 February 2007 5-formylamino-1H-pyrazole-4-carboxamide N-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide ; Batch 1 is valid until 31 May 2006 ethyl 5-amino-1H-pyrazole-4-carboxylate ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate 13.4% carbonic acid 60 mg 50 mg 10 mg 1 1 1 1288 0576 0576 a a a a a +5C +5C +5C +5C 1386 1285 1286 1286 1070,1487 1062 1287 1287 Monograph Leaflet Storage
6 December 2006
Order Code A0325100 A0325200 A0325450 A0325451 A1225000 A0325500 A0325800 A0325801
Reference Standard
Albendazole Alcuronium chloride Alfacalcidol Alfacalcidol - reference spectrum Alfadex Alfentanil hydrochloride - reference spectrum Alfuzosin hydrochloride Alfuzosin impurity A
Information Unit Sale Quantity Unit 50 mg 1 100 mg 1 5 mg 1 99.9% CHO ; Batch 3 is valid until 30 April 2006 n/a 1 150 mg 1 89.5% [CH0] n/a 1 50 mg 1 20 mg 1 N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl) (methyl)-amino]propyl]furan-2-carboxamide Extra charges a a c l a l a a
A0349000 Allantoin A0350000 Allopurinol New A0350010 Allopurinol impurity A
A0350020 Allopurinol impurity B A0350030 Allopurinol impurity C
99.2% CHO
Yes
A0350040 A0350050 A0351000 Y0000235 Y0000255 A0357000 A0360000 Y0000054 Y0000606 New Y0000687 New Y0000595 New Y0000607 A0363000 A0363700 A0900000 A0365000 A0368000 A0368010
Allopurinol impurity D Allopurinol impurity E Allylstrychnine bromide Almagate Almagate - reference spectrum Alprazolam - * psy Alprenolol hydrochloride Alprostadil Altizide Alverine citrate Alverine for peak identification Alverine impurity D Amantadine hydrochloride Ambroxol hydrochloride Amfetamine sulphate - reference spectrum Amidotrizoic acid dihydrate Amikacin Amikacin impurity A
2 1 1 1 n/a 1 1 1 1 1 1 1 1 2 n/a 1 1 1
10 mg 20 mg 10 mg 25 mg n/a 125 mg 100 mg 50 mg 5 mg 5 mg 0.125 mg 10 mg 100 mg 125 mg n/a 100 mg 200 mg 10 mg
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2
N-(3-cyclohexylpropyl)-N-ethyl-3-phenylpropan-1-amine
0576 0576 1285 2010 2010 1065 0628,0876 1488 0370 2156 2156 2156 0463 1489 0368 0873 1289 1289,1290
+5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C
a a a a l j a a a a a a a a l a a a
A0365900 Amikacin sulphate A0370000 Amiloride hydrochloride
2 1
200 mg 100 mg
1 1
93.1% CHNO 86% CHNO; 4-O-(3-amino-3-desoxy-alpha-D-glucopyranosyl)-6-O-(6-amino-6 -desoxy-alpha-D-glucopyranosyl)-N1-[(2S)-4-amino-2hydroxybutanoyl]-2-desoxy-L-streptamine 89.0% CHNOS 1290 0651
+5C +5C
a a For extra charges please see 2.2
Council of Europe, all rights reserved 2006
Catalogue No. 48-2006/4 Batch 2 1 1 1 1 1 1 1 3 1 1 1 1 1 [(2RS)-1-ethylpyrrolidin-2-yl]methanamine 4-amino-N-[[(2RS)-1-ethylpyrrolidin-2-yl]methyl]-5-(ethyl sulphonyl)-2-hydroxybenzamine 99.9% CHClNOS 20 mg 50 mg 40 mg 10 mg 1 1 1 1 Batch 2 is valid until 28 February 2007 (2-butyl-benzofuran-3-yl)-(4-hydroxy-3,5-diiodophenyl) methanone (2-butyl-benzofuran-3-yl)-(4-hydroxyphenyl)methanone 0803 1490 1490 1490 20 mg 100 mg 20 mg 1 1 1 0751 0803 0803 1291 +5C +5C +5C +5C +5C +5C +5C +5C a a g a a a a a 0651 1687 0874 0708,0813 1291 1291 +5C +5C +5C +5C +5C +5C Monograph Leaflet Storage
6 December 2006
Order Code Y0000020 Y0000173 A0420000 A0460000 A0496000 A0496005
Reference Standard
Amiloride impurity A 4-Aminobenzoic acid Aminocaproic acid 7-Aminodesacetoxycephalosporanic acid Aminoglutethimide Aminoglutethimide impurity A
Extra charges a a a a a a
A0496020 Aminoglutethimide impurity D
Information Unit Sale Quantity Unit 10 mg 1 methyl-3,5-diamino-6-chloropyrazine-2-carboxylate 60 mg 1 50 mg 1 100 mg 1 125 mg 1 20 mg 1 (3)-3-(3-aminophenyl)-3-ethylpiperidine-2,6-dione; (3-aminoglutethimide) 10 mg 1 3,3'-[diazenediyldi(4,1-phenylene)]bis(3-ethylpiperidine-2,6dione); (azoglutethimide)
A0560000 5-Amino-2,4,6-tri-iodo-N-methylisophthalamic acid A0575000 Amiodarone hydrochloride Y0000129 Amiodarone impurity D
Y0000130 A0590000 A0590002 A0590004
Amiodarone impurity E Amisulpride Amisulpride impurity A Amisulpride impurity B
n/a 3 n/a n/a n/a 1
n/a 150 mg n/a
1 1 1
0464 1491 2081 2082
+5C
l a l l
A0600000 Amitriptyline hydrochloride - reference spectrum Y0000049 Amlodipine besilate Y0000302 Ammonio methacrylate copolymer(type A) - reference spectrum Y0000303 Ammonio methacrylate copolymer(type B) - reference spectrum A0650000 Amobarbital - * psy A0700000 Amobarbital sodium - * psy A0800000 Amoxicillin trihydrate 1 1 3 85.4% CHNOS 500 mg 500 mg 100 mg 1 1 1
+5C +5C +5C
j j a
Y0000005 Amphotericin B A1000000 Ampicillin (anhydrous) 2 150 mg 1
2 3
500 mg 250 mg
1 1
960 IU per mg 98.0% CHNOS
Yes
-20C +5C +5C
c a a
A1100000 Ampicillin trihydrate
A1200000 A1210000 Y0000172 A1220000 A1230000
Anhydrotetracycline hydrochloride Antazoline hydrochloride Apomorphine hydrochloride - reference spectrum Alpha-apo-oxytetracycline Beta-apo-oxytetracycline
3 1 n/a 4 4
10 mg 50 mg n/a 20 mg 20 mg
1 1 1 1 1
94.2% CHNO
0594 0166 0167,0168,0260, 0577,0578,0813, 1140,1653 1292,20702 0167,0168,0578, 1168,1169 0168,0260,0577, 0578,0808,2211, 2212 0210,0211,1654 0972 0136 0198 0198
+5C +5C +5C +5C
a a l a a For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch 2 1 2 Yes +5C +5C +5C Information Unit Sale Quantity Unit 0.5 ml 1 About 27 Ph. Eur. Units per ml 10 mg 1 50 mg 1 Batch 1 is valid until 31 October 2006 Monograph Leaflet Storage Extra charges a a a
6 December 2006
Order Reference Standard Code A1250000 Aprotinin solution BRP A1269000 L-Arabinitol A1270000 Arginine
Y0000304 A1271000 Y0000079 Y0000080 Batch 1 is valid until 31 October 2006 1 2 n/a 1 2 3 2-(5-benzyl-3,6-dioxopiperazin-2-yl) acetic acid (diketopiperazine) ; Batch 2 is valid until 31 December 2005 Batch 1 is valid until 30 September 2006 100 mg n/a 60 mg 40 mg 10 mg 1 1 1 1 1 10 mg 1 methyl3-[[2-(propylamino)acetyl]amino]-4-methylthiophene-2carboxylate methyl 4-methyl-3-[[( 2RS)-2-[(1-methylethyl)amino] propanoyl]amino] thiophene-2-carboxylate Vitamin C 1688 0253,0958 0807 2086 0973 0973
Arginine aspartate Arginine hydrochloride Articaine hydrochloride Articaine impurity A
1 2 2 1
20 mg 50 mg 100 mg 10 mg
1 1 1 1
0579,0580 1381 0806,0930,1654, 2114 2096 0805,0885,0998 1688 1688 +5C +5C +5C +5C +5C +5C +5C +5C +5C a a a a a a l a a a
Y0000081 Articaine impurity E
A1300000 A1315000 Y0000305 A1320000 A1321000
Ascorbic acid Ascorbyl palmitate - reference spectrum Asparagine monohydrate Aspartame Aspartame impurity A
Yes Yes Yes
98.9% CHNOS
+5C +5C +5C +5C +5C +5C +5C +5C Yes
1-benzoyl-2-[(4RS)-1-methylhexahydro-1H-azepin-4-yl]diazane 4-(4-chlorobenzyl)phthalazin-1(2H)-one 3-(4-chlorobenzilidene)isobenzofuran-1(3H)-one 93.2% CHNO
Yes 6-demethylazithromycin 3-deoxyazithromycin
A1330000 A1335000 A1340000 A1341000 Y0000424 Y0000503 Y0000504 A1400000 Y0000231 Y0000230 Y0000029 A1500000 Y0000326 Y0000327 Y0000328 Y0000329 Y0000306 Y0000637 Y0000641 Y0000307 Y0000308
Aspartic acid Astemizole Atenolol Atenolol for column validation Atracurium besilate Atracurium for impurity F identification Atracurium for peak identification Atropine sulphate Atropine - reference spectrum Atropine for system suitability Azaperone Azathioprine Azelastine hydrochloride Azelastine impurity B Azelastine impurity D Azelastine impurity E Azithromycin Azithromycin for peak identification Azithromycin for system suitability Azithromycin impurity A Azithromycin impurity B
2 1 2 5 1 1 1 3 n/a 1 1 1 1 1 1 1 1 1 1 1 2
50 mg 150 mg 100 mg 100 mg 120 mg 5 mg 5 mg 50 mg n/a 0.4 mg 50 mg 100 mg 25 mg 5 mg 5 mg 5 mg 120 mg 15 mg 0.05 mg 10 mg 0.04 mg
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
0750,0797 1067 0703 0703 1970 1970 1970 0068,2056 2056 2056 1708 0369 1633 1633 1633 1633 1649 1649 1649 1649 1649
+5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C
a a a a f f f a l a a a a a a a a a a a a For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch 1 3 2 1 1 1 1 n/a 3 +5C +5C -20C +5C +5C +5C +5C a a a a a j l a Yes -20C Leaflet Storage Extra charges e
6 December 2006
Order Reference Standard Code Y0000285 B19 virus DNA for NAT testing BRP
B0070000 B0100000 B0200000 B0200050 B0250000 B0300000 Y0000295 B0305000
Bacampicillin hydrochloride Bacitracin zinc Baclofen Baclofen impurity A Bambuterol hydrochloride Barbital - * psy Basic butylated methacrylate copolymer -reference spectrum Beclometasone dipropionate anhydrous
Y0000351 Y0000352 Y0000469 B0400000 Y0000564 Y0000044 Y0000043 B0470000 1 1 1 2
Beclometasone dipropionate monohydrate Beclometasone dipropionate for system suitability Beclometasone dipropionate for peak identification Bendroflumethiazide Bendroflumethiazide impurity A Benfluorex hydrochloride Benfluorex hydrochloride for system suitability Benperidol
1 1 1 1 1 1 1 1
Yes Yes
+5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C
a a a a a a a a a a a a
B0477000 B0477010 B0490000 B0500000
Benserazide hydrochloride Benserazide impurity A Benzarone Benzathine benzylpenicillin
Information Unit Sale Monograph Quantity Unit 150 mg 5 B19 virus DNA content log 5.8 IU per ml for plasma pool testing See leaflet,0557, by NAT 1527,1646 92.9% CHClNOS 120 mg 1 0808,0852 150 mg 1 62.9 IU per mg 0465,0466,20702 50 mg 1 0653 50 mg 1 ()-4-amino-3-(4-chlorophenyl)butyric acid lactam 0653 100 mg 1 1293 500 mg 1 0170 n/a 1 1975 150 mg 1 99.1% CHClO 0654,0809,1449, 1709 10 mg 1 1709 10 mg 1 0654,1709 10 mg 1 0654,1709 100 mg 1 0370 5 mg 1 0370 50 mg 1 1601 360 mg 1 1601 100 mg 1 1010,1172,1254, 1708 50 mg 1 1173 20 mg 1 ()-2-amino-3-hydroxypropanohydrazide 1173 10 mg 1 1393 125 mg 1 90.7% CHNOS 0373 24.1% CHN (N,N' - dibenzylethylenediamine) +5C +5C +5C +5C
B0505000 B0550000 B0600000 New Y0000647 Y0000167 B0670000 B0680000 B0700000 B0900000 4 1 1 200 mg 50 mg 100 mg 1 1 1
Benzbromarone - reference spectrum Benzethonium chloride Benzocaine Benzophenone Benzyl alcohol Benzyl benzoate - reference spectrum S-Benzylmercaptoacetyltriglycin Benzylpenicillin potassium Benzylpenicillin sodium
n/a 1 1 1 1 n/a 1 1 7
n/a 100 mg 50 mg 40 mg 50 mg n/a 10 mg 50 mg 200 mg
1 1 1 1 1 1 1 1 1
99.4% CHNNaOS; Penicillin G sodium 88.4% [CHO] ; Batch 3 is valid until 31 March 2006
+5C +5C +5C +5C +5C +5C
l a a a a l a a a a a a For extra charges please see 2.2
B0950000 Betadex Y0000391 Betahistine dihydrochloride B0990000 Betahistine mesilate
1393 0974 0011,1088 1784 0256 0705 1372 0113,0148,0149 0113,0114,0148, 0149 1070,1487,1804 1665 1071
Catalogue No. 48-2006/4 Batch 4 1 1 3 2 2 1 2 1 1 2 1 1 1 100 mg 100 mg 100 mg 100 mg 15 mg 60 mg 10 mg 100 mg 100 mg 10 mg 50 mg 60 mg 30 mg 1 1 1 1 1 1 1 1 1 1 1 1 1 +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C a a a a a a a a a a a a a +5C Information Unit Sale Quantity Unit 75 mg 1 Batch 3 is valid until 31 May 2006 Monograph Leaflet Storage Extra charges a 0312,0354,0388, 0561 0548,0975 0809 Batch 2 is valid until 30 April 2006 0549,0810 0322,0811 0811 1072 ()-3-(4-ethylphenoxy)-1-[(1-methylethyl)amido]propan-2-ol 1072 1394 1395 Bifonazole impurity B trifluoroacetate 1395 Vitamin H 1073 1074 (1RS)-1-[(1SR,2SR,4SR)-bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl- 1074 3-(piperidin-1-yl)propan-1-ol (endo form) 0562 0595 0595 0595 0976,20702 1396 See leaflet,20716
6 December 2006
Order Code B1000000 Betamethasone
Reference Standard
B1030000 B1040000 B1045000 B1054000 B1055000 B1103000 B1103100 B1115000 B1110000 B1110004 B1116000 B1120000 B1121000
Betamethasone acetate Betamethasone dipropionate Betamethasone sodium phosphate Betamethasone-17-valerate Betamethasone-21-valerate Betaxolol hydrochloride Betaxolol impurity A Bezafibrate Bifonazole Bifonazole impurity B Biotin Biperiden hydrochloride Biperiden impurity A
B1130000 New B1140000 Y0000608 Y0000694 B1141000 Batch 1 is valid until 31 December 2006 1 1 30 mg 0.5 mg 1 1
1,3-bis(2-acetyl-3-hydroxyphenoxy)-2-propanol Bisacodyl Bisacodyl for peak identification Bisacodyl for system suitability Bleomycin sulphate
1 2 1 1 1
50 mg 50 mg 10 mg 5 mg 7 mg
1 1 1 1 1
Yes Yes
+5C +5C +5C +5C -20C
a a a a a
Y0000434 Boldine B1142000 Bordetella pertussis mouse antiserum BRP
8910 IU per vial; bleomycin A : 67.0%; Bleomycin B : 29.2%; demethylbleomycin A : 2.6% 99.4% CHNO Anti-PT: 19.5 ELU/vial Anti-FHA: 69 ELU/vial Anti-69k: 17 ELU/vial Anti-Fim 2/3: 28 ELU/vial
Yes
+5C -20C
a c
Yes
B1143000 New Y0000645 B1145000 Y0000200 B1150000 New Y0000677 B1152000 B1152050 B1153000 Y0000468 Y0000470
Bromazepam - * psy Bromazepam for system suitability - * psy Bromhexine hydrochloride Bromhexine impurity C Bromocriptine mesilate Bromocriptine mesilate for system suitability Bromperidol Bromperidol decanoate Brompheniramine maleate Brotizolam - * psy Brotizolam impurity B
3 1 2 2 2 1 1 1 1 1 1
60 mg 10 mg 100 mg 10 mg 30 mg 5 mg 100 mg 60 mg 100 mg 10 mg 10 mg
1 1 1 1 1 1 1 1 1 1 1
0778,0879 0879 0706 N-(2-aminobenzyl)-N-methylcyclohexanamine 0706 0596 0596 0616,1178 1397,1431 0977,1196 2197 2-bromo-4-(2-chlorophenyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3- 2197 a][1,4]diazepine (demethylbrotizolam) 1 mg 110 mg 1 1 99.8% CHO 0793 1075
Yes
+5C +5C +5C +5C -20C -20C +5C +5C +5C +5C +5C Yes +5C +5C
j j a a g g a a a j a f a For extra charges please see 2.2
B1155000 Brucella melitensis Rev. 1 strain BRP - * Biotox B1157300 Budesonide
1 3
Catalogue No. 48-2006/4 Batch 1 2 2 1179 1398 1398 +5C +5C +5C Information Unit Sale Quantity Unit 100 mg 1 100 mg 1 20 mg 1 4-(pyrrolidin-1-yl)-1-(4-hydroxy-2,6-dimethoxyphenyl)butan-1one Monograph Leaflet Storage Extra charges a a a 150 mg 5 mg 5 mg 100 mg 20 mg 20 3-nitro-4-phenoxy-5-sulphamoylbenzoic acid 3-amino-4-phenoxy-5-sulphamoylbenzoic acid (2RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide 6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide ; Batch 1 is valid until 30 April 2007 1 1 1 1 1 1 1076 1076 1076 0541 0541 0541 +5C +5C +5C +5C +5C +5C a a a g g G
6 December 2006
Order Reference Standard Code B1156000 Bufexamac B1157400 Buflomedil hydrochloride B1157410 Buflomedil impurity B 1 1 1 1 1 2
B1158000 Y0000309 Y0000310 B1160000 Y0000088 New Y0000089
Bumetanide Bumetanide impurity A Bumetanide impurity B Bupivacaine hydrochloride Bupivacaine impurity B Bupivacaine impurity E
4.92 mg per vial of CHNO
-20C
B1160490 B1160500 B1168000 Y0000357 B1168020 Y0000131 Y0000471 B1170000 B1217000 B1212000 B1215000 Plastic additive 07 99.8% CHNO 95.6% CHO
Buprenorphine - reference spectrum Buprenorphine hydrochloride - reference spectrum Buserelin Buserelin - Reference spectrum D-His-Buserelin Buspirone hydrochloride Buspirone for system suitability Busulfan Butyl parahydroxybenzoate Butylhydroxyanisole Butylhydroxytoluene
n/a n/a 1 n/a 1 1 1 1 1 3 1
n/a n/a 4.92 mg n/a 0.5 mg 5 mg 2 mg 50 mg 50 mg 50 mg 50 mg
1 1 1 1 1 1 1 1 1 1 1
-20C +5C +5C +5C +5C +5C +5C -20C +5C -20C
l l c l c g g a a a a
Y0000472 C0100000 C0166000 C0166001 Y0000499 Y0000473 Y0000474 C0200000 93.9% CHO 1 3 6 0.4 ml 0.1 mg 10 mg 1 1 1
Cabergoline Caffeine Calcifediol Calcifediol - reference spectrum Calcipotriol (anhydrous) - reference spectrum Calcipotriol monohydrate Calcipotriol monohydrate - reference spectrum Calcitonin (salmon)
1 3 1 n/a n/a 1 n/a 7
100 mg 100 mg 5 mg n/a n/a 5 mg n/a 0.98 mg
1 1 1 1 1 1 1 2
1180 1181 1077 1077 1077 1711 1711 0542 0881, 1216 0880 0581,30103,30105, 30106,30107 1773 0267,0268 1295 1295 2011 2011,2284 2284 0471 0471 0471 0883
Yes
+5C -20C -20C -20C -20C
c g c l l f l c c c c
Y0000632 Calcitonin-Gly C0200010 N-acetyl-cys1-calcitonin C0225000 Calcitriol
0.98 mg per vial of CHNOS ; Batch 6 is valid until 31 October 2006 About 0.9 mg per ml Batch 2 is valid until 31 March 2006 100.0% CHO ; Batch 5 is valid until 28 February 2007 Batch 4 is valid until 31 December 2005
C0226000 Calcitriol - reference spectrum C0249000 Calcium ascorbate - reference spectrum C0250000 Calcium folinate
n/a n/a 3
n/a n/a 125 mg
1 1 1
84.6% CHCaNO
0883 1182 0978,1606
+5C
l l a For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch 1 1 +5C +5C Unit Sale Quantity Unit 60 mg 1 100 mg 1 Calcium digluconate Information Monograph Leaflet Storage Extra charges a a
6 December 2006
Order Reference Standard Code C0299000 Calcium glucoheptonate C0300000 Calcium gluconate
Loss of 12.1% m/m Batch 2 is valid until 31 July 2006 Yes Batch 2 is valid until 31 May 2006 98.6 % CHNO
C0340000 C0350000 C0400000 C0405000 C0410000 C0426000 Y0000671 C0430000 Y0000113 C0450000 Y0000033 99.9% CHNO ; Batch 2 is valid until 31 August 2006 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide (10,11-dihydrocarbamazepine) ; Batch 4 is valid until 28 February 2007 Batch 3 is valid until 30 June 2006
Calcium levulinate dihydrate Calcium oxalate monohydrate Calcium pantothenate Camphor (racemic) Canrenone Caprylic acid Capsaicin Captopril Carbachol Carbamazepine Carbamazepine impurity A
1 1 3 1 3 1 1 2 1 3 5
1 1 1 1 1 1 1 1 1 1 1
1399 0172,0658,0979, 1047,1399 1296 20234 0470 0655 0688 1401,1471 1859,2336,2337 1079 1971 0543 0543 +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C a a a a a a g a a a a
l +4C +5C +5C +5C
C0451000 C0455000 C0460000 C0465000 C0470000 C0499900 C0550000 Y0000475 Y0000536 Y0000035 Y0000036
Carbasalate calcium - reference spectrum Carbenicillin sodium Carbidopa Carbimazole Carbocisteine Carbon dioxide - reference spectrum Carboplatin - reference spectrum Carboprost trometamol Carboprost trometamol - reference spectrum Carisoprodol Carisoprodol impurity A
n/a 2 1 1 1 n/a n/a 1 n/a 1 1
n/a 50 mg 50 mg 100 mg 50 mg n/a n/a 40 mg n/a 50 mg 10 mg
1 1 1 1 1 1 1 1 1 1 1
(2RS)-2-(hydroxymethyl)-2-methylpentyl(1-methylethyl)carbamate 1,3-bis(2-chloroethyl)urea
1185 812,956 0755 0884 0885 0375 1081 1712 1712 1689 1689
-20C +5C +5C
a a a l l c l a a
-20C Yes +5C
C0580004 C0580010 Y0000192 Y0000193 Y0000075 Y0000103 2 2 1 1
Carmustine - reference spectrum Carmustine impurity A Carteolol hydrochloride - reference spectrum Carteolol for system suitability Carvedilol - reference spectrum Carvedilol impurity C
n/a 1 n/a 1 n/a 1
n/a 20 mg n/a 30 mg n/a 10 mg
1 1 1 1 1 1
(2RS)-1-[benzyl[2-(2-methoxyphenoxy)ethyl]amino]-3-(9Hcarbazol-4-yloxy)propan-2-ol
1187 1187 1972 1972 1745 1745 0350 95.0% CHClNOS 0986
+5C +5C +5C
l c l a l a a c For extra charges please see 2.2
C0600000 Casein BRP
C0630000 Cefaclor
100000 mg 450 mg
Catalogue No. 48-2006/4 Batch 2 2 2 2 1 1 Yes 0986 0260,0577,0813 0708 0987 0987 1402 -20C +5C +5C +5C +5C +5C Monograph Leaflet Storage
6 December 2006
Order Code C0640000 C0650000 C0675000 C0682000 Y0000505 C0682300
Reference Standard
Delta-3-Cefaclor Cefadroxil Cefalexin monohydrate Cefalotin sodium Cefalotin for impurity B identification Cefamandole nafate
Extra charges c a a a a a
Y0000240 Cefapirin sodium C0682400 Cefatrizine propylene glycol C0682410 Cefatrizine impurity A
1 1 1
Information Unit Sale Quantity Unit 30 mg 1 250 mg 1 93.7% CHNOS 150 mg 1 94.1% CHNOS 100 mg 1 98.8% CHNNaOS 10 mg 1 125 mg 1 94.4% CHNNaOS (cefamandole nafate) corresponding to: 85.2% CHNOS (cefamandole) 4.4% CHNOS (cefamandole free acid) 100 mg 1 98.5% CHNNaOS 150 mg 1 81.8% CHNOS 60 mg 1 7-amino-(6R,7R)-3-[(2H-1,2,3-triazol-4-yl)sulfanyl]-methyl-8oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (7-ACA triazole) 150 mg 1 99.4% CHNOS 150 mg 1 95.2% CHClNOS 1650 1403 1403 +5C +5C +5C a a a Yes 88.4% CHNOS 93.6% CHNOS 94.3% CHNOS Batch 3 is valid until 31 May 2007 98.4% CHNNaOS 94.2% CHNOS (Cefradine) 1.8% CHNOS (Cefalexin) 85.5% CHNOS 83.1% CHNOS; (6R,7R)-7-[[(Z)-2-(2-aminothiazol-4-yl)-2-[(1-carboxy-1-methyl ethoxy)imino]acetyl]amino]-8-oxo-3-[(1-pyridinio)-methyl]-5thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylate (delta-2-ceftazidime) ; Batch 1 is valid until 30 June 2006 90.4% CHNNaOS ; Batch 2 is valid until 31 August 2006 E-isomer 96.9% CHNOS 96.6% CHNNaOS 1 1 1 1 1 1 1 1 1-acetyl-1-(4-ethoxyphenyl)-3,3-diethylurea +5C +5C +5C -20C +5C
C0682800 Y0000633 Y0000634 C0684000 C0684750 C0684800 Y0000420 New C0685000 Y0000506 C0688000 C0690000 15 mg 200 mg 100 mg n/a 80 mg 30 mg 10 mg 250 mg 300 mg 6 mg 200 mg 15 mg 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2
Cefazolin Cefepime dihydrochloride monohydrate Cefepime dihydrochloride monohydrate for system suitability Cefixime Cefoperazone dihydrate Cefoperazone sodium - reference spectrum Cefotaxime acid Cefotaxime sodium Cefotaxime sodium for peak identification Cefoxitin sodium Cefradine
2 1 1 2 1 n/a 1 4 1 2 3
Yes
+5C +5C +5C +5C +5C Yes +5C +5C +5C
a a a c a l a a a a a a a a
Y0000568 Cefradine for peak identification C0690500 Ceftazidime C0690510 Ceftazidime impurity A
0988 2126 2126 1188 1404 1404 0989 0708,0989 0989 0990 0167,0168,0578, 0708,0814 0814 1405 1405
C0691000 Ceftriaxone sodium C0692000 Ceftriaxone impurity A C0694990 Cefuroxime axetil C0695000 Cefuroxime sodium Y0000311 Celiprolol hydrochloride Y0000312 Celiprolol impurity I Y0000239 Celiprolol for peak identification C0698000 Cellulose acetate - reference spectrum Council of Europe, all rights reserved 2006
3 3 2 2 1 1 1 n/a
80 mg 10 mg 60 mg 150 mg 10 mg 0.02 mg 20 mg n/a
0991 +5C a 0991 +5C a 1300 +5C a 0988,0992 +5C a 1632 +5C a 1632 +5C a 1632 Yes +5C a 0887 l For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch n/a n/a 2 +5C Unit Sale Quantity Unit n/a 1 n/a 1 10 mg 1 Information Monograph Leaflet Storage Extra charges l l a
6 December 2006
Order Reference Standard Code C0698005 Cellulose acetate butyrate - reference spectrum C0698020 Cellulose acetate phthalate - reference spectrum C0700000 Cephaline hydrochloride
(RS)-1-[(4-chlorophenyl)phenylmethyl]piperazine 100% CHO
C0980650 C0980651 C0984100 C0990000
Cetirizine dihydrochloride Cetirizine impurity A Cetostearyl isononanoate - reference spectrum Cetyl alcohol
3 3 n/a 1
100 mg 10 mg n/a 250 mg
1 1 1 1
+5C +5C +5C
a a l a
Y0000073 Y0000074 C1000000 C1050000 Y0000104 C1100000 C1200000 C1300000 C1350000 C1400000 C1425000 C1435000 C1450000 C1500000 Y0000476 91.1% CHClNNaO 7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 4-oxide Batch 1 is valid until 28 February 2006
Cetyl palmitate 15 Cetyl palmitate 95 Cetylpyridinium chloride Chenodeoxycholic acid Chitosan hydrochloride Chlorambucil Chloramphenicol Chloramphenicol dipalmitate Chloramphenicol disodium disuccinate Chloramphenicol palmitate isomer Chloramphenicol sodium succinate Chlorcyclizine hydrochloride Chlordiazepoxide - * psy Chlordiazepoxide hydrochloride - * psy Chlordiazepoxide impurity A
1 1 1 1 1 1 2 1 3 1 1 1 1 1 1
60 mg 50 mg 50 mg 125 mg 30 mg 100 mg 500 mg 100 mg 25 mg 100 mg 1500 mg 100 mg 50 mg 100 mg 10 mg
1 1 1 1 1 1 1 1 1 1 1 1 2 1 1
1406 0314 0080,0081,0093, 0094,1530,1875 1084 1084 1085 0540,0702,0801, 0802,0847,0969, 1411 1906 1906 0379 1189,1275 1774 0137 0071,0473,0709 0473 0709 0473 0709 1086 0656,1974 0474 0474,0656 +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C a a a a a g a a a a a a j j a
Yes
C1510000 C1520000 C1540000 C1530000 Y0000569 96.9% CHO
Chlorhexidine Chlorhexidine diacetate Chlorhexidine dihydrochloride Chlorhexidine for performance test Chlorogenic acid
4 2 1 4 1
50 mg 10 mg 50 mg 30 mg 20 mg
1 1 1 1 1
+5C +5C +5C +5C +5C
g g a a a
C1600000 C1605000 C2223030 C1650000 C1700000 C1800000
Chloromethylnitroimidazole (2-Chlorophenyl)diphenylmethanol 1-(4-Chlorophenyl)-1-phenylethanol Chloroquine sulphate Chlorothiazide Chlorphenamine maleate
1 5 1 3 1 1
100 mg 20 mg 20 mg 200 mg 100 mg 100 mg
1 1 1 1 1 1
Batch 4 is valid until 31 January 2006 Clemastine fumarate impurity C Batch 2 is valid until 31 July 2006
0658 0657 0659 0657,0658,0659 0897,1823,1824, 1866 0369 0757 1190 0544,0545 0385,0394 0386,0977,1084, 1196
+5C +5C -20C +5C +5C +5C
a a c a a a For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch 1 1 1 1 1 10 mg 1 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1amine S-oxide (chlorpromazine sulphoxide) 3-(2-chloro-10H-phenothiazin-10-yl)-N-methypropan-1-amine (demethylchlorpromazine) 2-chloro-10H-phenothiazine 0475 1,3-Dipropylurea 2.0% E-isomer 0475 1087 1087 0815,1365 0546 0546 200 mg 10 mg 1 1 0475,20303 0475 +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C Yes -20C -20C 0386 +5C a a a a a a a g a a a c c 0386 +5C Monograph Leaflet Storage Extra charges a
6 December 2006
Order Reference Standard Code Y0000436 Chlorphenamine impurity A
Y0000437 Chlorphenamine impurity C
Information Unit Sale Quantity Unit 10 mg 1 2-(4-chlorophenyl)-4-(dimethylamino)-2-[2-(dimethylamino) ethyl]butanenitrile 10 mg 1 (3RS)-3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1amine
C1900000 Chlorpromazine hydrochloride Y0000507 Chlorpromazine impurity A
Y0000479 Chlorpromazine impurity D 1 1 1 4 1 5 4 6 4 1 ml 1 500 mg 1 100 mg 1 10 mg 100 mg 50 mg 50 mg 50 mg 10 mg 1 1 1 1 1 1
Y0000508 C1905000 C1905020 C1915000 C1950000 C1950020
Chlorpromazine impurity E Chlorpropamide Chlorpropamide impurity B Chlorprothixene hydrochloride Chlortalidone Chlortalidone impurity B
C2000000 Chlortetracycline hydrochloride
C2100000 Cholecalciferol
C2150000 Cholecalciferol for performance test
C2155000 C2158000 Y0000280 Y0000593 C2160000 New Y0000639 New Y0000609 New Y0000610 Y0000040 C2162701
Cholesterol Cholic acid Chondroitin sulphate sodium Chondroitin sulphate sodium (marine) Chymotrypsin BRP Cladribine Cladribine for peak identification Cladribine impurity C Ciclopirox Ciclopirox impurity A
2 1 1 1 2 1 1 1 1 2
60 mg 60 mg 250 mg 100 mg 100 mg 50 mg 10 mg 5 mg 100 mg 20 mg
1 1 1 1 1 1 1 1 1 1
2-(4-chloro-3-sulfamoylbenzoyl)benzoic acid ; Batch 4 is valid until 31 December 2005 89.7% CHClNO 0173 5.5% CHClNO 100% CHO; Vitamin D3 ; Batch 5 is valid until 28 February 2007 0072,0574,0575, 0598,1192,1193 0072,0082,0574, 0575,0598 99.2% CHO 0993 1189,1275 100% HO(CHNNaOS) 2064 2064 6.01 microkatals per mg 0476,0694 99.1% CHClNO 2174 2174 2-chloro-7H-purin-6-amine 21-74 1407 ()-2-(3-cyclohexyl-5-methyl-4,5-dihydroisoxazol-5-yl)acetic 1302,1407 acid 6-cyclohexyl-4-methyl-2-pyran-2-one 1302,1407 1 1 1 1 1 1 98.8% CHNO 1302 0994 0994 1408 1499
Yes
+5C +5C +5C +5C +5C +5C +5C +5C +5C +5C -20C +5C +5C +5C +5C +5C
a a a a a b b b a a c g a a a a For extra charges please see 2.2
C2162702 C2162700 C2163000 Y0000361 C2170000 C2174000
Ciclopirox impurity B Ciclopirox olamine Ciclosporin Ciclosporin for system suitability Cilastatin sodium Cilazapril
2 1 2 1 2 1
20 mg 150 mg 120 mg 5 mg 10 mg 50 mg
Catalogue No. 48-2006/4 Batch 1 +5C Leaflet Storage Extra charges a
6 December 2006
Order Reference Standard Code C2174002 Cilazapril impurity A
C2174005 Cilazapril impurity D
Information Unit Sale Monograph Quantity Unit 25 mg 1 1,1-dimethylethyl(1S,9S)-9-[[(S)-1-ethoxycarbonyl-3-phenylpro 1499 pyl]amino]-10-oxo-octahydro-6H-pyridazino[1,2a][1,2]diazepine -1-caboxylate 25 mg 1 (1S,9S)-9-[[(R)-1-ethoxycarbonyl-3-phenylpropyl]amino]-101499 oxo-octahydro-6H-pyridazino[1,2a][1,2]diazepine-1-carboxylic acid +5C a
C2175000 C2175500 C2177000 Y0000176 C2180000 Y0000362 Y0000363 Y0000198 C2190000 Y0000199 C2190050
Cimetidine Cimetidine hydrochloride Cinchocaine hydrochloride Cineole Cinnarizine Ciprofibrate Ciprofibrate for system suitability Ciprofloxacin Ciprofloxacin hydrochloride Ciprofloxacin hydrochloride for peak identification Ciprofloxacin impurity A
1 1 1 1 1 1 1 1 3 1 4
1 1 1 1 1 1 1 1 1 1 1
0756 1500 1088 1973 0816 2013 2013 1089 93.6% CHClFNO 0888,1353 0888,1089 7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3- 0888,1089 carboxylic acid (fluoroquinolonic acid) ; Batch 3 is valid until 30 April 2006
Yes
+5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C
a a a g a a a a a a a
100% [PtCl(NH)]
97.5% CHNO ; Batch 1 is valid until 30 November 2006
C2205000 C2205100 C2210000 A1202000 C2219000 Y0000320 Y0000321 Y0000269 Y0000262 C2221000 C2223000 C2248000 C2248010 3 2 1 n/a 1 200 mg 250 mg 5 mg n/a 10 mg 1 1 1 1 1
Cisapride monohydrate Cisapride tartrate Cisplatin Citric acid (anhydrous) Citric acid monohydrate Clarithromycin Clarithromycin for peak identification Clazuril for system suitability Clazuril for veterinary use - reference spectrum Clebopride malate Clemastine fumarate Clenbuterol hydrochloride Clenbuterol impurity B
1 1 2 1 1 2 1 1 n/a 1 1 1 1
30 mg 100 mg 150 mg 50 mg 50 mg 160 mg 30 mg 10 mg n/a 100 mg 100 mg 50 mg 20 mg
1 1 1 1 1 1 1 1 1 1 1 1 1
C2250000 C2269000 Y0000364 Y0000205 Y0000241
Clindamycin hydrochloride Clindamycin phosphate Clioquinol Clobazam - reference spectrum Clobazam impurity A
1-(4-amino-3,5-dichlorophenyl)-2-[(1,1-dimethylethyl)amino] ethanone (clenbuterol ketone) 93.3% CHClNOS 95.7% CHClNOPS ; Batch 1 is valid until 31 January 2006
0995 1503 0599 0455 0456 1651 1651 1714 1714 1303 1190 1409 1409 0582,0583,0996 0996 2111 1974 1974 7-chloro-5-phenyl-1,5-dihydro-1,5-dihydro-3H-1,5-benzodiazepine-2,4-dione
Yes Yes
+5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C
a a g a a a a a l a a a a a a g l a
For extra charges please see 2.2
6 December 2006
Reference Standard
Yes
Yes
Order Code Y0000559 Y0000570 Y0000571 C2285000 Y0000313 Y0000358 C2300000 C2320000 C2332000 C2360000 Y0000132 1 1 1 1 1 1 1 2 1 1 1 Yes 2127 2127 2127 1090 2054 2054 0318 0997,1046 0997 0889 0889 +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C
Clobetasol propionate Clobetasol for peak identification Clobetasol impurity J Clobetasone butyrate Clofazimine Clofazimine for system suitability Clofibrate Clomifene citrate Clomifene citrate for performance test Clomipramine hydrochloride Clomipramine impurity C
Extra charges a a a a a a a a a a a
Y0000133 Clomipramine impurity D
Information Unit Sale Quantity Unit 40 mg 1 99.6% CHClFO 2 mg 1 0.4 mg 1 50 mg 1 150 mg 1 10 mg 1 0.5 ml 1 50 mg 1 44% of Z-isomer ; Batch 1 is valid until 31 December 2006 50 mg 1 100 mg 1 10 mg 1 94.5% Clomipramine impurity C; 3-(3-chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1amine 10 mg 1 3-(3,7-dichloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,Ndimethylpropan-1-amine 5 mg 1 3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine 0889 +5C a 2-Amino-2'-chloro-5-nitrobenzophenone 3-Amino-4-(2-chlorophenyl)-6-nitro-1-quinolin-2-one +5C +5C +5C +5C
Y0000134 C2385000 C2385010 C2385015 Y0000286 C2400000 Y0000392 Y0000393 C2424400 50 mg 25 mg 25 mg n/a 100 mg 20 mg 20 mg 1 mg see information on the accompanying leaflet 1 mg 1 mg 1 mg 1 15 IU per vial 1 34 IU per vial 3 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 n/a 1 1 1 1
Yes Yes Yes See leaflet,0697 See leaflet,0697 Yes Yes
+5C +5C +5C -20C -20C -20C -20C
a j a a l a a a c c c c
C2424550
0.20 IU per vial (determined using toxin neutralisation test)
0889 1974 0890 0890 0890 0477 1716 1716 0362,0363,0364, 0697 20708
C2424500
C2425600
C2430000 C2450000 1 n/a 1 n/a 2 60 mg n/a 40 mg n/a 10 mg 1 1 1 1 1
Clomipramine impurity F Clonazepam - * psy Clonazepam impurity A Clonazepam impurity B Clonazepam - reference spectrum Clonidine hydrochloride Closantel sodium dihydrate Closantel for system suitability Clostridia (multi-component) rabbit antiserum(for vaccines-vet.use)BRP Clostridium tetani guinea pig antiserum (for vaccines human use) BRP Clostridium tetani guinea pig antiserum (for vaccines - vet. use) BRP Clostridium tetani rabbit antiserum (for vaccines - vet. use) BRP Clotrimazole Cloxacillin sodium 2 3 100 mg 125 mg 1 1 94.6% CHClNNaOS
C2460000 Y0000162 C2480000 C2500000 Y0000334
Clozapine Cocaine hydrochloride - reference spectrum Cocoyl caprylocaprate Codeine - reference spectrum Codeine impurity A (methylcodeine)
7,8-didehydro-4,5 -epoxy-3,6 -dimethoxy-17-methylmorphinan
0757 +5C g 0661,0663,0668, +5C a 2260 1191 +5C g 0073 l 1411 +5C a 0074,0075,0076 l 0074,0075,0076, +5C a 1412 For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch n/a 1 1 1 1 1 3 Yes +5C +5C +5C +5C +5C -20C 1412 1416,2060 0758 0758 1775 0319,20702 0320 Monograph Leaflet Storage
6 December 2006
Order Code C2500100 C2510000 C2580000 Y0000209 Y0000374 C2600000 Y0000277
Reference Standard
Codeine hydrochloride dihydrate - reference spectrum Codergocrine mesilate Colchicine Colchicine for system suitability Colestyramine Colistimethate sodium Colistin sulphate (for LC assay)
Information Unit Sale Quantity Unit n/a 1 60 mg 1 50 mg 1 50 mg 1 10 mg 1 100 mg 1 12850 IU per mg 25 mg 1 33.7% colistin E2, 2.6% colistin E3, 3.3% colistin E1-I, 3.1% colistin E1-7MOA, 44.2 % colistin E1. 25.0 mg of colistin sulphate per vial 25 mg 1 576 000 IU per vial; For microbiological assay only Extra charges l a a a a a a Yes -20 C
C2700000 C2725000 C2800000 Y0000438 C2900000 n/a 250 mg 80 mg 1000 mg 99.9% CHO 1 1 1 1
Colistin sulphate for microbiological assay Copovidone - reference spectrum Cortisone acetate Coumarin Cotton wool. standard for neps
2 n/a 5 1 1
0891 0321,0736,0767 2120 0036
+5C +5C Room temp.
a l a a a
C2950000 C2970000 C2970005 C3000000
Crospovidone - reference spectrum Crotamiton Crotamiton impurity A Cyanocobalamin
n/a 1 2 4
n/a 100 mg 30 mg 20 mg
1 1 1 1
98.9%CHNO(sum of E and Z-isomers); 2.9% Z-isomers N-ethyl-N-(2-methylphenyl)but-3-enamide Vitamin B12 ; Batch 3 is valid until 31 July 2006
Batch 1 is valid until 30 September 2006
98.0% CHClNO Daunorubicin aglycone Batch 1 is valid until 30 April 2006
C3090000 Cyclizine hydrochloride C3200000 Cyclobenzaprine hydrochloride C3230000 Cyclohexa-1,4-dienylglycine C3245000 Cyclopentolate hydrochloride C3250000 Cyclophosphamide C3280000 Cyproheptadine hydrochloride C3283000 Cyproterone acetate C3290000 Cysteine hydrochloride monohydrate C3300000 Cystine C3350000 Cytarabine D0070000 Dalteparin sodium Y0000600 Danaparoid sodium D0100000 Dapsone D0125000 Daunorubicin hydrochloride D0120000 Daunorubicinone D0160000 Deferoxamine mesilate D0201000 Dehydrohexetidine Y0000611 Dembrexine hydrochloride monohydrate D0300000 Demeclocycline hydrochloride Council of Europe, all rights reserved 2006 92.4% CHClNO
1 1 1 1 1 1 2 1 1 1 2 1 2 3 2 2 1 1 4
50 mg 100 mg 80 mg 60 mg 50 mg 30 mg 30 mg 50 mg 100 mg 150 mg 250 mg 200 mg 100 mg 100 mg 10 mg 30 mg 50 mg 10 mg 100 mg
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
0892 l 1194 -20C c 1194 -20C c 0269,0270,0547, +5C a 0710,1505 1092 +5C a 0408,0464 +5C a 0814 +5C a 1093 +5C a 0711 +5C a 0817,0846 +5C a 1094 +5C g 0895 +5C a 0998 +5C a 0760 +5C a 0828 +5C a 2090 +5C b 0077 +5C a 0662 +5C a 0662 +5C a 0896 -20C a 1221 +5C a 2169 +5C a 0176 +5C a For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch 2 +5C Information Unit Sale Quantity Unit 10 mg 1 Batch 1 is valid until 31 March 2006 Monograph Leaflet Storage Extra charges a
6 December 2006
Order Reference Standard Code D0350000 N-Demethylerythromycin A
Y0000228 D0406000 D0406200 D0430000 D0431000 D0480000 D0500000 D0600000 D0630000 D0650000 98.8% CHO 0.98 mg per vial of CHNOS ; Batch 5 is valid until 30 November 2006 99.9% CHO +5C +5C +5C +5C -20C +5C +5C +5C -20C
Demethylflumazenil - reference spectrum Deoxyminoxidil Deptropine citrate Dequalinium chloride Dequalinium chloride for performance test Desacetylvinblastine Desipramine hydrochloride Deslanoside Desmethylmetrifonate Desmopressin
n/a 4 1 1 1 1 1 2 1 6
n/a 0.25 mg 60 mg 50 mg 50 mg 1 mg 100 mg 150 mg 30 mg 0.98 mg
1 1 1 1 1 2 1 1 1 1
0179,0274,0490, 0552,1098 1917 0937 1308 1413 1413 1276 0481 0482 1133 0712 l a a a a c a a a c
Y0000509 Desogestrel Y0000510 Desogestrel for system suitability D0400000 Desoxycortone acetate
1 1 1
50 mg 10 mg 250 mg
1 1 1
Yes
+5C +5C +5C
a a a
Y0000001 Detomidine hydrochloride D0660020 Detomidine impurity B New D0700000 Dexamethasone 2 1 1 1 3 1 3 1 1 10 mg 10 mg 50 mg 50 mg 60 mg 5 mg 25 mg 50 mg 1 1 1 1 1 1 1 1 100 mg 1
1 1 4
100 mg 20 mg 60 mg
1 1 1
(RS)-(1-benzyl-1H-imidazol-5-yl)(2,3-dimethylphenyl)methanol Batch 3 is valid until 30 April 2007
+5C +5C +5C +5C
a a a a
D0710000 Dexamethasone acetate
Y0000538 Y0000511 D0718000 D0720000 D0720800 D0730000 D0731000 D0731005
Dexamethasone isonicotinate Dexamethasone isonicotinate for impurity C identification Dexamethasone pivalate Dexamethasone sodium phosphate Dexchlorpheniramine maleate Dexpanthenol Dextran Dextran 1
Average molecule mass : 930-1000 Fraction with less than 3 glucose units : 8.0 to 10.5% Fraction with more than 9 glucose units : 10.0 to 12.5% M M M M M 3050-M 3850 88000 - M 10450 30500- M 40900 58900- M 70300 121800- M 238200
1717 1717 0322,0809,0850, 1327 1414 1414 0312,0388,0768, 1376,2237 0548,0933,0975, 2237 2237 2237 1327 0549,0735,0810 1196 0761 0999,1000,1001 1506
Yes
+5C +5C +5C +5C +5C +5C +5C +5C
a a a a a a a a
D0732000 D0733000 D0734000 D0735000 D0736000 D0737000
Dextran Vo Dextran 4 for calibration Dextran 10 for calibration Dextran 40 for calibration Dextran 70 for calibration Dextran 250 for calibration
1 1 1 1 1 1
10 mg 50 mg 50 mg 50 mg 50 mg 50 mg
1 1 1 1 1 1
20239 20239 20239 20239 20239 20239
+5C +5C +5C +5C +5C +5C
a a a a a a For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch +5C +5C +5C +5C Monograph Leaflet Storage
6 December 2006
Reference Standard
Yes
+5C +5C +5C +5C +5C +5C +5C +5C +5C +5C
Order Code D0738000 D0739000 D0740000 Y0000261 D0750000 D0940000 Y0000596 D0950000 D0970000 D1000000 Y0000480 Y0000481 D1010000 New Y0000275 Y0000259 Y0000264 D1039990 D1040000 D1050000 D1060000 Y0000439 Y0000440 Y0000441 Y0000442 1 1 3 1 n/a 1 1 1 2 1 1 1 1 2 1 n/a 2 3 3 1 1 1 1 1 Yes +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C 20239 20239 0020 0020 0713 0022 0022 0550 0817 0464,0941 2300 2300 0762 2017 1718 1718 1508 1002,1281,1508 0661,0663,0668 1197 2200 2200 2200 2200
Dextran 40 for performance test Dextran 60/70 for performance test Dextromethorphan hydrobromide Dextromethorphan impurity A Dextropropoxyphene hydrochloride - reference spectrum Diazepam - * psy Diazepam for system suitability - * psy Diazoxide Dibenzocycloheptene Dibenzosuberone Dibrompropamidine diisetionate Dibrompropamidine for system suitability Dibutyl phthalate Dichlorodiaminocyclohexaneplatinum Diclazuril for system suitability Diclazuril for veterinary use - reference spectrum Diclofenac potassium Diclofenac impurity A Dicloxacillin sodium Dicycloverine hydrochloride Didanosine Didanosine for system suitability Didanosine impurity A Didanosine impurity G
Information Unit Sale Quantity Unit 50 mg 1 50 mg 1 100 mg 1 Batch 2 is valid until 30 April 2006 5 mg 1 (S,13S,14S)-3-methoxymorphinan n/a 1 30 mg 1 0.5 mg 1 50 mg 1 20 mg 1 100 mg 1 10 mg 1 20 mg 1 1 ml 1 10 mg 1 Batch 1 is valid until 30 April 2007 20 mg 1 n/a 1 100 mg 1 5 mg 1 1-(2,6-dichlorophenyl)indolin-2-one 250 mg 1 93.7% CHClNNaOS 100 mg 1 10 mg 1 10 mg 1 10 mg 1 1,7-dihydro-6H-purin-6-one (hypoxanthine) 10 mg 1 9-(2,3-dideoxy--D-glycero-pentofuranosyl)-9H-purin-6-amine (2',3'-dideoxyadenosine) 150 mg 1 100% CHO Extra charges a a g g l j j a a a a a a g a l a a a a a a a a
100% CHO. Dried at 100-105C for 2 h
99.0% CHO 98.5% CHO ; Batch 6 is valid until 30 June 2006
D1200000 D1250000 D1300000 Y0000217 D1410000 D1500000 D1600000 D1700000 D1750000 D1800000 Y0000640 D1900000 Y0000554 50 mg 250 mg n/a 1 ml 100 mg 10 mg 10 mg 30 mg 250 mg 5 mg 30 mg 10 mg 1 1 1 1 1 1 1 1 1 1 1 1
Dienestrol Diethanolamine fusidate Diethylcarbamazine citrate Diethylene glycol (monoethyl ether) - reference spectrum Diethyl phthalate Diethylstilbestrol Diethylstilbestrol dimethyl ether Diethylstilbestrol monomethyl ether Diflunisal Digitoxin Digoxigenin Digoxin Digoxin for peak identification
3 1 1 n/a 1 1 1 1 1 2 1 7 1
0483,0484 0798,0848 0271 1198 0897 0483,0484 0484 0484 0818,0864 0078,0079,0117 0079 0079 0079
Yes
+5C +5C +5C +5C +5C +5C +5C +5C +5C
a a g l a a a a a a f f f For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch 1 n/a n/a 1 1 3 2 n/a -20C +5C +5C +5C -20C 1310 1310 1776 1512 1416,2060 0551 0600 0485,20702 Yes +5C Monograph Leaflet Storage
6 December 2006
Order Code Y0000232 D1940001 Y0000216 Y0000053 D1945000 D1950000 D1952000 D1954000
Reference Standard
Dihydralazine for system suitability Dihydralazine sulphate (hydrated) - reference spectrum Dihydrocodeine hydrogen tartrate - reference spectrum 17 alpha-dihydroequilin Dihydroergocristine mesilate Dihydroergotamine mesilate Dihydroergotamine tartrate Dihydrostreptomycin sulphate
Information Unit Sale Quantity Unit 10 mg 1 n/a 1 n/a 1 10 mg 1 98.2% CHO 250 mg 1 100 mg 1 150 mg 1 100.0% CHNO. Dried at 100-105C at constant weight 200 mg 1 820 IU per mg; International standard provided for an interim period 10 mg 1 100.0% CHO Extra charges a l l c a a a a 5 mg 200 mg 10 mg (2,3)-3-acetyloxy-5-[2-(dimethylamino)ethyl]-2-(4-methoxy phenyl)-2,3-dihydro-1,5-benzothiazepin-4(5)-one 1 1 1 2014 2014 1004,1199 1004 Yes -20C -20C +5C +5C +5C +5C +5C +5C +5C -20C -20C +5C c c a a
Y0000544 Y0000482 D1980000 D1982000
Dihydrotachysterol Dihydrotachysterol for system suitability Diltiazem hydrochloride Diltiazem impurity A
1 1 3 1
D2000000 D2046000 Y0000234 D2050000 D2200000 D2205000 D2255000 D2250000 D2250015 Batch 1 is valid until 30 April 2006 99.8% dimeticone
Dimenhydrinate (2,6-Dimethylphenoxy)acetone N,N-Dimethylacetamide - reference spectrum Dimethyl sulfoxide Dimeticone Dimetindene maleate Dinoprost trometamol Dinoprostone Dinoprostone impurity C
1 1 n/a 2 2 1 1 2 1
100 mg 50 mg n/a 1 ml 200 mg 50 mg 60 mg 100 mg 10 mg
1 1 1 1 1 1 1 1 1
98.2% CHNO 99.8% CHO (E)-7-[(1S,2R,3R)-3-hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]5-oxocyclopentyl]-hept-5-enoic acid (5-trans-PGE ; (5E)-PGE) 94.6% CHO
0601 1029 1667 0763 0138,1470 1417 1312 1311 1311,1488
a a l a a a c c a
Y0000094 Y0000095 D2600000 Y0000135 D2630000 Y0000258
Diosmin Diosmin for system suitability Diphenhydramine hydrochloride Diphenhydramine impurity A Diphenoxylate hydrochloride - reference spectrum Diphtheria toxin BRP - * Biotox
1 2 1 2 n/a 1
50 mg 5 mg 100 mg 10 mg n/a 1 ml
1 1 1 1 1 1
2-(diphenylmethoxy)-N-methylethanamine
1611 1611 0023,1190 0023 0819 See leaflet,0443
+5C +5C +5C +5C
a a a a l f
D2700000 Diphtheria vaccine (adsorbed) BRP Y0000376 Dipivefrine hydrochloride Y0000394 Dipivefrine for system suitability D2750100 Dipotassium clorazepate - reference spectrum Council of Europe, all rights reserved 2006
3 1 1 n/a
32 mg 100 mg 10 mg n/a
1 1 1 1
Nominal concentration of Diphtheria toxin: 1 Lf/ml (0.4l/ml) Yes +5C Systemic toxicity: 77.6 LD/ml (determined in the subcutaneous challenge test in guinea pigs) Maximum intradermal toxicity: 75,000Lr/Lf (determined in the guinea pig intradermal skin test) Toxicity in the Vero cell assay: concentrations of 5x10- Lf/ml and below cause cytotoxic effects. 160 IU per vial See leaflet,20706 Yes -20C c 1719 +5C g 1719 +5C g 0898 l For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch 1 1 1 1 1 1 1 1 2 0486 1199 1313 0232 1006 1005 0603 1007 1007 +5C +5C +5C +5C +5C +5C +5C +5C +5C Monograph Leaflet Storage
6 December 2006
Order Code D2800000 D2850000 D2880000 D2900000 D2920000 D2922000 D2950000 D2953000 D2953025
Reference Standard
Diprophylline Dipyridamole Dirithromycin Disodium edetate Disopyramide Disopyramide phosphate Disulfiram Dithranol Dithranol impurity C
Extra charges a a a a a a a g g
New D2953050 Dithranol impurity D
Information Unit Sale Quantity Unit 100 mg 1 50 mg 1 100 mg 1 97.4% CHNO 100 mg 1 100 mg 1 100 mg 1 100 mg 1 125 mg 1 20 mg 1 Dithranol-dimer 4,4',5,5'-tetrahydroxy-9,9'-bianthracenyl-10,10'(9H,9'H)-dione ; Batch 1 is valid until 31 May 2006 20 mg 1 94.9% CHO; 1-hydroxyanthracen-9(10H)-one ; Batch 2 is valid until 31 March 2007 1007 +5C g 100 mg 150 mg n/a 30 mg 150 mg 150 mg 50 mg 10 mg 10 mg 10 mg 100 mg 50 mg 91.2% DHA ethyl ester (E)-3-(6,11-dihydrodibenzo[b,e]thiepin-11-ylidene)-N,N'dimethylpropan-1-amine -oxide (4RS)-1-ethyl-4-[2-[(2-hydroxyethyl)amino]ethyl]-3,3-diphenylpyrolidin-2-one 99.2% CHNOS 50 mg 10 mg 60 mg 10 mg 10 mg n/a 20 mg 25 mg 150 mg 100 mg n/a 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1200 2063,20429 1418 2078 1009 1008 0664,1200 1748 1748 1748 1314 1314 1201 1201 +5C +5C +5C +5C +5C +5C +5C -20C -20C +5C +5C +5C +5C +5C +5C +5C +5C +5C -20C +5C 1589 a a l a a a a a c c a a a a a a a l a a c a l
D2954000 D2954600 D2954500 Y0000365 D2955000 D2957000 D2960000 Y0000612 Y0000613 Y0000614 D2962000 D2962005 1 1 1 1 1 n/a 2 2 5 3 n/a
Dobutamine hydrochloride Docosahexaenoic acid ethyl ester Docusate sodium - reference spectrum Dodecyl gallate Domperidone Domperidone maleate Dopamine hydrochloride Dopexamine dihydrochloride Dopexamine impurity B Dopexamine impurity F Dosulepin hydrochloride Dosulepin impurity A
1 2 n/a 1 1 1 1 1 1 1 1 1
D2963000 Doxapram hydrochloride Y0000208 Doxapram impurity B
Y0000553 Y0000551 Y0000552 D2964500 D2964510 D2964520
Doxazosin mesilate Doxazosin impurity D Doxazosin impurity F Doxepin hydrochloride - reference spectrum Doxepin impurity A Doxepin impurity B
D2975000 Doxorubicin hydrochloride D3000000 Doxycycline hyclate Y0000163 Doxylamine hydrogen succinate - reference spectrum
2125 2125 2125 1096 dibenzo[b,e]oxepin-11(6H)-one 1096 (11RS)-11-[3-(dimethylamino)propyl]-6,11-dihydrodibenzo[b,e] 1096 oxepin-11-ol 99.0% CHClNO 0714,0662,1590 85.6% CHNO 0272,0820
Catalogue No. 48-2006/4 Batch 1 1 n/a 1 1 4-(diphenylmethoxy)piperidine 1-[4-(1,1-dimethylethyl)phenyl]-4-(4-hydroxypiperidin-1-yl)butan-1-one n/a 1 2 n/a 2 1 1 1 100 mg 1 n/a 150 mg 10 mg 10 mg 1 1 1 1 n/a 20 mg 100 mg 1 1 1 n/a 10 mg 10 mg 1 1 1 150 mg 1 +5C a 1589 +5C Information Unit Sale Quantity Unit 50 mg 1 N,N-dimethyl-2-[1(RS)-1-phenyl-1-(pyridin-4-yl)ethoxy] ethanamine Monograph Leaflet Storage Extra charges a
6 December 2006
Order Reference Standard Code Y0000160 Doxylamine impurity A
D3100000 Droperidol
Y0000249 Ebastine - reference spectrum Y0000247 Ebastine impurity C Y0000248 Ebastine impurity D
1008,1009,1010, 1172 2015 2015 2015 +5C +5C
l a a
Y0000270 Econazole - reference spectrum Y0000254 Econazole for system suitability E0050000 Econazole nitrate
+5C +5C
l a a
Y0000296 E0085000 Y0000537 Y0000512
Econazole nitrate - reference spectrum Eicosapentaenoic acid ethyl ester Emedastine difumarate Emedastine impurity E
2049 0665,2049 0513,0921,0935, 1017,1018 0665 97.6% EPA ethyl ester 2063,20429 2242 1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidaz 2242 ole.
+5C +5C +5C +5C
l a a a a
E0100000 Emetine hydrochloride
Yes Yes
E0110000 E0109000 Y0000615 Y0000629 New Y0000678 Y0000136 Y0000137 E0150000 E0180000 E0180500 E0200000 E0305000 E0300000
Enalapril for system suitability Enalapril maleate Enalaprilat dihydrate Enalaprilat for system suitability Enalaprilat impurity G Enilconazole Enilconazole impurity E Endotoxin standard BRP Enoxaparin sodium Enoxolone Enterokinase BRP Ephedrine hydrochloride (racemic) - * Drug Precursor Ephedrine hydrochloride - * Drug Precursor
1 2 1 1 1 1 1 4 3 1 1 1 1
20 mg 50 mg 100 mg 10 mg 0.005 mg 60 mg 20 mg 11 mg 200 mg 100 mg 500 mg 50 mg 150 mg
1 1 1 1 1 1 1 1 1 1 1 1 1
(1RS)-1-(2,4-dichlorophenyl)-2-(-1H-imidazol-1-yl)ethanol 10000 IU per vial Batch 2 is valid until 31 December 2005
Yes
+5C +5C +5C +5C +5C +5C +5C -20C +5C +5C +5C +5C +5C
a a a a a a a a a a a i i
Batch 2 is valid until 30 June 2006
E0400000 E0430000 E0440000 E0500000 E0530000 E0550000
4-Epianhydrotetracycline hydrochloride 4-Epichlortetracycline hydrochloride 4-Epidemeclocycline hydrochloride 6-Epidoxycycline hydrochloride 4-Epioxytetracycline Epirubicin hydrochloride
4 3 1 4 6 4
10 mg 20 mg 20 mg 50 mg 40 mg 100 mg
1 1 1 1 1 1
82% CHNO ; Batch 5 is valid until 31 January 2007 96.4% CHClNO ; Batch 3 is valid until 31 August 2006
0080,0081,0093, 0094,1530,1875 1420 1420 1749 1749 1749 1720 1720 20614 0828,1097 1511 0350 0715 0487,0488,0489, 1367 0210,0211,1654 0173 0176 0272,0820 0198,0199 0662,0714,1590
+5C +5C +5C +5C +5C -20C
a a a a a c For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch 6 1 2 Yes 0210,0211,1654 1512 See leaflet,0249 +5C -20C -20C Monograph Leaflet Storage Extra charges a c c
6 December 2006
Order Reference Standard Code E0600000 4-Epitetracycline hydrochloride Y0000052 Equilin E0850010 Eq Influenza Subtype 1 Strain A/eq/Newmarket/77 Horse Antiserum BRP 2 See leaflet,0249 Yes -20C c
E0850021 Eq Influenza Subtype 2 American-like/Newmarket Horse Antiserum BRP 2 See leaflet,0249
E0850022 Eq Influenza Subtype 2 European-like/Newmarket Horse Antiserum BRP 1 6 500 mg 1 99.8% CHO; Vitamin D2 ; Batch 5 is valid until 28 February 2007 1 mg 1
Information Unit Sale Quantity Unit 20 mg 1 86.8% CHClNO ; Batch 5 is valid until 31 May 2006 15 mg 1 99.7% CHO 1 mg 3 Assigned SRH antibody titre: 125 mm +/-20%; Common standard OIE Strain A/eq/Newmarket/77 1 mg 3 Assigned SRH antibody titre: 180 mm +/- 20%; Common standard OIE Strain A/eq/Newmarket/1/93 1 mg 3 Assigned SRH antibody titre: 155 mm +/- 20%; Common standard OIE Strain A/eq/Newmarket/2/93 Yes -20C c See leaflet,0249 Yes -20C -20C c c
New Y0000712 Eq Influenza Subtype 2 American-like/South Africa Horse Antiserum BRP E0900000 Ergocalciferol
E1000000 E1100000 E1200000 Y0000051 Y0000177 E1300000 E1305000 2 4 1 1 1 2 100 mg 100 mg 50 mg 0.25 mg 1 1 1 1 50 mg 1 50 mg 1
Ergometrine maleate - * Drug Precursor Ergosterol Ergotamine tartrate - * Drug Precursor Erysipelas ELISA coating antigen BRP Erythritol Erythromycin Erythromycin A
2 3 2 1 1 4 2
50 mg 20 mg 100 mg 0.4 mg 1000 mg 250 mg 250 mg
1 1 1 1 1 1 1
Yes
+5C -20C +5C -20C +5C -20C -20C -20C -20C
i c i c a a a a a
E1310000 Erythromycin B
E1320000 Erythromycin C
E1400000 E1500000 E1500800 E1515000
Erythromycin estolate Erythromycin ethylsuccinate Erythromycin stearate Erythropoietin BRP
0082,0574,0575, 0598,1192,1193 0223 0082 0224 0.5ml Freeze dried (0.367g protein) See leaflet,0064 99.8% CHO 1803 960 IU per mg 0179,20702 96.7% CHNO 0179,0274,0293, 0490,0552,1098 99.0% Erythromycin B 0179,0274,0490, 0552,1098 97.6% CHNO ; Batch 3 is valid until 28 February 2006 0179,0274,0490, 0552,1098 0552 0274 0490 32500 IU per vial; 0.250 mg erythropoietin per vial; New unit sale : 1316 only ONE vial (2R)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone estra-1,3,5(10)-triene-3,17alpha-diol 3-benzoate 1742 1742 0139 0139 1614 0821,1203 0821 1614
Yes
+5C +5C +5C -20C
a a a b
Y0000324 Y0000338 E1600000 Y0000201 Y0000045 E1620000 Y0000314 Y0000046
Esketamine hydrochloride - reference spectrum Esketamine impurity D - * narc Estradiol benzoate Estradiol benzoate impurity E Estradiol butyrate Estradiol hemihydrate Estradiol for peak identification Estradiol valerate
n/a 1 1 1 1 2 1 1
n/a 10 mg 250 mg 10 mg 10 mg 100 mg 10 mg 50 mg
1 1 1 1 1 1 1 1
+5C +5C +5C +5C +5C +5C +5C
l k a a a a a a For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch 2 1 2 1 1 1 2 n/a n/a 2 +5C +5C +5C +5C +5C +5C +5C +5C Information Monograph Leaflet Storage Extra charges a a a a a a a l l g
6 December 2006
Order Code E1680000 E1680005 E1700000 E1800000 E1830000 E1840000 E1850000 A1202800 E1860100 E1900000
Reference Standard
Estriol Estriol impurity A Estrone Etacrynic acid Etamsylate Ethacridine lactate monohydrate Ethambutol hydrochloride Ethanol (anhydrous) - reference spectrum Ethanol 96% - reference spectrum Ethinylestradiol
Unit Sale Quantity Unit 50 mg 1 20 mg 1 9,11-didehydroestriol 15 mg 1 99.9% CHO 100 mg 1 30 mg 1 50 mg 1 250 mg 1 99.1% CHClNO n/a 1 n/a 1 100 mg 1
2-ethyl-2-methylsuccinic acid
+5C +5C +5C
E2000000 E2150000 E2250000 E2195000 E2195900 E2202000 E2205500 Y0000617 E2300000 E2400000 E2425000 88.2% 1-N-Ethylgaramin sulphate 82.3% 1,1'-Ethylidenebistryptophan
Ethionamide Ethosuximide Ethosuximide impurity A Ethyl acetate - reference spectrum Ethylcellulose - reference spectrum 1-N-Ethylgaramine sulphate 1,1'-Ethylidenebistryptophan Ethyl indole-3-carboxylate Ethylmorphine hydrochloride - reference spectrum Ethylnicotinamide Ethyl parahydroxybenzoate
1 1 1 n/a n/a 1 2 1 n/a 1 2
100 mg 30 mg 50 mg n/a n/a 125 mg 5 mg 10 mg n/a 150 mg 50 mg
1 1 1 1 1 1 1 1 1 1 1
+5C +5C +5C +5C +5C
a a a l l a a a l a a
2-ethylamino-1-(3-hydroxyphenyl)ethanone (etilefrone)
2-(7-ethylindol-3-yl)ethanol
Yes 2-hydroxyethyl 2-[[3-(trifluoromethyl)phenyl]amino]-benzoate
E2450000 E2451000 E2451010 Y0000572 E2470000 E2470050 E2499900 E2499901 E2499914 E2500000 E2503000 E2503004 E2600000 E5000000 F0005000
Etifenin Etilefrine hydrochloride Etilefrine impurity A Etidronate disodium Etodolac Etodolac impurity H Etofenamate Etofenamate for peak identification Etofenamate impurity G Etofylline Etomidate Etomidate impurity B Etoposide Eugenol Famotidine
1 1 1 1 1 1 1 1 1 1 1 1 4 2 2
25 mg 75 mg 20 mg 5 mg 60 mg 10 mg 40 mg 15 mg 20 mg 100 mg 100 mg 25 mg 150 mg 500 l 100 mg
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
methyl 1-[(1RS)-1-phenylethyl]-1H-imidazole-5-carboxylate 97.5% CHO
1203 1203 1512 0457 1204 1591 0553 1318 1317 0140,0821,0926, 0940 0141 0764 0764 0899 0822 1351 1272,1383 2102 0491 0233 0409,0431,0900, 1262,1263,2134 0585 1205 1205 1778 1422 1422 1513 1513 1513 0492 1514 1514 0823 1100 1012 +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C a a a a a a a a a a a a a a a
Catalogue No. 48-2006/4 Batch 1 1 1 1 1012 1012 +5C +5C a a 1012 1012 Yes +5C +5C Monograph Leaflet Storage Extra charges a a
6 December 2006
Order Reference Standard Code Y0000382 Famotidine for system suitability F0006000 Famotidine impurity A
F0007000 Famotidine impurity B
Y0000409 Famotidine impurity D
Information Unit Sale Quantity Unit 10 mg 1 10 mg 1 3-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]-thio] propanamide 10 mg 1 3,5-bis[2-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl] thio]-ethyl]-4-1,2,4,6-thiatriazine1,1-dioxide 10 mg 1 3-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl] propanamide 110 mg 1 99.9% CHNOS Yes Yes
Y0000556 Y0000660 F0030000 Y0000415 F0040000 F0040010 F0040020 F0041000 F0048000 F0048005 10 mg 120 mg 0.994 mg 150 mg 20 mg 20 mg 100 mg 100 mg 20 mg methyl(1-benzimidazol-2-yl)carbamate methyl[5(6)-chlorobenzimidazol-2-yl]carbamate 10 mg 25 mg 100 mg n/a n/a n/a 50 mg 20 mg 1 1 1 1 1 1 1 1 1322 1322 0901 0901 1210 1103 1211 1211 1 1 1 1 1 1 1 1 1 3 3 1 n/a n/a n/a 1 1
Febantel Febantel for system suitability Felodipine Felypressin Fenbendazole Fenbendazole impurity A Fenbendazole impurity B Fenbufen Fenofibrate Fenofibrate impurity A
1 1 1 1 2 1 1 1 2 3
2176 2176 1013 1634 1208,1458 1208 1208 1209 1322 1322
+5C +5C +5C -20C +5C +5C +5C +5C +5C +5C +5C +5C +5C
a a a c a a a a a a a a
F0048010 Fenofibrate impurity B
F0048035 Fenofibrate impurity G
F0050000 F0051000 F0054990 F0055000 F0060000 F0060040
Fenoterol hydrobromide Fenoterol hydrobromide - reference spectrum Fentanyl - reference spectrum Fentanyl citrate - reference spectrum Fenticonazole nitrate Fenticonazole impurity D
100.0% CHClO (4-chlorophenyl)(4-hydroxyphenyl)methanone ; Batch 2 is valid until 31 May 2006 2[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid (fenofibric acid) 1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl propanoyl] oxy]-2-methylpropanoate contains 4.0% m/m of the diastereoisomers
()-1-[2-(2,4-dichlorophenyl)-2-hydroxyethyl]-3-[4-(phenyl suphanyl)benzyl]imidazolium nitrate 99.8% CHNO
+5C +5C +5C +5C +5C +5C +5C
a l l l a a a a a a a
F0100000 Y0000090 Y0000091 F0120000 F0120005
Ferrous gluconate Finasteride Finasteride for system suitability Flecainide acetate Flecainide impurity A
1 1 1 1 1
1000 mg 50 mg 100 mg 200 mg 50 mg
1 1 1 1 1
0493 1615 1615 1324 3-[2,5-bis(2,2,2-trifluoroethoxy)phenyl]-1,5,6,7,8,8a-hexahydro 1324 imidazo[1,5-a]pyridine (piperidin-2-yl)methanamine 1324 Yes 95.3% CHClFNNaOS ; Batch 5 is valid until 30 April 2006 1 1 1 1 1721 1721 0661,0663,0668
F0120010 Y0000138 Y0000139 F0150000
Flecainide impurity B Flubendazole Flubendazole for system suitability Flucloxacillin sodium
1 1 1 6
25 mg 25 mg 20 mg 250 mg
+5C +5C +5C -20C
a a a c For extra charges please see 2.2
6 December 2006
Reference Standard
Order Code Y0000557 Y0000558 Y0000573 Y0000574 F0175000 Y0000419 New F0180000 F0188000 Y0000335 1 1 1 1 1 1 2 n/a 1 Yes +5C +5C +5C 1 2 60 mg 0.1 mg 1 1 1517 ethyl(RS)-9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-benzo[i,j] 1517 quinolizine-2-carboxylate (flumequine ethyl ester) ; Batch 1 is valid until 30 June 2006 Batch 2 is valid until 31 October 2006 a a 2287 2287 2287 2287 0766 1781 0767 1326 1326 +5C +5C +5C +5C +5C +5C +5C
Fluconazole Fluconazole for peak identification Fluconazole impurity B Fluconazole impurity C Flucytosine Fludarabine phosphate Fludrocortisone acetate Flumazenil - reference spectrum Flumazenil impurity B
Information Unit Sale Quantity Unit 50 mg 1 10 mg 1 10 mg 1 94.6% CHNOF 5 mg 1 100 mg 1 100 mg 1 97.6% CHFNOP 100 mg 1 Batch 1 is valid until 30 April 2007 n/a 1 5 mg 1 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4] benzodiazepine-3-carboxylic acid Extra charges a a a a a a a l a
F0189000 Flumequine F0189020 Flumequine impurity B
+5C +5C Yes +5C +5C
2-methyl-3-(trifluoromethyl)aniline ethyl 2-chloropyridine-3-carboxylate 100% CHFO. Dried at 100-105C for 2 hours 99.6% CHO
F0188500 F0189900 Y0000265 Y0000266 F0190000 Y0000169 Y0000443 Y0000444 Y0000445 F0200000 F0230000 Y0000454 F0245000 F0250000 F0253000 F0253020 F0253030 1 1 1 2 1 25 mg 60 mg 100 mg 120 mg 15 mg 1 1 1 1 1
Flumetasone pivalate Flunarizine dihydrochloride Flunarizine dihydrochloride - reference spectrum Flunarizine dihydrochloride for system suitability Flunitrazepam - * psy Flunitrazepam - reference spectrum Flunixin meglumine Flunixin impurity B Flunixin impurity C Fluocinolone acetonide Fluocortolone pivalate Diacetylfluorescein Fluoresceine sodium - reference spectrum Fluorouracil Fluoxetine hydrochloride Fluoxetine impurity B (methyl(3-phenylpropyl)amine) Fluoxetine impurity C
1 3 n/a 1 1 n/a 1 1 1 3 1 1 n/a 1 3 4 3
100 mg 100 mg n/a 20 mg 100 mg n/a 10 mg 10 mg 50 mg 100 mg 100 mg 100 mg n/a 50 mg 250 mg 5 mg 5 mg
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
methyl(3-phenylpropyl)amine ()-methyl-[3-phenyl-3-(3-trifluoromethylphenoxy)-propyl] amine ; Batch 2 is valid until 31 January 2006
1327 0816 1722 1722 1280 0717 1696 1696 1696 0494 1212 1213 1213 0611,0766 1104 1104 1104 1693 1693
+5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C
a a l a j l a a a a a a l a a a a a a
Y0000064 Flupentixol dihydrochloride Y0000067 Flupentixol impurity D
Y0000078 Flupentixol impurity F
2-[2-[4-[3-[(EZ)-2-(trifluoromethyl)-9H-thioxanthen-9ylidene]propyl]piperazin-1-yl]ethoxy]ethanol 2-[4-[(EZ)-3-[(9RS)-2-(trifluoromethyl)-9H-thioxanthen-9-yl] prop-2-enyl]piperazin-1-yl]ethanol
1693 1014,1015 1014,1015
+5C +5C +5C
a a a For extra charges please see 2.2
F0260000 Fluphenazine decanoate Y0000009 Fluphenazine enantate
Catalogue No. 48-2006/4 Batch 1 1 1 n/a 1 1 1 1 +5C +5C +5C +5C +5C +5C +5C +5C 1 1 1 1 N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide 99.1% CHFOS S-methyl 6a,9a-difluoro-11b-hydroxy-16a-methyl-3-oxo-17apropionyloxy-androsta-1,4-diene-17-carbothioate (S-methyl derivative) 50 mg 20 mg 100 mg 10 mg 1 1 1 1 1423 1423 1750 1750 a a a a 0904,1014 1014,1015 1014,1015 0905 1519 1519 1723 1723 +5C +5C +5C Monograph Leaflet Storage
6 December 2006
Order Code F0280000 Y0000298 Y0000299 Y0000211 F0285200 F0285202 Y0000236 Y0000375
Reference Standard
Fluphenazine dihydrochloride Fluphenazine octanoate Fluphenazine sulphoxide Flurazepam monohydrochloride - reference spectrum Flurbiprofen Flurbiprofen impurity A Fluspirilene Fluspirilene impurity C
Information Unit Sale Quantity Unit 50 mg 1 10 mg 1 10 mg 1 n/a 1 50 mg 1 20 mg 1 (2RS)-2-(biphenyl-4-yl)propanoic acid 20 mg 1 10 mg 1 8-[4,4-bis(4-fluorophenyl)butyl]-3-(hydroxymethyl)-1-phenyl -1,3,8-triazaspiro[4.5]decan-4-one Extra charges a a a l a a a a
F0285600 F0285603 Y0000284 Y0000221
Flutamide Flutamide impurity C Fluticasone propionate Fluticasone impurity D
(RS)-(2-fluorophenyl)(4-fluorophenyl)phenylmethanol Star anise oil 91.5 % CHNO Batch 1 is valid until 30 November 2006
Yes
Yes
10-Formylfolic acid disodium (ethoxyoxydophosphanyl)formate
F0290000 F0290010 Y0000386 F0300000 F0372000 Y0000339 Y0000340 F0380000 F0389000 F0389004 F0399900 F0399950 F0400000 F0400010 3 1 100 mg 1 25 mg 2 99.6% CHNOP 1,3-dihydroxy-2-(hydroxymethyl)propan-2-aminium (1,2-dihydroxypropyl)phosphonate 18060 IU per vial, 95.2% CHNO,xHSO
Flutrimazole Flutrimazole impurity B Foeniculin for peak identification Folic acid Formoterol fumarate dihydrate Formoterol fumarate dihydrate for impurity I identification Formoterol fumarate for system suitability Formylfolic acid Foscarnet sodium hexahydrate Foscarnet impurity B Fosfomycin calcium - reference spectrum Fosfomycin sodium - reference spectrum Fosfomycin trometamol Fosfomycin trometamol impurity A
1 1 1 7 2 1 1 2 1 1 n/a n/a 1 1
100 mg 60 mg 100 mg 250 mg 10 mg 10 mg 10 mg 30 mg 50 mg 10 mg n/a n/a 1500 mg 50 mg
1 1 1 1 1 1 1 1 1 1 1 1 1 1
1424 1424 0804 0067 1293,1724 1724 1724 0978,1606 1520 1520 1328 1329 1425 1425 0180,0197,20702
+5C +5C +5C +5C +5C +5C +5C -20C +5C +5C
+5C +5C Yes -20C +5C
a a a a a a a c a a l l a a a a
F0450000 Framycetin sulphate
F0550000 Fructose
F0600000 Fumaric acid
100 mg
+5C
F0700000 Furosemide F0702000 Furosemide impurity A
1 3
100 mg 5 mg
1 1
2-chloro-4-(furfurylamino)-5-sulphamoylbenzoic acid
0177,0178,0187, 0188,0204,0209, 1061,1570 0365,0902,1190, 1592 0391 0391
+5C +5C
a a For extra charges please see 2.2
6 December 2006
Reference Standard
Order Code F1000000 G0049000 G0050000 G0100000 G0150000 Y0000675 Y0000676 Y0000513 Y0000514 New G0200000 G0300000 G0325000 G0325010 n/a 1 2 1 1 1 1 1 1 5 2 2 1 Yes Yes +5C +5C +5C +5C +5C +5C +5C +5C -20C +5C +5C +5C 0718 0718,1524 1524 1524 Yes +5C +5C +5C +5C 1 2 2 2 1 1 1 1 0.012 mg 50 mg 10 mg 10 mg 1 1 1 1 1 a a a a 2223 2223 0906 0906 0906 +5C +5C +5C +5C +5C a a a a a 0798,0848 1381 1215 0181 1070,1487 2306 2306 1694 1694 0331,20702 0078,0079,2168 0718 0718
Fusidic acid - reference spectrum Galactitol Galactose Gallamine triethiodide Gammacyclodextrin Gemcitabine hydrochloride Gemcitabine impurity A Gemfibrozil Gemfibrozil for system suitability Gentamicin sulphate Gitoxin Glibenclamide Glibenclamide impurity A
Extra charges l a a a a g g a a c a a a
Y0000242 Glibenclamide impurity B
G0326000 Gliclazide G0326004 Gliclazide impurity B G0326012 Gliclazide impurity F
Y0000515 Y0000516 G0340000 G0342000
Glimepiride Glimepiride for system suitability Glipizide Glipizide impurity A
Information Unit Sale Quantity Unit n/a 1 50 mg 1 60 mg 1 Batch 1 is valid until 31 August 2006 100 mg 1 50 mg 1 50 mg 1 99.9% CHClFNO 20 mg 1 5 mg 1 0.196 mg 1 25 mg 2 16500 IU per vial ; Batch 4 is valid until 31 March 2007 30 mg 1 100 mg 1 100 mg 1 4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzenesulphonamide 10 mg 1 methyl [[4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]phenyl] sulphonyl]carbamate 20 mg 1 Batch 1 is valid until 31 August 2006 25 mg 1 2-nitroso-octahydrocyclopenta[c]pyrrole 25 mg 1 1-(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(2-methylphenyl) sulphonyl]urea 60 mg 1 99.4% CHNOS
Y0000523 Glipizide impurity C
4-[2-(5-methylpyrazine-2-carboxamido)ethyl]benzene sulphonamide ethyl [2-[4-[(cyclohexylcarbamoyl)sulphamoyl]phenyl]ethyl] carbamate 0.952 mg pure human glucagon per vial
Y0000643 Glipizide impurity D Y0000191 Human glucagon G0350500 Glucose
1 1 1
10 mg 0.952 mg 100 mg
1 2 1
Yes
+5C -20C +5C
a c a
G0355000 Glutamic acid 1 1 n/a 1 2 10 mg 50 mg n/a 2000 mg 2000 mg 1 1 1 1 1
50 mg
+5C +5C +5C +5C +5C
a a j l a a For extra charges please see 2.2
Y0000517 G0360000 G0400000 G0400002 G0400004
Glutathione Glutethimide - * psy Glycerol (85 per cent) - reference spectrum Glycerol dibehenate Glycerol distearate
0906 1635 0177,0178,0187, 0188,0204,0209, 1061,1215,1570 0750,0797,1445, 2076 1670 1291 0496,0497 1427 1428
Catalogue No. 48-2006/4 Batch +5C +5C +5C +5C +5C +5C +5C -20C -20C Monograph Leaflet Storage
6 December 2006
Reference Standard
Order Code G0400006 G0400007 G0400008 G0400101 G0400100 New G0450000 Y0000433 G0460000 G0525000 Y0000125 Y0000126 Y0000019 Y0000194 G0550000 Y0000396 Y0000477 1 1 2 n/a 2 3 1 1 4 1 n/a 1 1 1 1 1 Yes Yes -20C -20C +5C +5C +5C 1695 +5C 1 a 1429 1430 0495 1331 1331,1355 0614,0752 1772 0277,1536,1772 0827 1636 1636 1636 1636 0907,1662,20702 1695 1695
Glycerol monolinoleate Glycerol mono-oleate Glycerol monostearate 40-55 Glyceryl trinitrate - reference spectrum Glyceryl trinitrate solution Glycine Ammonium glycyrrhizate Glycyrrhizate (monoammonium) Gonadorelin Goserelin Gosereline - reference spectrum 4-D-Ser-goserelin Goserelin validation mixture Gramicidin Granisetron hydrochloride Granisetron impurity A
Extra charges a a a l g a a a c c l c c a a a
Y0000478 Granisetron impurity B
Information Unit Sale Quantity Unit 2000 mg 1 2000 mg 1 2000 mg 1 Batch 1 is valid until 30 September 2006 n/a 1 0.5 ml 1 1% m/m in ethanol ; Batch 1 is valid until 28 February 2007 50 mg 1 Batch 2 is valid until 28 February 2007 70 mg 1 300 mg 1 80.6% CHNO 5.08 mg 1 5.08 mg per vial of CHNO 4.93 mg 1 4.93 mg per vial of CHNO n/a 1 0.1 mg 1 1 mg 1 Supplied with the Ph. Eur. reference chromatogram 250 mg 1 1081 IU per mg 120 mg 1 99.8% CHClNO 1 mg 1 2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2 H-indazole-3-carboxamide 1 mg 1 N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole -3-carboxamide 10 mg 1 endo-3-amino-9-methyl-9-azabicyclo[3.3.1]nonane 50 mg 1 Batch 1 is valid until 30 June 2006 2200 mg 1 99.5% CHO Yes 100 mg 125 mg 10 mg 50 mg 1 1 1 1 99.6% CHClFNO [1,3-dichloro-6-(trifluoromethyl)phenantren-9-yl]methanol +5C +5C +5C +5C +5C +5C +5C +5C Yes Yes Yes Yes 2 2 5 1 Yes Yes Yes +5C +5C +5C +5C +5C +5C -20C +5C a a a a a a a
Y0000395 G0600000 New Y0000619 G0700000 Y0000117 Y0000118 H0100000
Granisetron impurity E Griseofulvin Guaiacol Guaifenesin Halofantrine hydrochloride Halofantrine impurity C Haloperidol
1 2 1 1 1 1 1
H0100100 H0150000 H0185000 H0190000 H0200000 2 2 2 1 2 0.5 ml 1 ml 40 mg 600 mg 0.5 ml 3
Haloperidol decanoate Halothane - reference spectrum Heparin Low-Molecular-Mass for assay BRP Heparin Low-Molecular-Mass for calibration CRS Heparin sodium BRP
1 n/a 4 1 3
60 mg n/a 1 ml 25 mg 2 ml
1 1 5 1 1
Anti-IIa activity : 33 IU per ml; Anti-Xa activity : 113 IU per ml. Mn = 3700 1010 IU per ml ; Batch 2 is valid until 31 January 2007
a l b a a b b b e a For extra charges please see 2.2
H0205010 Hepatitis A vaccine (inactivated, adsorbed) Type B BRP
1695 0182 1978 0615 1979 1979 0616,0995,1178, 1503 1397,1431 0393 See leaflet,0828 0828 0332,0333,0569, 0686,20705 See leaflet,20714 262 IU per ml; Please contact us for information on the type needed for your use 16.6 micrograms per ml See leaflet,20715 20 micrograms per ml See leaflet,1056 HCV-RNA content 500 IU per vial; For plasma pool testing by NAT See leaflet,20621 0801,0802,0847
Y0000389 H0210010 H0215000 H0220000
Hepatitis B vaccine (rDNA) BRP method A (thiomersal free) Hepatitis B vaccine (rDNA) BRP method B Hepatitis C Virus RNA for NAT testing BRP Heptadecanol
Catalogue No. 48-2006/4 Batch 1 1 3 1 1 1 1 4 1 2 1 1 1 1 n/a 1 1 1 3 1 1 2 2 1 700 mg 3 96 mg 1 1320 mg 3 Contains 1.0 mg Immunoglobulin G per vial 75.7% to 80.9% of the total protein is the main band (Ig), protein content: 5% Each vial contains 0.7 gram of immunoglobulin G Set of 103 plasma pool samples 91 IU per vial 120 IU per vial 23 IU per vial 328 IU per mg 1 3 1 3 1 1 1 1 1 Batch 3 is valid until 30 November 2006 1 uc 26 mg 34 mg 30 mg 10 mg 1 2 5 5 3 1000 mg 1 96,7% to 98,7% of the total protein is the main band (albumin), protein content : 5% 285 IU anti-D immunoglobulin per ampoule 8.2 IU per vial 8.6 IU per vial; Common standard with FDA Common standard with FDA 10.2 IU per vial 0255 Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes +5C -20C -20C -20C -20C -20C +5C +5C +5C a c c c c c a a a 1980 1980 0772 1436 1221 0183 1437 20814 0143 0144 0911 0910 0500,0720 0720 1617 +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C Information Unit Sale Quantity Unit 150 mg 1 30 mg 1 (2RS)-6-methylhept-5-en-2-amine 10 mg 1 50 mg 1 100 mg 1 500 mg 1 100 mg 1 500 mg 1 250 mg 1 250 mg 1 100 mg 1 100 mg 1 100 mg 1 25 mg 1 n/a 1 Monograph Leaflet Storage Extra charges a a a g a a a a a a a a a a l
6 December 2006
Order Code Y0000063 Y0000057 H0250000 H0330000 H0325000 H0400000 H0420000 H0500000 H0600000 H0700000 H0750000 H0755000 H0800000 H0830000 H0837000
Reference Standard
Heptaminol hydrochloride Heptaminol impurity A alpha-Hexachlorocyclohexane Hexamidine diisetionate Hexetidine Hexobarbital Hexylresorcinol Hide powder Histamine dihydrochloride Histamine phosphate Histidine Histidine hydrochloride monohydrate Homatropine hydrobromide Homatropine methylbromide L-Homocysteine thiolactone hydrochloride - reference spectrum H0900000 Human albumin for electrophoresis BRP
Y0000219 Y0000667 H0920000 H0920500 H0950000
Human anti-D immunoglobulin BRP Human coagulation factor VII concentrate BRP Human coagulation factor VIII concentrate BRP Human coagulation factor IX concentrate BRP Human hepatitis A immunoglobulin BRP
H0990000 Human immunoglobulin BRP
H1000000 Human immunoglobulin for electrophoresis BRP
See leaflet,20713 See leaflet,20710 See leaflet,20704 See leaflet,20711 See leaflet,0338, 0769 See leaflet,0338, 0918 0338,0918
Y0000488 Human immunoglobulin (molecular size) BRP 1 1 1 1 1 1 4 1 1 3502 mg 170 mg 87 mg 1 ml 50 mg 20 mg 150 mg 10 mg 10 mg
H1005000 H1100000 H1110000 Y0000502 H1115000 H1120000 H1200000 New Y0000646 New Y0000710
Human Plasma Pools for NAT validation Human rabies immunoglobulin BRP Human tetanus immunoglobulin BRP Human vaccinia immunoglobulin Hyaluronidase BRP Hydralazine hydrochloride Hydrochlorothiazide Hydrocodone hydrogen tartrate 2.5-hydrate - * narc Hydrocodone for peak identification - * narc
See leaflet, 0338, 0918,1928 See leaflet,20621 See leaflet,0723 0398 See leaflet 0912 0829 0394,0546 1784 1784
Yes
-20C -20C -20C -20C +5C +5C +5C +5C +5C
c c c b a a a k k For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch 8 7 Batch 1 is valid until 31 December 2005 -20C +5C +5C +5C +5C Information Unit Sale Quantity Unit 100 mg 1 Batch 7 is valid until 31 March 2007 125 mg 1 Monograph Leaflet Storage Extra charges a a
6 December 2006
Order Reference Standard Code New H1300000 Hydrocortisone H1400000 Hydrocortisone acetate
99.9% CHNO 98.8% CHNO
Yes
H1425000 H1426000 Y0000446 B0650000 H1428000 Y0000119 H1429400 H1429700 H1430000 Y0000186 H1435000 Y0000011 Y0000012 Y0000013 Y0000483 Y0000484 Resorcinol 7-hydroxy-2-methyl-4H-1-benzopyran-4-one. (1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate (norhyoscine) (1R,2R,4S,5S,7S)-9-butyl -7-[[(2S)-3-hydroxy2-phenylpropanoyl]oxy]-3-oxa -9-azoni atricyclo [3.3.1.02,4]nonane (1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate (1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl(2S)-3-hydroxy-2-phenyl -propanoate 1 1 25 mg 10 mg 1 1 0737 0737
Hydrocortisone hydrogen succinate Hydrogenated wool fat Hydromorphone hydrochloride - * narc Hydrous benzoyl peroxide - reference spectrum Hydroxocobalamin Hydroxycarbamide Hydroxyethyl salicylate 4-Hydroxyphenoxymethylpenicillin D-alpha-(4-Hydroxy-phenyl)glycine Hydroxypropylbetadex Hydroxyzine hydrochloride Hymecromone Hymecromone impurity A Hymecromone impurity B Hyoscine Hyoscine impurity A
2 1 1 n/a 1 1 1 2 1 1 2 1 1 1 1 1
100 mg 250 mg 10 mg n/a 10 mg 175 mg 125 mg 50 mg 50 mg 10 mg 600 mg 100 mg 25 mg 25 mg 10 mg 10 mg
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
0335,0353,0561 0321,0334,0734, 0767 0768,1131 0969 2099 0704 0913,0914,0915 1616 1225 0148,0149 0813 1804 0916,1086,1092 1786 1786 1786 2167 2167 +5C +5C +5C -20C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C a a k l a a a a a a a a a a g g a a
H1450000 Hyoscine butylbromide Y0000447 Hyoscine butylbromide impurity E
H1500000 Hyoscine hydrobromide Y0000448 Hyoscine hydrobromide impurity B 1 1 n/a 3 2 n/a 100 mg 1.15 ml 1 1 1 100 mg 10 mg 1 1
1 1
50 mg 10 mg
1 1
0106,0500 0106 0501 0501 0347 0721 0721
+5C +5C +5C +5C
g g g g
H1600000 Hyoscyamine sulphate Y0000449 Hyoscyamine impurity E
H5000000 Hypromellose phthalate - reference spectrum I0020000 Ibuprofen B1220000 Ibuprofen impurity B
solution of 0.06% m/V in acetonitrile (2RS)-2-(4-Butylphenyl)propanoic acid - to be diluted as appropriate. 3-[4-(2-methylpropyl)phenyl]propanoic acid 1 1 1 1 100.0% CHClNOP
Yes
+5C +5C
l a g
Y0000140 I0050000 I0060000 I0060100
Ibuprofen impurity F Idoxuridine Ifosfamide Ifosfamide - reference spectrum
1 1 1 n/a
5 mg 50 mg 50 mg n/a
0721 0669 1529 1529
+5C +5C +5C
a a a l For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch 1 1 1 1 1 1 2 Yes +5C +5C +5C +5C +5C -20C +5C Monograph Leaflet Storage
6 December 2006
Order Code I0060002 I0060004 I0060010 I0060012 I0086000 I0090000 I0100000
Reference Standard
Ifosfamide impurity A Ifosfamide impurity B Ifosfamide impurity E Ifosfamide impurity F Imidazole Imipenem Imipramine hydrochloride
Information Unit Sale Quantity Unit 30 mg 1 3-[(2-chloroethyl)amino]propyl dihydrogen phosphate 20 mg 1 bis[3-[(2-chloroethyl)amino]propyl] dihydrogen diphosphate 10 mg 1 3-chloro-N-(2-chloroethyl)propan-1-amine 10 mg 1 (RS)-2-chloro-3-(2-chloroethyl)-1,3,2-oxazaphosphinane 2-oxide 100 mg 1 100 mg 1 92.8% CHNOS 50 mg 1 Batch 1 is valid until 30 June 2006 Extra charges a a a b a c g
Y0000540 I0150000 I0150020 I0200000 Y0000349 97.7% CHClNOS 4-chloro-3-sulphamoyl-N-(2-methyl-1H-indol-1-yl)-benzamide
Immunoglobulin panel for anti-D antibodies test BRP Indapamide Indapamide impurity B Indometacin Insulin aspart
1 3 2 1 1
2000 mg 150 mg 5 mg 50 mg 3.89 mg
1 1 1 1 1
1529 1529 1529 1529 1424 1226 0029,0408,0817, 0889,1787 See leaflet, 20626 1108 1108 0092,0922 2084 Yes -20C +5C +5C +5C -20C a a a g c
I0305000 3 1 3 2 3 1 2 1 1 1 1 1 1 1 1 1 1 10 mg 100 mg 100 mg 1 1 1 10 mg 50 mg 10 mg 1 1 1 125 mg 1 1 ml 0.2 ml 0.6 ml 0.2 ml 50 mg 150 mg 50 mg 1 1 2 1 1 1 1 About 1.46 mg per ml about 7.19 mg per ml about 1 mg per ml about 1 mg per ml 5.93 mg 8.61 mg 1 1 7.03 mg 1
Insulin (bovine)
7.99 mg
0854,1637
Yes Yes Yes Yes Yes Yes Yes
-20C -20C -20C -20C -80C -80C -80C -80C +5C +5C +5C 1114 1114 1115 1115, 1754 +5C +5C +5C +5C
c c c c d d d d a a a a a a a
I0310000
Insulin (human)
Y0000348 Insulin lispro I0320000 Insulin (porcine)
3.89 mg [insulin aspart + B28isoAsp insulin aspart + A21Asp insulin aspart + B3Asp insulin aspart + B3isoAsp insulin aspart] per vial 7.99 mg insulin + A21 desamido per vial ; Batch 2 is valid until 28 February 2006 7.03 mg insulin + A21 desamido per vial ; Batch 2 is valid until 31 March 2006 5.93 mg insulin lispro per vial 8.61 mg [porcine insulin + A21-desamido porcine insulin] per vial
I0320300 I0320301 I0320330 I0320331 I0328000 I0320800 I0320810
Interferon alfa-2a Interferon alfa-2b Interferon gamma 1b Interferon gamma-1b validation solution Iobenguane sulphate Iohexol Iohexol impurity A
0838,0854,1637, 1638 2085 0838,0854,1637, 1638 1110 1110 1440 1440 1111,1112,1113 1114 1114
I0320820
Iohexol impurity J
5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodo benzene-1,3-dicarboxamide 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodobenzene-1, 3-dicarboxamide
Y0000672 Iohexol for peak identification I0329000 Iopamidol I0329010 Iopamidol impurity A
Y0000406 Iopamidol impurity H
N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-amino-2,4,6-triiodoisophthalamide 4-chloro-N,N'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-(2-hydro 1115 xypropanoyl)amino)2,6-diiodobenzenz-1,3-dicarboxamide
+5C 0700 0751 +5C +5C
a a a For extra charges please see 2.2
I0330000 I0340000
Iopanoic acid Iotalamic acid
Catalogue No. 48-2006/4 Batch Yes Yes 1 1 1 1 5 1 3 0919 0919 0772 +5C +5C +5C a a a 1754 1754 2009 2009 +5C +5C +5C +5C Monograph Leaflet Storage
6 December 2006
Order Code Y0000555 New Y0000658 Y0000141 Y0000142
Reference Standard
Iotrolan Iotrolan for system suitability Ioxaglic acid Ioxaglic acid impurity A
Extra charges a a a a
I0360000 Ipratropium bromide Y0000276 Ipratropium bromide impurity A
I0361000
Ipratropium bromide impurity B
Information Unit Sale Quantity Unit 100 mg 1 5 mg 1 125 mg 1 20 mg 1 3-amino-5[[(2-hydroxyethyl)amino]carbonyl]-2,4,6-trioiodobenzoic acid 120 mg 1 Batch 4 is valid until 31 October 2006 5 mg 1 (1R,3r,5S,8r)-3-hydroxy-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane 10 mg 1 (1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane +5C +5C +5C
96.6% CHO ; Batch 1 is valid until 31 July 2006
Yes
Batch 3 is valid until 31 August 2006 94.3% CHO 98.8% CHO 24.5% CHNO 99.9% CHNO; Isosorbide-5-nitrate
I0375000 I0380000 I0400000 Y0000037 I0460000 I0465000 Y0000070 I0500000 I0599990 I0600000 I0700000 I0725000 I0750000 I0775000 I0775010 I0775020 I0800000 I0900000 Y0000366 Y0000367 2 1 1 1 2 150 mg 150 mg 20 mg 150 mg 150 mg 1 1 1 1 1
Isoconazole Isoconazole nitrate Isoemetine hydrobromide Isoflurane - reference spectrum Isoleucine Isomalt Isomaltooligosaccharide Isoniazid Isoprenaline hydrochloride Isoprenaline sulphate Isopromethazine hydrochloride Isopropyl hexadecanoate Isopropyl tetradecanoate Isosorbide dinitrate Isosorbide mononitrate Isosorbide-2-nitrate Isotretinoin Isoxsuprine hydrochloride Isradipine Isradipine impurity D
1 1 1 n/a 1 2 1 1 1 2 4 2 3 1 2 2 3 1 1 1
200 mg 200 mg 25 mg n/a 50 mg 3000 mg 0.9 mg 100 mg 50 mg 500 mg 50 mg 100 mg 2 ml 250 mg 100 mg 50 mg 60 mg 50 mg 125 mg 5 mg
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1018 1017 0080,0081 1673 0770 1531 1506 0146 1332 0502 0524 0839 0725 1117,1118 1117,1118 1117,1118 0693,1019 1119 2110 2110 1335 1336 1982,1983,20702 1982,1983,20702 0032,0033,0645
Yes
+5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C
a a a l a a a a a a a a a g h f a a g g
I7000000 I8000010
Itraconazole Ivermectin
Y0000041 Josamycin Y0000042 Josamycin propionate K0100000 Kanamycin B sulphate
99.2% CHNO methyl 1-methylethyl 4-(2,1,3-benzoxadiazol-4-yl) -2,6-dimethylpyridine-3,5-dicarboxylate Batch 1 is valid until 31 January 2007 83.9% CHO (compound HB); 5.9% CHO (compound HB) 1000 Ph. Eur. units per mg 930 Ph. Eur. units per mg Batch 1 is valid until 31 December 2006
Yes
+5C +5C +5C +5C +5C
a a a a a For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch 2 +5C Unit Sale Quantity Unit 150 mg 1 799 IU per mg Information Monograph Leaflet Storage Extra charges a
6 December 2006
Order Reference Standard Code K0200000 Kanamycin monosulphate
Y0000450 K0551000 Y0000246 Y0000244 Y0000245 K0600000
Ketamine hydrochloride - * narc Ketamine impurity A Ketobemidone hydrochloride - reference spectrum Ketobemidone impurity B Ketobemidone impurity C Ketoconazole
1 1 n/a 1 1 1
10 mg 50 mg n/a 5 mg 5 mg 150 mg
1 1 1 1 1 1
+5C +5C +5C +5C +5C
k a l a a a
K1000000 K2000000 K2000010 K2000015 Y0000486 Y0000626 Y0000164 Y0000161
3-Ketofusidic acid Ketoprofen Ketoprofen impurity A Ketoprofen impurity C Ketorolac trometamol Ketorolac trometamol for peak identification Ketotifen hydrogen fumarate - reference spectrum Ketotifen impurity G
3 2 3 2 1 1 n/a 2
10 mg 50 mg 5 mg 5 mg 10 mg 5 mg n/a 3 mg
1 1 1 1 1 1 1 1
Yes
+5C +5C +5C +5C +5C +5C +5C
0032,0033,0053, 0485,0645,1289, 1290,20702 1020 1-[(2-chlorophenyl)(methylimino)methyl]cyclopentanol 1020,1742 1746 1-(4-(3-hydroxyphenyl)-1-methyl-4-piperidyl)ethanone 1746 1-(4-(3-hydroxyphenyl)-4-piperidyl)propan-1-one 1746 0921,1067,1270, 1335 Batch 2 is valid until 30 September 2006 0798,0848 Batch 1 is valid until 30 September 2006 0922,1157,1209 3-acetylbenzophenone 0922 2-(3-carboxyphenyl)propionic acid 0922 1755 1755 1592 4-(1-methylpiperidin-4-ylidene)-4H-benzo(4,5)cyclohepta(1,2-b) 1592 thiophen-9,10-dione a g a a g g l a +5C +5C +5C +5C +5C a a a a a
L0050000 L0129000 Y0000257 A1206000 L0100000 93.8% CHO
Labetalol hydrochloride Lactitol monohydrate Lactobionic acid Lactose (anhydrous) Lactose
1 2 1 1 1
80 mg 60 mg 100 mg 100 mg 100 mg
1 1 1 1 1
Yes
L0130000 Y0000188 Y0000425 Y0000518 Y0000426 New Y0000654 Y0000685 New Y0000487 New Y0000674 L0375000 L0376000 n/a n/a 1
Lactulose Lactulose for system suitability Lamivudine Lamivudine for system suitability 1 Lamivudine for system suitability 2 Leflunomide Letrozole Leflunomide impurity A Leflunomide for peak identification Leucine Leuprorelin
2 2 1 1 1 1 1 1 1 2 4
3000 mg 12 mg 150 mg 10 mg 10.3 mg 100 mg 70 mg 25 mg 1 mg 50 mg 0.925 mg
1 1 1 1 1 1 1 1 1 1 1
0923 1337 1647 1061 0177,0178,0187, 0188,0204,0209, 1215,1570 99.7% CHO 0924,1230 0924,1230 99.7% CHNOS 2217 2217 2217 2330 99.7% CHN 2334 4-(trifluoromethyl)aniline 2330 2330 0771,0874 0.925 mg per vial of pure leuprorelin peptide CHNO ; Batch 1442 3 is valid until 31 July 2006 1442
Yes
+5C +5C +5C +5C +5C +5C +5C +5C +5C +5C -20C
a a a a a g a g g a c l For extra charges please see 2.2
L0376001 Leuprorelin - reference spectrum
Catalogue No. 48-2006/4 Batch 1 1 n/a 1 1 +5C +5C 2 1 1 1 1 100 mg 60 mg 20 mg (2R)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol (dextrodropropizine) 1 1 1 1339 1339 0038 1535 1535 +5C +5C +5C +5C +5C a a a a a 0726,1728 0726 1728 1484 1484 Yes +5C +5C Monograph Leaflet Storage
6 December 2006
Order Code Y0000047 L0380000 Y0000048 L0390000 L0390008
Reference Standard
Levamisole for system suitability Levamisole hydrochloride Levamisole - reference spectrum Levocabastine hydrochloride Levocabastine impurity D
New L0399900 L0399905 L0400000 L0420000 L0420002
Levocarnitine Levocarnitine impurity A Levodopa Levodropropizine Levodropropizine impurity A
Information Unit Sale Quantity Unit 80 mg 1 50 mg 1 n/a 1 125 mg 1 20 mg 1 1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenyl-4-piperidine carboxylic acid 125 mg 1 Batch 1 is valid until 30 April 2007 50 mg 1 4-(trimethylammonio)but-2-enoate Extra charges a a l a a
L0500000 L0505000 L0551000 L0570000 L0595000 L0600000 L0650000 L0655000 L0700000 L0702000 L0702100 L0720000 1 1 1 1 1 1 3 1 1 1 1 1 1 60 mg 50 mg 50 mg 150 mg 15 mg 20 mg 60 mg 20 mg 10 mg 50 mg 100 mg 0.8 mg 10 mg 1 1 1 1 1 1 1 1 1 1 1 1 1
Levomepromazine hydrochloride Levomepromazine maleate Levonorgestrel Levothyroxine sodium Lidocaine Lidocaine hydrochloride Lincomycin hydrochloride Lindane Liothyronine sodium Lisinopril dihydrate Lisinopril dihydrate for performance test Lithium clavulanate
1 1 1 2 1 1 2 1 5 1 2 4
100 mg 50 mg 30 mg 100 mg 50 mg 100 mg 250 mg 250 mg 50 mg 50 mg 2 mg 125 mg
1 1 1 1 1 1 1 1 1 1 2 1
20303 0925,20303 0926 90.0% CHINNaO 0401,0728 0727,1362 0227,1242,1363 87.4% CHNOS 0582,0583,0996 0772 98.7% CHINNaO 0401,0728 1120 1120 98.8% CHLiNO; 1 mg of CHLiNO corresponds to 1.157 mg of 1140,1653 CHKNO
Yes
+5C +5C +5C +5C +5C +5C +5C +5C -20C +5C +5C +5C
a a a a a a a a a a a a
L0720800 Y0000112 L0745000 L0750000 Y0000322 Y0000341 New Y0000688 Y0000603 Y0000604 Y0000605 L0750500 New Y0000576 New Y0000718
Lithocholic acid Lobeline hydrochloride Lomustine Loperamide hydrochloride Loperamide hydrochloride for system suitability Loperamide oxide monohydrate Loratadine Loratadine for system suitability Loratadine impurity F Loratadine impurity H Lorazepam - * psy Lorazepam for system suitability Lorazepam impurity D
1189,1275 +5C a 1988 +5C a 0928 +5C a 0921,0929,1729 +5C g 0929 Yes +5C g 1729 +5C g 2124 +5C a 2124 Yes +5C a 2124 +5C a 2124 +5C a 1121 +5C j 1121 +5C j (5RS)-7-chloro-5-(2-chlorophenyl)-4,5-dihydro-1H-1,4-benzodia 1121 +5C a zepine-2,3-dione For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch 2 1 2 2 1 1 2 2 10 mg 1 99.3% CHOPS diethyl (2RS)-2-[(methoxy)(methylsulfanyl)-S-phosphinothioyl] butane dioate (isomalathion) diethyl (2RS)-2-(dimethoxy-S-phosphinothioyl)-butanedioate (maloxon) 1343 60 mg 250 mg 10 mg 1 1 1 +5C +5C -20C -20C +5C +5C +5C +5C +5C Yes Yes -20C +5C +5C a a c c -20C +5C +5C +5C Monograph Leaflet Storage
6 December 2006
Order Code L0790000 L0800000 Y0000397 L0900000 1538,1563 0558 2114 0805,0806,0930, 1654 1445 1343 1343
Reference Standard
Lovastatin Lynestrenol Lysine acetate Lysine hydrochloride
Information Unit Sale Quantity Unit 40 mg 1 99.7% CHO ; Batch 1 is valid until 31 October 2006 50 mg 1 60 mg 1 50 mg 1 Batch 1 is valid until 30 September 2006 Extra charges c a a a
M0088000 Magnesium aspartate dihydrate M0120000 Malathion M0120005 Malathion impurity A
M0120010 Malathion impurity B
M0100000 Y0000143 M0160000 M0200000 99.8% CHO ; Batch 1 is valid until 31 December 2006 98.6% CHO 1 1 100 mg 25 mg 1 1
Maleic acid Malic acid - reference spectrum Maltitol Mannitol
1 n/a 2 4
100 mg n/a 1200 mg 1200 mg
1 1 1 1
a l a a a a
M0206000 Maprotiline hydrochloride M0206040 Maprotiline impurity D
3-(9,10-dihydro-9,10-ethanoanthracen-9-yl)-N-methylprop-2en-1-amine; (dehydromaprotiline) 4.3 log (ie 20000) infective viral units per vial
0365,0925 2080 1235,1236 0435,0559,1381, 1531 1237 1237
Batch 1 is valid until 31 March 2007
Yes
+5C +5C +5C +5C -20C +5C +5C +5C
M0210000 M0215000 Y0000144 Y0000168 M0220000 M0240000 New M0250000 M0250010 Y0000598 M0252600 M0253000 M0260000 M0260100 Y0000267 M0300000 M0350000 M0370000 M0370020 M0400000 M0500000
Measles vaccine (live) BRP Mebendazole Mebendazole for system suitability Mebendazole - reference spectrum Meclozine hydrochloride Medronic acid Medroxyprogesterone acetate Medroxyprogesterone acetate for performance test Medroxyprogesterone acetate for system suitability Mefenamic acid Mefloquine hydrochloride Megestrol acetate Megestrol acetate - reference spectrum Meglumine - reference spectrum Menadione Menthol Mepivacaine hydrochloride Mepivacaine impurity B Meprobamate - * psy Mepyramine maleate
1 1 1 n/a 1 1 2 2 1 1 1 2 n/a n/a 1 4 1 1 1 1
80 mg 20 mg 20 mg n/a 150 mg 20 mg 100 mg 50 mg 10 mg 50 mg 100 mg 50 mg n/a n/a 100 mg 150 mg 100 mg 60 mg 100 mg 1000 mg
5 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
()-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
1057,0213 1208,1254 0845 0845 0622 0641 0673,1094,1593 0673 0673 1240 1241 0673,1593 1593 2055 0507 0619,0623 1242 1242 0407,1689 0278
+5C +5C +5C +5C +5C +5C
c a a l a a a a c a a a l l a a a a j a For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch +5C +5C +5C Monograph Leaflet Storage
6 December 2006
Reference Standard
Order Code New Y0000679 New Y0000680 Y0000297 Y0000337 Y0000316 Y0000317 Y0000227 Y0000097 Y0000096 M0600000 Y0000301 M0600500 New M0600900 M0600905 1 1 1 n/a 1 1 1 1 1 1 n/a 3 3 2 Yes +5C +5C +5C +5C +5C +5C +5C +5C +5C 0931 1128 1128 1129 1128 1127 1130 +5C +5C +5C 2 1 n/a n/a 1 n/a n/a n/a 1 200 mg n/a 1 1 n/a 1 50 mg 200 mg n/a 1 1 1 a a l l a l l 0278 0278 1699,1993 1674 1674 1674 1925 1730 1730 0509 2077 0272,0820 1346 1346
Mepyramine impurity A Mepyramine impurity C Mesalazine Mesna - reference spectrum Mesna impurity C Mesna impurity D Meso-rich exametazime Mesterolone Mesterolone impurity A Mestranol Metacresol - reference spectrum Metacycline hydrochloride Metamizole sodium Metamizole impurity A
Information Unit Sale Quantity Unit 10 mg 1 N-(4-methoxybenzyl)pyridin-2-amine 10 mg 1 125 mg 1 n/a 1 10 mg 1 2-(acetylsulphanyl)ethanesulphonic acid 10 mg 1 2,2'-disulphanediyl)bis(ethanesulphonic acid) 0.5 mg 1 60 mg 1 99.3% CHO 30 mg 1 17-hydroxy-1alpha-methylandrost-4-en-3-one 100 mg 1 n/a 1 100 mg 1 100 mg 1 Batch 2 is valid until 30 April 2007 10 mg 1 4-formylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-3-pyrazol3-one Extra charges a g a l a a a a a a l a a a
M0605000 Metformin hydrochloride New Y0000770 Methacrylic acid-ethyl acrylate copolymer (1:1) - type A M0610000 Methacrylic acid-ethylacrylate copolymer(1:1) - reference spectrum M0610030 Methacrylic acid-ethyl acrylate copolymer (1:1), dispersion 30%-ref.sp Y0000323 Methacrylic acid-ethyl acrylate copolymer (1:1) - type B M0620000 Methacrylic acid-methylmethacrylate copolymer(1:1)reference spectrum M0630000 Methacrylic acid-methylmethacrylate copolymer(1:2)reference spectrum M0800000 Methadone hydrochloride - reference spectrum Y0000428 Methanol - reference spectrum M0900000 Methaqualone - reference spectrum M0920001 Methenamine - reference spectrum M0950000 DL-Methionine M0960000 Methionine M1000000 Methotrexate Y0000602 Methotrexate for peak identification M1000008 Methotrexate impurity D n/a n/a n/a n/a 1 1 4 1 2 1 3 10 mg 20 mg 1 1 n/a n/a n/a n/a 50 mg 50 mg 100 mg 20 mg 10 mg 1 1 1 1 1 1 1 1 1
88.6% CHNO ; Batch 3 is valid until 28 February 2006
0408,1787 1989 0510 1545 0624 0788,1027 0560 0560 0560 4-[[(2-amino-4hydroxypteridin-6-yl)methyl]methyl-amino] benzoic acid 4-[[(2,4-diaminopteridin-6-yl)methyl]methylamino]benzoic acid (4-amino-N10-methylpteroic acid, APA) 0560 0045
Yes Yes
+5C +5C +5C +5C +5C +5C +5C
l l l l a a g g g g a For extra charges please see 2.2
New Y0000664 Methotrexate impurity E
M1100000 3-Methoxymethyldopa
Catalogue No. 48-2006/4 Batch +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C Monograph Leaflet Storage
6 December 2006
Reference Standard
Order Code M1300000 M1400000 M1450000 M1470000 M1500000 M1550000 M1551000 M1556000 Y0000398 New M1625000 M1650000 M1700000 M1750000 M1755000 M1755200 M1755220 Y0000190 M1770180 Y0000418 Y0000407 M1770200 M1800000 M1800900 M1800902 M1808000 M1824990 M1825000 M1824995 1 1 4 1 1 1 3 2 1 2 1 1 2 1 1 1 n/a 2 1 1 2 1 1 2 1 1 2 1 Yes +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C 1575 1028,1448 +5C +5C 1 1 g a 0511,0919 0512 0755 0318 0045,0755 0932 0678,1378 1497 2129 1108 0409,1262,2134 0189 0312,0388,0561 0933 0768,1131 1131 1675 0051 1990 1990 0051,1497 0410 1132 1132 1347 1348 0674,0856,1303 1348
Methylatropine bromide Methylatropine nitrate Methylcarbidopa Methyl 2-(4-chlorophenoxy)-2-methylpropionate Methyldopa Methylene chloride 2-(1-Methylethyl) pentanoic acid Methyl 12-hydroxystearate Methyl nicotinate Methylnitrosoindoline Methyl parahydroxybenzoate Methylphenobarbital - * psy Methylprednisolone Methylprednisolone acetate Methylprednisolone hydrogen succinate Methylprednisolone hydrogen succinate for performance test N-Methylpyrrolidone - reference spectrum Methyl ricinoleate Methylrosanilinium chloride Methylrosanilinium for system suitability Methyl stearate Methyltestosterone Methylthioninium chloride Methylthioninium impurity A Metixene hydrochloride Metoclopramide Metoclopramide hydrochloride Metoclopramide impurity A
Extra charges a a a a a a a a a a a j a a a a l a a a a a a a a a a a
M1825010 Metoclopramide impurity E Y0000145 Metoprolol impurity A
Information Unit Sale Quantity Unit 100 mg 1 100 mg 1 1 mg 1 0.5 ml 1 50 mg 1 2 ml 1 25 mg 1 100 mg 1 Batch 1 is valid until 31 January 2006 25 mg 1 100 mg 1 Batch 1 is valid until 30 April 2007 100 mg 1 500 mg 1 150 mg 1 100 mg 1 125 mg 1 50 mg 1 n/a 1 125 mg 1 Batch 1 is valid until 31 March 2006 40 mg 1 10 mg 1 100 mg 1 100 mg 1 50 mg 1 methylene blue 20 mg 1 3-(dimethylamino)-7-(methylamino)phenothiazin-5-ylium 75 mg 1 100 mg 1 50 mg 1 25 mg 1 4-(acetylamino)-5-chloro-N-(2-diethylaminoethyl)-2-methoxy benzamide 20 mg 1 N,N-diethylethane-1,2-diamine 10 mg 1 (2RS)-1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]propan2-ol
Y0000171 M1830000 M1845000 New M1850000 M1851000 Y0000069
Metoprolol succinate - reference spectrum Metoprolol tartrate Metrifonate Metronidazole Metronidazole benzoate Metronidazole benzoate - reference spectrum
n/a 1 1 2 1 n/a
n/a 60 mg 100 mg 50 mg 50 mg n/a
1 1 1 1 1 1
Batch 1 is valid until 31 March 2007
1448 1028 1133 0675,0934 1424 0934
+5C +5C +5C +5C
l a a a a l For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch 2 1 1 1 1 1 1 1 50 mg 70 mg 100 mg 0.08 mg acide 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a] [1,4]benzodiazepine-3-carboxylique 27.5% of silibinin (A+B) 90.8% CHClNO 0936,1065 2071 0936 1030 0937 1731 1731 50 mg 120 mg 1 mg 125 mg 50 mg 30 mg 5 mg 1 1 1 1 1 1 1 1 1 1 1 2 1 1 2 1 1 1 1029 0846 0935,1335 0513,1148 0936 +5C +5C +5C +5C +5C +5C -20C +5C +5C +5C -20C -20C a a a a a j c j a a g c 0675 1029 1029 +5C +5C +5C Information Unit Sale Quantity Unit 10 mg 1 2-methyl-4-nitroimidazole ; Batch 1 is valid until 30 April 2007 100 mg 1 2 mg 1 1,1'-[(3,3',5,5'-tetramethylbiphenyl-4,4'-diyl)bisoxy] dipropan-2-amine 2 mg 1 (2RS)-2-(2,6-dimethylphenoxy)propan-1-amine Monograph Leaflet Storage Extra charges a a a
6 December 2006
Order Reference Standard Code New Y0000087 Metronidazole impurity A M1860000 Mexiletine hydrochloride Y0000202 Mexiletine impurity C
Y0000203 M1875000 M1880000 M1900000 Y0000562
Mexiletine impurity D Mianserin hydrochloride Miconazole Miconazole nitrate Midazolam impurity C
M2200000 Y0000539 Y0000599 M2280000 M2300000 Y0000490 Y0000491
Midazolam - * psy Milk thistle standardised dry extract Midazolam for system suitability - * psy Minocycline hydrochloride Minoxidil Misoprostol Misoprostol impurity A
Y0000378 Mitomycin M2305000 Mitoxantrone hydrochloride M2305005 Mitoxantrone impurity A
1 2 3
120 mg 60 mg 5 mg
1 1 1
99.2% CHO mixture of methyl 7-[(1RS,2SR, 3SR)-3-hydroxy-2-[(1E,4RS)-4-hydroxy-4-methyloct1-enyl]-5-ox ocyclopentyl]heptanoate and methyl 7-[(1RS,2SR,3SR)-3-hydroxy-2-[(1E,4SR)-4-hydroxy4-methyloct -1-enyl]-5-oxocyclopentyl]heptanoate (8-epimisoprostol), 99.1% CHNO 97.8% CHClNO 1-amino-5,8-dihydroxy-4-[[2-[(2-hydroxyethyl)amino]ethyl] amino]anthracene-9,10-dione ; Batch 2 is valid until 31 March 2006 100.0% CHNOS 13.45 mg protein per ml
1655 1243 1243
+5C +5C +5C
g a a
Y0000635 Y0000636 Y0000251 M2900000 Y0000028 Y0000451 Y0000452 Y0000226 Y0000222
Modafinil Modafinil for system suitability Molgramostim Mometasone furoate Morantel hydrogen tartrate Morphine hydrochloride (trihydrate) - * narc Morphine sulphate - * narc Moxonidine Moxonidine impurity A
1 1 1 1 2 1 1 1 1
110 mg 0.1 mg 0.3 ml 100 mg 50 mg 10 mg 40 mg 50 mg 10 mg
1 1 1 1 1 1 1 1 1
99.7% CHClNO 4,6-dichloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2-methyl-5pyrimidinamine 4.6 log (ie40000) infective viral units per vial
2307 2307 1641 1449 1546 0097 1244 1758 1758
Yes
+5C +5C -80C +5C +5C +5C +5C +5C +5C
a a d a a k k a a
M3600000 Mumps vaccine (live) BRP M3805000 Mupirocin - reference spectrum M3805500 Mupirocin calcium - reference spectrum M3806000 Mupirocin lithium Council of Europe, all rights reserved 2006
1 n/a n/a 1
33 mg n/a n/a 100 mg
5 1 1 1
95.4% CHOLi
0538,1057 Yes -80C d 1450 l 1451 l 1450,1451 +5C a For extra charges please see 2.2
6 December 2006
Reference Standard
Order Code Y0000489 Y0000519 Y0000692 Y0000690 Y0000691 Y0000689 Y0000485 N0020000 N0020020 N0020030 Y0000146 N0025000 Y0000077 Y0000120 1 2 1 1 1 1 1 1 1 2 1 1 n/a 1 Yes Yes Yes Yes Yes +5C 1594 1594 1594 +5C +5C +5C 1 1 1 a a a 1700 1700 20607 20607 20607 20607 1805 1350 1350 1350 1789 0828,1134 1594 1594 +5C +5C -80C -80C -80C -80C +5C +5C +5C +5C +5C +5C
Mycophenolate mofetil Mycophenolate mofetil for peak identification Mycoplasma fermentans BRP Mycoplasma hyorhinis BRP Mycoplasma orale BRP Mycoplasma synoviae BRP Myo-inositol Nabumetone Nabumetone impurity D Nabumetone impurity F Nadolol Nadroparin calcium Naftidrofuryl - reference spectrum Naftidrofuryl impurity A
Extra charges a a d d d d a a a a a a l a
Y0000121 Naftidrofuryl impurity B
Y0000122 Naftidrofuryl impurity C
Y0000331 Naftidrofuryl impurity F
Information Unit Sale Quantity Unit 30 mg 1 10 mg 1 Batch 1 is valid until 30 June 2006 1 ml 1 1 ml 1 1 ml 1 1 ml 1 1020 mg 1 99.8% CHO 60 mg 1 99.8% CHO 10 mg 1 (E)-4-(6-methoxynaphthalen-2-yl)but-3-en-2-one 10 mg 1 6,6'-dimethoxy-2,2'-binaphthalenyl 100 mg 1 250 mg 1 n/a 1 10 mg 1 2-[(naphtalen-1-yl)methyl]-3-(tetrahydrofuran-2-yl)propanoic acid 25 mg 1 98% CHO; ethyl 2-[(naphtalen-1-yl)methyl]3-(tetrahydrofuran-2-yl)propanoate 50 mg 1 97.5% CHNO; 2-(diethylamino)ethyl 3-[(naphtalen-1-yl)2-[(naphtalen-1-yl)methyl]propanoate 10 mg 1 2-[(diethylamino)ethyl 2-[(naphthalen-2-yl)methyl]-3(tetrahydrofuran-2-yl)propanoate
Yes
N0050000 N0075000 N0075005 New Y0000695 Y0000400 Y0000410 Y0000542 Y0000547 Y0000548 N0080000 Y0000252 N0100000 N0200000
Nalidixic acid Naloxone hydrochloride dihydrate Naloxone impurity A Naloxone for peak identification Naltrexone hydrochloride Naltrexone impurity C Nandrolone decanoate Nandrolone decanoate for peak identification Nandrolone decanoate for system suitability Naphazoline hydrochloride Naphazoline hydrochloride - reference spectrum Naphazoline nitrate Naphazoline impurity A
1 1 2 1 1 1 1 1 1 3 n/a 2 3
100 mg 100 mg 10 mg 10 mg 50 mg 15 mg 5 mg 10 mg 10 mg 50 mg n/a 10 mg 25 mg
1 1 1 1 1 1 1 1 1 1 1 1 1
Yes
+5C +5C +5C +5C +5C +5C -20C -20C -20C +5C +5C +5C
0701 0729,2099 4,5-epoxy-3,14-dihydroxymorphinan-6-one (noroxymorphone) 0729 0729 1790 N-(3-butenyl)-noroxymorphone 1790 1992 1992 1992 1162 0730 0147 N-(2-aminoethyl)-2-(naphthalen-1-yl)acetamide 0147,0730 (naphthylacetylethylenediamine)
a a a a a a c c c a l a a
N0250000 Y0000399 Y0000631 N0300000
Naproxen Naproxen (racemic) Naproxen impurity L Neamine
1 1 1 3
100 mg 10 mg 10 mg 0.5 mg
1 1 1 1
90.0% CHNO
0731 0731 1702 0180,0197
+5C +5C +5C +5C
a a a a For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch 1 1 Yes -20C +5C Leaflet Storage Extra charges a a
6 December 2006
Order Reference Standard Code N0399000 Neohesperidin-dihydrochalcone N0399004 Neohesperidin-dihydrochalcone impurity B
N0400000 Neomycin sulphate
Yes
-20C
N0401000 N0500000 N0550000 N0559000 Y0000520 Y0000521 Y0000388
Neomycin sulphate for microbiological assay Neostigmine bromide Neostigmine metilsulfate Netilmicin sulphate Nevirapine (anhydrous) Nevirapine for peak identification Newcastle Disease Vaccine (inactivated) BRP
2 1 1 1 1 1 1
Yes
Information Unit Sale Monograph Quantity Unit 125 mg 1 89.9% CHO 1547 10 mg 1 89% CHO; 7-[[2-O-(6-deoxy--L-mannopyranosyl) 1547 --D-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyph enyl)-4H-1-benzopyran-4-one (neodiosmin) 50 mg 1 Not to be used for microbiological assay 0032,0033,0053, 0180,0197,0485, 0645 19850 IU per vial ; Batch 1 is valid until 31 December 2005 25 mg 1 0197,20702 50 mg 1 0046 50 mg 1 0626 25 mg 2 14656 IU per vial 1351,20702 99.8% CHNO 30 mg 1 2255 0.058 mg 1 2255 4 uc 1 The kit contains :1 vial BRP1 NDV reference antigen, 1 vial BRP1 0870 NDV control antigen, 1 vial BRP1 NDV coating antibody, 1 vial BRP1 NDV conjugated, detection antibody Yes Yes -20C +5C +5C -20C +5C +5C -20C a a a a g g c n/a 10 mg 1 1 [(6aR,9R,10aS)-10a-methoxy-4,7-dimethyl-4,6,6a,7,8,9,10,10aoctahydroindol[4,3-fg]quinolin-9-yl]methyl 5-chloropyridine-3-carboxylate 1998 1998 +5C l a
Y0000287 Nicergoline - reference spectrum Y0000283 Nicergoline impurity A
n/a 1
+5C +5C +5C +5C +5C +5C 0627 +5C
N0560000 N0600000 N0590000 N0590200 N0700000 N0750000 N0750010 92.6% CHN x 2 CHO 1 20 mg 1
Niclosamide (anhydrous) Nicotinamide Nicotine - reference spectrum Nicotine ditartrate Nicotinic acid Nifedipine Nifedipine impurity A
1 1 n/a 2 1 1 1
50 mg 50 mg n/a 20 mg 100 mg 50 mg 20 mg
1 1 1 1 1 1 1
0679,0680 0047 1452,1792 1452,1792 0459,0859 0627,1013 0627
a a l a a a a a
N0750015 Nifedipine impurity B
Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5dicarboxylate Dimethyl 2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5dicarboxylate
Y0000178 N0800000 N0845000 N0845006 N0845008 N0850000 N0850010
Nifuroxazide - reference spectrum Nikethamide Nimesulide Nimesulide impurity C Nimesulide impurity D Nimodipine Nimodipine impurity A
n/a 1 1 1 1 2 2
n/a 1 ml 100 mg 25 mg 20 mg 50 mg 1 ml
1 1 1 1 1 1 1
2-phenoxyaniline 4-nitro-2-phenoxyaniline 2-methoxyethyl 1-methylethyl 2,6-dimethyl-4-(3-nitrophenyl) pyridine-3,5-dicarboxylate
1999 0233 1548 1548 1548 1245 1245
Yes
+5C +5C +5C +5C +5C +5C
l a a a a a a
N0900000 Nitrazepam - * psy N0900010 Nitrazepam impurity A
1 1
100 mg 25 mg
1 1
3-amino-6-nitro-4-phenylquinol-2-one
0415,0898,1121 0415
+5C +5C
j a For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch 2 2 1246 1246 +5C +5C Information Unit Sale Quantity Unit 60 mg 1 20 mg 1 ethyl methyl-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5dicarboxylate; (nitrophenylpyridine analogue) Monograph Leaflet Storage Extra charges a a n/a 100 mg 50 mg n/a 250 mg 10 mg 99.8% CHNO 1 1 1 1 1 1 +5C +5C +5C +5C 1550 1135 0058 0416 99.3% CHNOS 1453 (EZ)-N,N'-[thiazole-2,4-diylbis(methylenesulphanediylethylene)] 1453 bis(N'-methyl-2-nitroethene-1,1-diamine) 17-acetoxy-6-methyl-19-norpregn-4-ene-3,20-dione 99.1% CHNO l a a l a a +5C +5C +5C +5C +5C a a g l g g
6 December 2006
Order Reference Standard Code N0905000 Nitrendipine N0905005 Nitrendipine impurity A n/a 1 1 n/a 1 1 1 1 1 n/a 4 1 100 mg 50 mg 10 mg n/a 200 mg 15 mg 1 1 1 1 1 1 1551 1551 2336,2337 1454 0254,0285,0732 4[(1R)-2-amino-1-methoxyethyl]benzene-1,2-diol (noradrenaline 0285,0732 methyl ether) 2-chloro-1-(3,4-dihydroxyphenyl)ethanone 0285,0732 N-benzyl-1-phenylmethanamine 0285,0732 Dipotassium clorazepate impurity B Batch 1 is valid until 31 May 2007
N0930000 N0950000 N1000000 N1050000 N1090000 N1090060
Nitric oxide - reference spectrum Nitrofural Nitrosotriaminopyrimidine Nitrous oxide - reference spectrum Nizatidine Nizatidine impurity F
N1080000 N1080005 Y0000670 N1084000 N1100000 New Y0000681
Nomegestrol acetate Nomegestrol acetate impurity A Nonivamide Nonoxinol 9 - reference spectrum Noradrenaline tartrate Noradrenaline impurity D
New Y0000682 Noradrenaline impurity E New Y0000686 Noradrenaline impurity F N1130000 Norcyclobenzaprine N1140000 Nordazepam -* psy New N1200000 Norethisterone N1225000 Norethisterone acetate Y0000522 Norethisterone for system suitability N1230000 Norfloxacin N1230010 Norfloxacin impurity A
1 1 1 1 2 1 1 1 1
10 mg 10 mg 25 mg 50 mg 100 mg 100 mg 10 mg 50 mg 20 mg
1 1 1 1 1 1 1 1 1
7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3carboxylic acid (corresponding also to pefloxacin impurity F) Cathine
0941 0898,1466 0234,1212 0850 0234 1248 1248,1460
Yes
+5C +5C +5C +5C +5C +5C -20C +5C +5C
a a a j a a c a a
5600 IU per mg CHNO
Yes
N1250000 N1279000 N1280000 N1300000 N1400000 O0100900 Y0000368 O0101000 O0120000 O0120010
Norgestrel Norpseudoephedrine hydrochloride - * psy Nortriptyline hydrochloride Noscapine Nystatin Octoxinol 10 Octyl gallate Octyldodecanol Ofloxacin Ofloxacin impurity A
1 2 2 1 4 2 1 4 1 1
30 mg 50 mg 10 mg 100 mg 300 mg 300 mg 30 mg 400 mg 50 mg 20 mg
1 1 1 1 1 1 1 1 1 1
94.8% CHO (RS)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de][1,4]benzoxazine-6-carboxylic acid (FPA)
0940 0683 0941 0102,0515,0516 0517,1292,20702 1553 2057 1136 1455 1455
+5C +5C +5C +5C -20C +5C +5C +5C +5C +5C
a j a a c a a a a a
Catalogue No. 48-2006/4 Batch 2 1455 +5C Information Unit Sale Quantity Unit 20 mg 1 (RS)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid ; Batch 1 is valid until 31 March 2007 Monograph Leaflet Storage Extra charges a Yes
6 December 2006
Order Reference Standard Code New O0120050 Ofloxacin impurity E
Omeprazole sulphone 89.8% CHClNO
O0146000 O0146010 O0150000 O0151000 Y0000218 Y0000197 Y0000196 Y0000195 O0180000 Y0000101 Y0000100 Y0000102 9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one Batch 1 is valid until 31 January 2007 1 1 1 2 3 150 mg 110 mg 10 mg 250 mg 20 mg 1 1 1 1 1 (RS)-N,N-dimethyl-2-[(3-methylphenyl)phenylmethoxy] ethanamine (meta-methylbenzyl isomer) 80.0% CHO 93.8% CHNNaOS 0048 2260 2260 2017 2017
Olsalazine sodium Olsalazine sodium for performance test Omeprazole Omeprazole impurity D Ondansetron hydrochloride dihydrate Ondansetron for LC system suitability Ondansetron for TLC system suitability Ondansetron impurity D Orciprenaline sulphate Orphenadrine citrate Orphenadrine hydrochloride Orphenadrine impurity E
1 1 2 2 2 1 1 2 2 1 1 1
60 mg 60 mg 50 mg 5 mg 200 mg 10 mg 30 mg 10 mg 100 mg 100 mg 100 mg 30 mg
1 1 1 1 1 1 1 1 1 1 1 1
1457 1457 0942,1032 0942,1032 2016 2016 2016 2016 1033,1332 1759 1760 1759,1760
+5C +5C -20C -20C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C
a a c c g g g g a a a a a a a g g
O0200000 Y0000638 Y0000560 Y0000271 Y0000272
Ouabain Oxacillin sodium monohydrate Oxacillin for peak identification Oxaliplatin Oxaliplatin impurity B
Y0000273 Oxaliplatin impurity C
10 mg
2017
+5C
Y0000274 Oxaliplatin impurity D
5 mg
99.8 % CHNOPt ; Batch 1 is valid until 28 February 2007 (SP-4-2)-diaqua[(1R,2R)-cyclohexane-1,2-diamine-kN,kN'] platinum (diaquodiaminocyclohexaneplatinum) ; Batch 2 is valid until 31 October 2006 (OC-6-33)-[(1R,2R)-cyclohexane-1,2-diamine-kN,kN'][ethanedioato(2-)-kO,kO]dihydroxyplatinum ; Batch 1 is valid until 31 July 2006 (SP-4-2)-[(1S,2S)-cyclohexane-1,2-diamine-kN,kN'][ethanedioato(2-)-kO,kO]platinum (S,S-enantiomer of oxaliplatin)
2017
+5C
O0225000 Y0000543 Y0000350 Y0000404 Y0000390
Oxazepam - * psy Oxazepam for peak identification - * psy Oxeladin hydrogen citrate Oxeladin impurity C Oxeladin impurity D
1 1 1 1 1
50 mg 0.008 mg 50 mg 10 mg 20 mg
1 1 1 1 1
2-(diethylamino)ethyl 2-ethyl-2-phenylbutanoate 2-(2-diethylaminoethoxy)ethyl 2-phenyl-butyrate dihydrogen citrate 1 1 1 1 methyl [5-(phenylsulphonyl)-1H-benzimidazole-2-yl]carbamate
0778,1191 0778 1761 1761 1761 1458 1458 1458 2170
Yes
+5C +5C +5C +5C +5C +5C +5C +5C +5C
j j g g g a a a a
O0225800 Y0000224 Y0000225 New Y0000709
Oxfendazole for veterinary use Oxfendazole impurity B Oxfendazole with impurity D Oxitropium bromide
2 1 1 1
50 mg 10 mg 10 mg 50 mg
Catalogue No. 48-2006/4 Batch 1 +5C Leaflet Storage Extra charges a
6 December 2006
Order Reference Standard Code New Y0000715 Oxitropium bromide impurity B
Y0000713 Oxitropium bromide impurity D
Information Unit Sale Monograph Quantity Unit 15 mg 1 (1R,2R,4S,5S,7s)-7-[[(2S)-3-hydroxy-2-phenylpropanoyl]oxy]-9, 2170 9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane (methylhyoscine) 10 mg 1 (1R,2R,4S,5S,7s,9r)-9-ethyl-9-methyl-7-[(2-phenylprop-2-enoyl) 2170 oxy]-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane (apo-N-ethylhyoscine) +5C g 50 mg 20 mg 20 mg 8-hydroxy-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid ethyl 5-ethyl-8-oxo-5,8-dihydro-1,3-dioxolo[4,5-g]quinoline-7carboxylate 0628,0876,1072 1386 1251 1354 1354 1793 1793 50 mg 100 mg 150 mg 150 mg 10 mg 4-(diethylamino)but-2-ynyl()-2-(cyclohex-3-enyl)-2cyclohexyl-2-hydroxyacetate 7,8-didehydro-4,5 alpha-epoxy-14-hydroxy-3-methoxy -17-methylmorphinan-6-one (14-hydroxycodeinone) 100 mg 25 mg 1 1 1 1 1 1 1 1 1 1 1353 1353 1353 +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C a a a a a a a a k a
O0240000 Oxolinic acid O0240005 Oxolinic acid impurity A O0240010 Oxolinic acid impurity B 1 1 1 1 2 1 1
1 1 1
O0250000 O0260000 O0270000 O0288000 O0288005
Oxprenolol hydrochloride Oxybendazole Oxybuprocane hydrochloride Oxybutynin hydrochloride Oxybutynin impurity A
Y0000492 Oxycodone hydrochloride - * narc Y0000453 Oxycodone impurity D
O0290000 O0300000 O0400000 New O0500000 O0700000 O0770000 P0090000 Y0000524 P0100000 3 1 1 1 2 n/a n/a n/a n/a 1 2000 mg 100 mg 20 mg 25 mg 100 mg n/a n/a n/a n/a 250 mg 1 1 1 1 1 1 1 1 1 1
Oxymetazoline hydrochloride Oxyphenbutazone Oxytetracycline Oxytetracycline hydrochloride Oxytocin Oxytocin/Desmopressin validation mixture Palmitic acid Pamidronate disodium pentahydrate Pancreas powder (amylase and lipase) BRP
1 1 6 4 3 2 3 1 3
80 mg 100 mg 100 mg 20 mg 41 mg 0.2 mg 100 mg 10 mg 2000 mg
1 1 1 1 1 1 1 1 1
90.2% CHNO ; Batch 5 is valid until 31 December 2005 Batch 3 is valid until 31 March 2007 1.24 mg per vial of CHNOS about 0.1 mg oxytocin + 0.1 mg desmopressin per vial Batch 2 is valid until 31 March 2006
0943 0418 0198,0199 0198,1030 0779,0780 0712,0779,0780 0229,0882,2058 1779 0350
+5C +5C +5C +5C -20C -20C +5C +5C +5C +5C +5C +5C +5C +5C
a a a a c c a a a
P0200000 P0250000 Y0000577 P0270000 P0300000 P0302000 Y0000058 Y0000293 P0302500 P0305000
Pancreas powder (protease) BRP Pancuronium bromide Pancuronium bromide for system suitability Papaverine hydrochloride Paracetamol Paraffin, hard - reference spectrum Paraffin, liquid - reference spectrum Paraffin (white soft) - reference spectrum Paraffin, yellow soft - reference spectrum Parnaparin sodium
41.4 Ph. Eur. U. lipolytic activity per mg; 56.3 Ph. Eur. U. amylolytic activity per mg ; Batch 2 is valid until 31 October 2006 1.48 Ph. Eur. U. per mg ; Batch 2 is valid until 31 October 2006 0350 Vecuronium impurity B 0681,1769 0681 0102,0573 0049 1034 0239,0240 1799 1554 0828,1252
+5C
a g g a a l l l l a For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch 1 1 2 1 2 2018,2283 2283 +5C +5C g g 2283 2018,2283 2018,2283 +5C +5C +5C Monograph Leaflet Storage Extra charges g g g
6 December 2006
Order Reference Standard Code Y0000578 Paroxetine hydrochloride (anhydrous) Y0000281 Paroxetine hydrochloride hemihydrate Y0000233 Paroxetine impurity A
Y0000579 Paroxetine hydrochloride (anhydrous) impurity C
Y0000256 Paroxetine impurity D
Y0000580 Paroxetine impurity E
Information Unit Sale Quantity Unit 100 mg 1 100 mg 1 97.4% CHClFNO 5 mg 1 (3S,4R)-3-[[1,3-benzodioxol-5-yloxy]methyl]-4-phenylpiperidine (desfluoroparoxetine) 10 mg 1 (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluorophenyl)piperidine (N-benzylparoxetine) 5 mg 1 (3R,4S)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl) piperidine ((+)-trans-paroxetine) ; Batch 1 is valid until 31 July 2006 5 mg 1 (3RS,4RS)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4fluorophenyl)piperidine (cis-paroxetine) 10 mg 1 [(3S,4R)-1-benzyl-4-(4-fluorophenyl)piperidin-3-yl]methanol 2283 +5C g 5 mg 200 mg 10 mg 1 1 1 2283 2018 1460 1460 Yes +5C +5C +5C +5C g g a a
Y0000581 Y0000630 P0309000 P0309020
Paroxetine hydrochloride (anhydrous) impurity H Paroxetine for system suitability Pefloxacin mesilate dihydrate Pefloxacin impurity B
1 1 1 1
P0309030 Pefloxacin impurity C 1 1 100 mg 20 mg 1 1
0.01 mg
1-ethyl-6-chloro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (chlorinated homologue of pefloxacin) 1-ethyl-6-fluoro-5-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (isopefloxacin) (2S)-1-[2-(cyclopent-1-enyl)phenoxy]-3-[(1,1-dimethylethyl) amino]propan-2-ol
1460 1461 1461
+5C +5C +5C
a a a
P0307000 Penbutolol sulphate P0307005 Penbutolol impurity A
10.0% CHNO
+5C +5C +5C +5C
P0310000 P0320000 P0400100 P0405000 P0405500 P0405510 Y0000417 P0500000 P0510000 Y0000076 Y0000098 Y0000099 2 1 1 1 1 2000 mg 150 mg 10 mg 40 mg 30 mg 1 1 1 1 1
Penicillamine Penicillamine disulphide Pentaerythrityl tetranitrate diluted Pentamidine diisetionate Pentazocine - reference spectrum Pentazocine hydrochloride - reference spectrum Pentazocine lactate - reference spectrum Pentobarbital - * psy Pentoxifylline Pentoxyverine hydrogen citrate - reference spect. Pentoxyverine impurity A Pentoxyverine impurity B
1 1 1 1 n/a n/a n/a 1 1 n/a 1 1
100 mg 100 mg 600 mg 30 mg n/a n/a n/a 500 mg 100 mg n/a 10 mg 10 mg
1 1 1 1 1 1 1 1 1 1 1 1
P0525000 Y0000010 Y0000237 Y0000207 Y0000206
Pepsin powder BRP Pergolide mesilate Perindopril impurity A Perindopril for stereochemical purity Perindopril for system suitability
1-phenylcyclopentanecarboxylic acid 2-(diethylamino)ethyl 1-phenylcyclopentanecarboxylate (caramiphen) 0.99 Ph. Eur. U. per mg 99.9% CHNOS (2S,3aS,7aS)-octahydro-1Hindole-2-carboxylic acid
0566 0566 1355 1137,1436 1462 1463 2000 0200,0419 0851 1621 1621 1621 0682 1555 2019 2019 2019
+5C +5C +5C +5C
a a h a l l l j a l a a
Yes Yes
+5C +5C +5C +5C +5C
6 December 2006
Reference Standard
Order Code Y0000238 P0550000 Y0000021 P0600000 P0600002 P0800000 New P0850000 New P0900000 P0950000 P1000000 P1100000 2 1 1 n/a 1 1 2 3 2 2 3 Yes +5C +5C +5C +5C +5C +5C +5C +5C +5C -20C
Perindopril tert-butylamine Perphenazine Pertussis toxin BRP Pethidine hydrochloride - reference spectrum Pethidine impurity A Phenazone Pheniramine maleate Phenobarbital - * psy Phenoxyethanol Phenoxymethylpenicillin Phenoxymethylpenicillin potassium
Information Unit Sale Quantity Unit 40 mg 1 100 mg 1 0.05 mg 2 n/a 1 20 mg 1 1-methyl-4-phenylpiperidine (MPP) 50 mg 1 250 mg 1 Batch 1 is valid until 30 April 2007 250 mg 1 Batch 2 is valid until 30 April 2006 2 ml 1 250 mg 1 250 mg 1 99.0% CHKNOS Extra charges a a f l a a a j a a a
(4-butyl-4-hydroxy-1,2-diphenyl-3,5)-pyrazolidinedione
+5C +5C +5C +5C +5C +5C
P1109000 P1150000 P1200000 Y0000147 P1240000 P1250000 New Y0000683 Y0000229 P1255100 P1260000 P1290000 P1300000 Y0000493 P1400000 P1500000 P1600000 P1605000 P1609000 Norephedrin
Phentolamine mesilate - reference spectrum Phenylalanine Phenylbutazone Phenylbutazone impurity B Phenylephrine Phenylephrine hydrochloride Phenylephrine hydrochloride for peak identification Phenylmercuric acetate - reference spectrum Phenylmercuric borate - reference spectrum Phenylpropanolamine hydrochloride - * Drug Precursor Phenytoin Phenytoin sodium Phloroglucinol (anhydrous) Pholcodine - reference spectrum Phthalylsulfathiazole Physostigmine salicylate Physostigmine sulphate Phytomenadione
n/a 3 1 1 1 2 1 n/a n/a 1 1 1 1 n/a 1 1 1 3
n/a 60 mg 100 mg 20 mg 60 mg 50 mg 2 mg n/a n/a 50 mg 100 mg 250 mg 210 mg n/a 100 mg 100 mg 100 mg 150 mg
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
87.0% trans-phytomenadione, 12.6% cis-phytomenadione, 0.09% trans-epoxyphytomenadione; Vitamin K1 ; Batch 2 is valid until 28 February 2007
2019 0629,0904 See leaflet,1356 0420 0420 0421 1357 0189,0201,0630 0781 0148 0113,0114,0148, 0149 1138 0782,0796,1161 0422,1574 0422 1035 0632,1205 0632,1035 2042 0103 0683 1253,1988 0521 2301,2302 0522 0352 0286 0684 1036 +5C +5C +5C +5C Yes +5C +5C +5C +5C l a a a a a a l l i a a a l a a a a
P1609010 P1645000 P1645005 Y0000124 1 1 125 mg 50 mg
trans-Epoxyphytomenadione Picotamide monohydrate Picotamide impurity A Pidolate impurity B
2 1 1 1
10 mg 125 mg 25 mg 50 mg
1 1 1 1 1 1
4-methoxybenzene-1,3-dicarboxylic acid (2S)-2-[[[(2S)-5-oxopyrrolidin-2-yl]carbonyl]amino]pentanedioic acid
1036 1358 1358 1619 1619 0633
+5C +5C +5C +5C
a a a a +5C a +5C a For extra charges please see 2.2
Y0000123 Pidolic acid P1650000 Pilocarpine hydrochloride Council of Europe, all rights reserved 2006
Catalogue No. 48-2006/4 Batch +5C +5C +5C +5C +5C +5C Monograph Leaflet Storage
6 December 2006
Reference Standard
Order Code P1700000 Y0000106 Y0000525 Y0000401 P1750000 P1800000 Y0000061 P1890000 P1900000 P2000000 P2100000 Y0000288 Y0000038 P2120000 P2120002 P2130000 P2130100 P2150000 P2152000 P2152015 1 1 1 1 1 1 n/a 3 1 1 1 2 1 1 1 2 3 1 1 1 Yes +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C 0104 0104,0633 2179 2179 1254 0634,0871,1789 1743 1168,1169 0423 0424 0425 1733 2001 1556 1556 0944 0944 0808,0852 1359 1359
Pilocarpine nitrate Pilocarpine nitrate for system suitability Pimobendan Pimobendan for system suitability Pimozide Pindolol Pipemidic acid trihydrate - reference spectrum Piperacillin Piperazine adipate Piperazine citrate Piperazine hydrate Piracetam Pirenzepine dihydrochloride monohydrate Piretanide Piretanide impurity A Piroxicam Piroxicam for system suitability Pivampicillin Pivmecillinam hydrochloride Pivmecillinam impurity C
Extra charges g g a g a a l a a a a a a a a a a a a a
P2155001 Plastic additive 01 1 1 1 2 1 1 250 mg 1 250 mg 1
90001,90002,30114 90001,30114
+5C +5C +5C +5C +5C +5C +5C
a a a a a a a
P2155003 Plastic additive 03
E0800000 Plastic additive 04 P2155005 Plastic additive 05 P2155008 Plastic additive 08
Information Unit Sale Quantity Unit 50 mg 1 20 mg 1 10 mg 1 0.1 mg 1 150 mg 1 100 mg 1 n/a 1 100 mg 1 94.5% CHNOS 250 mg 1 250 mg 1 250 mg 1 120 mg 1 99.8% CHNO ; Batch 1 is valid until 31 March 2006 250 mg 1 100 mg 1 20 mg 1 4-phenoxy-3(1H-pyrrol-1-yl)-5-sulphamoylbenzoic acid 100 mg 1 10 mg 1 Batch 2 is valid until 31 March 2007 50 mg 1 99,2% CHNOS 100 mg 1 99.0% CHClNOS 10 mg 1 methylene 2,2-dimethylpropanoate (2RS,4S)-2-[[[(hexahydo1H-azepin-1-yl)methylene]amino]methyl]-5,5-dimethylthiazolidin -4-carboxylate 2 ml 1 (2RS)-2-ethylhexyl) benzene-1,2-dicarboxylate Synonym: di(2-ethylhexyl)phthalate 100 mg 1 N,N'-ethylenedialcanamide Synonym: N,N'-diacylethylenediamines 500 mg 1 Epoxidised soya oil 500 mg 1 Epoxidised linseed oil 500 mg 1 Ethylene bis [3,3-di(3-1,1-dimethylethyl-4-hydroxyphenyl) butyrate] R
30101 90001,30114 30103,30104,30105, 30106 30103,30105,30106, 30107 30103,30105,30106, 30107
500 mg
4,4',4''-[(2,4,6-trimethylbenzene-1,3,5-triyl)tris(methylene)]tris[2,6-bis(1,1-dimethylethyl)phenol] Synonym: 2,2',2'',6,6',6''-hexatert-butyl-4,4',4''-[2,4,6-trtimethyl-1,3,5benzenetriyl)trismethylene]triphenol Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate ; Batch 1 is valid until 31 August 2006
30103,30105,30106, 30107
+5C
Catalogue No. 48-2006/4 Batch 2 1 1 1 1 1 1 1 1 1 100 mg 100 mg 1 1 500 mg 500 mg 100 mg 100 mg 1 1 1 1 200 mg 500 mg 1 1 +5C +5C +5C +5C +5C +5C +5C +5C 250 mg 1 +5C a a a a a a a a a +5C Information Unit Sale Quantity Unit 200 mg 1 Tris (2,4-di-1,1-dimethylethylphenyl) phosphite R Monograph Leaflet Storage Extra charges a
6 December 2006
Order Reference Standard Code P2155012 Plastic additive 12
P2155014 Plastic additive 14 P2155015 Plastic additive 15
P2155016 P2155017 P2155018 O0140000
Plastic additive 16 Plastic additive 17 Plastic additive 18 Plastic additive 20
E1260000 Plastic additive 21 P2155022 Plastic additive 22
200 mg
+5C
P2160000 Poliomyelitis vaccine (inactivated) BRP
0.6 mg
-80C
P2161000 Poliomyelitis vaccine (oral) BRP 1 1 1 1 1 n/a 4 30 mg 100 mg 100 mg 100 mg 100 mg n/a 120 mg 1 1 1 1 1 1 1
1 ml
30103,30105,30106, 30107 1,3,5-tris(3,5-di-1,1-dimethylethyl-4-hydroxybenzyl)-1H,3H,5H-1, 30103,30105,30106 3,5-triazine-2,4,6-trione 2,2'-Di(octadecycloxy)-5,5'-spirobi(1,3,2-dioxaphosphorinane) R 30103,30105,30106 Dioctadecyl disulphide 30103,30104,30105, 30106 Didodecyl 3,3'-thiodipropionate R 30103,30105,30106 Dioctadecyl 3,3'-thiodipropionate R 30103,30105,30106 30103 Oleamide R 30103,30105,30106, 30107 Erucamide R 30103,30107 Copolymer of dimethyl butanedioate and 30103 1-(2-hydroxyethyl)-2,2,6,6-tetramethylpiperidin-4-ol Synonyms: copolymer of dimethyl succinate and (4-hydroxy-2,2,6,6-tetramethylpiperidin-1-yl)ethanol di(isooctyl)2,2'-[(dioctylstannylene)bis(thio)]diacetate 30110,30111 containing about 27% of (tri(isooctyl)2,2',2''- [monooctylstannylidyne)tris(thio)] triacetate. Tin-content of 15.4% 430-95-285 Ph. Eur. D-Antigen Units per ml for types 1-2-3, 0214,2066,2065, Yes respectively 2328,2061,2067, 1934,2329,20720 log CCID50/ml for types 1,2,3 and total virus content: 6.99, See leaflet,0215 Yes 6.06, 6.83 and 7.20, respectively -20C 1464 1464 1464 1464 1464 0733 0203 +5C +5C +5C +5C +5C Yes +5C -20C d a a a a a l a
P2163920 P2164009 P2164020 P2164021 P2164030 P2170000 P2400000
Poloxamer 124 Poloxamer 188 Poloxamer 237 Poloxamer 338 Poloxamer 407 Polyacrylate - reference spectrum Polymyxin B sulphate
67.4% polymyxin B1, 7.8% polymyxin, 2.6% polymyxin B3, 7.3% polymyxin B1-I 203360 IU per vial
Y0000355 Y0000289 Y0000290 Y0000291 Y0000007 P2600000 P2649610
Polymyxin B sulphate for microbiological assay Polysorbate 20 - reference spectrum Polysorbate 40 - reference spectrum Polysorbate 60 - reference spectrum Polysorbate 80 - reference spectrum Poly(vinyl chloride) Potassium clavulanate - reference spectrum
1 n/a n/a n/a n/a 1 n/a
25 mg n/a n/a n/a n/a 100 mg n/a
1 1 1 1 1 1 1
0426 1914 0427 0428 90001,90002,30114 1140
+5C
a l l l l a l For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch 1 1 2 1 n/a 2 -20C 2076 0618 0685 1142 2059 2059 +5C +5C +5C +5C Monograph Leaflet Storage
6 December 2006
Order Code Y0000315 P2650000 P2660000 Y0000466 Y0000215 Y0000223
Reference Standard
Potassium hydrogen aspartate hemihydrate Potassium sorbate Povidone Povidone (iodinated) Pravastatin sodium - reference spectrum Pravastatin impurity A
Y0000204 P2669000 P2670000 P2675000 50 mg 150 mg 10 mg 99.8% CHNO (RS)-2-benzoyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a] isoquinolin-4-one ; Batch 1 is valid until 28 February 2007 99.1% CHO 1,2-dihydroprednicarbate 50 mg 100 mg 10 mg 150 mg 120 mg 1 1 1 1 1 1 1 1 1 1 1 5 3
Pravastatin 1,1,3,3-tetramethylbutylamine Prazepam -* psy Praziquantel Praziquantel impurity A
1 1 2 2
Information Unit Sale Quantity Unit 50 mg 1 100 mg 1 50 mg 1 10 mg 1 n/a 1 10 mg 1 (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl -8-[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphtha len-1-yl]heptanoic acid (6'-epipravastatin) ; Batch 1 is valid until 30 November 2006 30 mg 1 76.4% pravastatin Extra charges a a a a l c 2059 1466 0855 0855 -20C +5C +5C +5C +5C +5C +5C +5C +5C Yes c j a a a a a a a
P2680000 P2698000 P2698060 P2700000
Prazosin hydrochloride Prednicarbate Prednicarbate impurity F Prednisolone
P2800000 Prednisolone acetate
Batch 3 is valid until 28 February 2007 29 IU per vial
Yes
()-N-(methylphenyl)-2-(propylamino)propanamide 100% CHNO
Yes
Y0000582 P2804000 P2805000 P2810000 P2900000 P2920000 Y0000263 P2939000 P2939060 P2939025 P2940000 P2950000 Y0000369 P3000000 P3050000 P3090000 P3100000 P3200000
Prednisolone acetate for peak identification Prednisolone hexanoate Prednisolone pivalate Prednisolone sodium phosphate Prednisone Pregnenolone isobutyrate Prekallikrein activator in albumin BRP Prilocaine Prilocaine hydrochloride Prilocaine impurity E Primaquine diphosphate Primidone Primidone for peak identification Probenecid Procainamide hydrochloride Procaine benzylpenicillin Procaine hydrochloride Prochlorperazine maleate
1 1 1 3 3 4 1 1 1 1 2 1 1 1 1 2 1 1
10 mg 10 mg 100 mg 150 mg 50 mg 100 mg 1 ml 150 mg 100 mg 25 mg 500 mg 150 mg 5 mg 100 mg 100 mg 250 mg 100 mg 100 mg
1 1 1 1 1 1 3 1 1 1 1 1 1 1 1 1 1 1
96.3% CHNOS; 39.7% CHNO (procaine)
0856 1467 1467 0335,0353,0354, 0735 0734,0736,0933, 0975,1467 0734 1212 0734,0736 0549,0735,0810 0354 0993 See leaflet,20615 1362 1363 1362,1363 0635 0584 0584 0243 0567 0115 0050 0244,20303
+5C +5C +5C +5C +5C -20C -20C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C
a a a a a a b a a a a a a a a a a a For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch 1 1 n/a 2 +5C +5C +5C +5C +5C +5C +5C 2 2 1 2 n/a 1 1 1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy]phenyl] -3-phenylpropenone 99.9% CHO ; Batch 2 is valid until 31 October 2006 100 mg 50 mg n/a 10 mg 10 mg 1 1 1 1 1 60 mg 1 2002 a a a g l g g 0429 0429 2002 2002 +5C +5C Monograph Leaflet Storage
6 December 2006
Order Code P3300000 Y0000148 Y0000179 Y0000181
Reference Standard
Progesterone Progesterone impurity C Proguanil hydrochloride - reference spectrum Proguanil impurity C
Extra charges a a l a
Y0000182 Proguanil impurity D
Information Unit Sale Quantity Unit 250 mg 1 10 mg 1 (20R)-20-hydroxypregn-4-en-3-one n/a 1 10 mg 1 1,5-bis(4-chlorophenyl)biguanide ; Batch 1 is valid until 31 December 2005 10 mg 1 1,5-bis(1-methylethyl)biguanide ; Batch 1 is valid until 30 November 2006
P3350000 Proline
P3390000 P3400000 P3490000 Y0000455 Y0000456
Promazine hydrochloride Promethazine hydrochloride Propacetamol hydrochloride - reference spectrum Propafenone hydrochloride Propafenone impurity B
0785,0910,0911, 1049 0475,1365,20303 0524,20303 1366 2103 2103
Yes
Y0000278 Y0000016 Y0000017 Y0000018 P3500000 P3600000 Y0000318 Y0000319 New P3640000 P3650000 P3700000 P3750000 P3760000 P3760020 P3800000 P3850000 Y0000387 P3900000 P4000000 Y0000402 Y0000403 1 2 30 mg 50 mg 1 1
Propanol - reference spectrum Propofol Propofol for peak identification Propofol impurity J Propranolol hydrochloride Propranolol hydrochloride for performance test Propylene glycol dilaurate Propylene glycol monolaurate Propyl gallate Propyl parahydroxybenzoate Propylthiouracil Propyphenazone Protirelin D-His-Protirelin Proxyphylline Pseudoephedrine hydrochloride - * Drug Precursor Pseudoisoeugenyl 2-methylbutyrate for peak identification Purpureaglucoside A Purpureaglucoside B Pyrantel embonate Pyrantel impurity A
n/a 3 2 2 2 3 1 1 2 2 1 3 3 2 1 2 1 1 1 1 1
n/a 290 mg 0.1 ml 20 mg 30 mg 20 mg 100 mg 100 mg 50 mg 100 mg 100 mg 200 mg 5.03 mg 0.5 mg 100 mg 100 mg 100 mg 25 mg 25 mg 10 mg 20 mg
1 1 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 1
2036 1558 1558 2,6-bis (1-methylethyl)-1,4-benzoquinone 1558 Batch 1 is valid until 30 April 2006 0568,0923 Batch 2 is valid until 30 September 2006 0568 2087 1915 Batch 1 is valid until 1 November 2006 1039 0431,0852,1263 0525 0636 5.03 mg per vial of pure protirelin peptide CHNO 1144 approx. 0.1 mg per vial ; Batch 1 is valid until 30 September 2006 1144 0526 0487,1367 Anise oil 2108 0117 0117 1680 1-methyl-2-[(Z)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyri 1680 midine 0859 1255
Yes
+5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C -20C -20C +5C +5C +5C +5C +5C +5C +5C +5C +5C
l a a a g g a a a a a a c c a i a a a a a a a For extra charges please see 2.2
P4050000 Pyrazinamide P4099900 Pyridostigmine bromide
6 December 2006
Reference Standard
Order Code P4099910 P4100000 P4200000 Y0000659 Q0100000 Q0200000 R0100000 R0145000 R0145005 1 1 1 1 1 2 4 2 2 Yes 1255 0245 0288 2180 0017,0018,0019 0017,0018,0019 See leaflet,0451 1368 1368 +5C +5C +5C +5C +5C +5C -20C +5C +5C
Pyridostigmine impurity A Pyridoxine hydrochloride Pyrimethamine Pyrrolidone Quinidine sulphate Quinine sulphate Rabies vaccine (inactivated) for veterinary use BRP Ramipril Ramipril impurity A
Extra charges a a a a a a c a a
R0145010 Ramipril impurity B
1368
+5C
R0145015 Ramipril impurity C
Information Unit Sale Quantity Unit 20 mg 1 pyridin-3-yl-dimethylcarbamate 100 mg 1 250 mg 1 20 mg 1 300 mg 1 300 mg 1 86 mg 3 11 IU per vial 20 mg 1 10 mg 1 (2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(methoxycarbonyl)-3phenylpropyl]amino]propanoyl]octahydrocyclopenta[b]pyrrole-2 -carboxylic acid (ramipril methylester) 10 mg 1 (2S,3aS,6aS)-1-[(S)-2-[[(S)-1-[(methylethoxy)carbonyl]-3phenylpropyl]amino]propanoyl]octahydrocyclopenta[b]pyrrole2-carboxylic acid (ramipril isopropyl ester) 10 mg 1 (2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(ethoxycarbonyl)-3-cyclohexylprop yl]amino]propanoyl]octahydrocyclopenta[b]pyrrole-2- carboxylic acid (hexahydroramipril) ; Batch 1 is valid until 31 December 2005 1368 +5C a 10 mg 1 +5C a
R0145020 Ramipril impurity D
R0150000 Ranitidine hydrochloride Y0000416 Ranitidine impurity J
2 2
1 1
ethyl (2S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro 1368 -1H- cyclopenta[e]pyrrolo[1,2a]pyrazin-2-yl]-4-phenylbutanoate (ramipril diketopiperazine) ; Batch 1 is valid until 31 May 2006 Batch 1 is valid until 30 April 2006 0946,1453 1,1'-N-[methylenebis(sulphanediylethylene)]bis(N'-methyl-2-nitro 0946 ethene-1,1-diamine) Yes Yes
+5C +5C +5C +5C +5C +5C
a a a a a a
Y0000411 Y0000457 Y0000458 Y0000459 3 2 5 1 1 1 1 3 1 1 250 mg 100 mg 1 mg 100 mg 250 mg 150 mg 1 1 1 1 1 1 100 mg 1 100 mg 1500 mg 1000 mg 1 1 1
Ranitidine for system suitability Repaglinide Repaglinide for system suitability Repaglinide impurity E
1 1 1 1
100 mg 0.00025 mg 20 mg 20 mg 6 mg 5 mg 1 1 1 1
R0200000 Reserpine R0250000 Residual solvents solution class 1 R0300000 Retinol acetate
Yes Yes
+5C +5C -20C +5C
a g c a +5C a +5C a +5C a +5C a +5C a +5C a charges please see 2.2
R0290000 Retinol esters
R0500500 Reviparin sodium Y0000377 Ribavirin Y0000353 Ribavirin for system suitability R0600000 Riboflavin R0630000 Riboflavin sodium phosphate Y0000149 Rifabutin Council of Europe, all rights reserved 2006
0946 2135 2135 2-ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl] 2135 amino]-2-oxoethyl]benzoic acid 99.8% CHNO 0528 Batch 1 is valid until 31 May 2006 20424 1044000 IU per g 0218,0219,0220, 1192,1193 0217,0218,0219, 0220 0828 100.0% CHNO 2109 2109 Vitamin B2 ; Batch 2 is valid until 31 October 2006 0292,0786 0786 96.3% CHNO 1657 For extra
Catalogue No. 48-2006/4 Batch 1 1 3 1 1 3 n/a 1 1 1 1 Yes Yes Yes +5C +5C +5C -180C -20C 1657 0052 0052 0432 0432 0432,20702 2020 2020 1559 1559 0162,1057 +5C +5C +5C +5C +5C -20C Monograph Leaflet Storage
6 December 2006
Order Code Y0000184 R0700000 R0800000 R0900000 R0950000 R1000000 Y0000250 Y0000187 R1000600 Y0000370 R1300000
Reference Standard
Rifabutin impurity A Rifampicin Rifampicin quinone Rifamycin B Rifamycin S Rifamycin sodium Rilmenidine dihydrogenophosphate - reference spectrum Rilmenidine for system suitability Risperidone Risperidone for system suitability RK 13 cells
Information Unit Sale Quantity Unit 20 mg 1 (N-(2-methylpropyl)-4-piperidone) 500 mg 1 100 mg 1 50 mg 1 50 mg 1 300 mg 1 856 IU per mg n/a 1 30 mg 1 100 mg 1 20 mg 1 1 ml 2 cell lines (kidney, rabbit) titration of live measles, mumps and rubella vaccines Extra charges a a a a a c l a g g d
96.8% CHNO 3.6 log (ie 4000) infective viral units per vial 38.2% ruscogenin 60.4% neoruscogenin
Y0000527 Y0000594 R1500000 Y0000220 R2000000 Y0000494 1 1 1 2 2 1 3 2 5 mg 1 5 mg 1 10 mg 1 100 mg 30 mg 50 mg 50 mg 5 mg 1 1 1 1 1
Rocuronium for peak identification Rocuronium bromide - reference spectrum Roxithromycin Roxithromycin for system suitability Rubella vaccine (live) BRP Ruscogenins
1 n/a 4 1 1 1
10 mg n/a 125 mg 5 mg 18 mg 10 mg
1 1 1 1 5 1
1764 1764 1146 1146 1057,0162 1847 1795 0947 0787 0529,1033 0529,0687 0529,0687 0529,0687 0529,0687
Yes
+5C +5C -80C +5C Yes +5C +5C +5C +5C +5C +5C +5C +5C
g l a a d a a a a a a a a a
Y0000105 S0040000 S0050000 S0100000 Y0000030
Rutoside trihydrate Saccharin Saccharin sodium Salbutamol Salbutamol impurity B
Y0000071 Salbutamol impurity D
Y0000031 Salbutamol impurity F
Y0000034 Salbutamol impurity G
Y0000032 Salbutamol impurity I
0.006 mg
(1RS)-2-[(1,1-dimethylethyl)amino]-1-(4-hydroxyphenyl)ethanol (1RS)-2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2-hydroxybenzaldehyde 1,1'-[oxybis[methylene(4-hydroxy-1,3-phenylene)]]bis[2-[(1,1dimethylethyl)amino]ethanol] 91.3% salbutamol impurity G; 2-[benzyl(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanone (1RS)-2-[(1,1-dimethylethyl)amino]-1-[3-(hydroxymethyl)-4benzyloxyphenyl]ethanol
0529,0687
+5C
S0150000 S0200000 Y0000405 Y0000422 Y0000423
Salbutamol sulphate Salicylic acid Salicylic acid impurity B Salmeterol xinafoate Salmeterol for system suitability
2 2 1 1 1
50 mg 100 mg 10 mg 40 mg 25 mg
1 1 1 1 1
4-hydroxyisophthalic acid 99.6% CHNO
0687 0366,1156 0366 1765 1765
Yes
+5C +5C +5C +5C +5C
Catalogue No. 48-2006/4 Batch 1 1 1 +5C +5C +5C Unit Sale Quantity Unit 50 mg 1 25 mg 1 50 mg 1 Information Monograph Leaflet Storage Extra charges a a a
6 December 2006
Order Reference Standard Code S0360000 Selegiline hydrochloride S0360090 (RS)-Selegiline hydrochloride S0400000 Senna extract
99.4% CHO ; Batch 2 is valid until 30 September 2006 83.4% CHNOS 83.4% CHNNaOP
+5C +5C +5C +5C +5C -20C -20C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C
100.0 %
S0450000 S0460000 Y0000371 S0500000 S0600000 S0650000 S0660000 Y0000014 S0695000 Y0000300 Y0000039 S0700000 S0710000 S0750000 S0760000 S0765000 S0781000 S0780000 Y0000620 S0785000 Y0000210 Y0000268 S0800000 Y0000662 S0808000 S0808060 S0900000 Batch 1 is valid until 31 March 2006 3 2 2 1 1 33 mg 100 mg 1 1 1 1 1
Serine Sertaconazole nitrate Sestamibi labelling kit Silicone elastomer Silicone oil Simvastatin Sisomicin sulphate Sodium alendronate Sodium amidotrizoate Sodium aminosalicylate dihydrate - reference spectrum Sodium ascorbate Sodium calcium edetate Sodium cetostearylsulphate Sodium cromoglicate Sodium cyclamate Sodium diclofenac Sodium hyaluronate - reference spectrum Sodium hyaluronate BRP Sodium laurilsulfate Sodium picosulphate Sodium polystyrene sulphonate - reference spectrum Sodium propionate - reference spectrum Sodium salicylate Ribonucleic acid Sodium stearyl fumarate Sodium stearyl maleate Sodium taurocholate BRP
1 1 1 1 1 3 1 2 1 n/a 1 1 1 2 2 2 n/a 2 1 1 n/a n/a 1 1 1 1 2
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1260 1260 0206,0207,0208, 1261 0788,1027 1148 1926 30109 30108 1538,1563 1351 1564 1150 1993 1791 0231 0847 0562 0774 1002,1281 1472 0912 0802 1031 1909 2041 0413 2090 1567 1567 0350 a a a a a c a a a l a a a a a a l a a a l l a a a a a
S0930000 Sodium valproate S0945000 Somatostatin S0947000 Somatropin
50 mg 125 mg 1 uc 2000 mg 1 ml 100 mg 50 mg 150 mg 125 mg n/a 50 mg 100 mg 100 mg 10 mg 100 mg 100 mg n/a 300 mg 40 mg 100 mg n/a n/a 100 mg 100 mg 50 mg 10 mg 10000 mg 150 mg 2.55 mg 35 mg 2.55 mg somatostatin peptide per vial 1.69 mg somatropin monomer per vial ; Batch 1 is valid until 31 October 2006 1.7 mg somatropin per vial Yes Yes 0678 0949 See leaflet,0950, 0951,0952 0950,0951,0952 0592
+5C +5C +5C +5C Room temp. +5C -20C -20C -20C +5C
a c a a a For extra charges please see 2.2
New Y0000711 Somatropin/desamidosomatropin resolution mixture S0950000 Sorbic acid
Catalogue No. 48-2006/4 Batch 1 3 +5C +5C Information Unit Sale Quantity Unit 50 mg 1 99.2% CHO 1200 mg 1 97.9 % CHO ; Batch 2 is valid until 28 February 2007 Monograph Leaflet Storage Extra charges a a
6 December 2006
Order Code Y0000385 1,4-Sorbitan S1000000 Sorbitol
Reference Standard
Y0000114 Sotalol hydrochloride Y0000115 Sotalol impurity B
1 1
25 mg 20 mg
1 1
2048 0435,0436,0437, 1235,1236,1337, 1381,1531,2048 2004 N-[4-[[(1-methylethyl)amino]acetyl]phenyl]methanesulphonami- 2004 de 81.3% CHClNO and CHClNO 1152 +5C +5C a a Yes Yes +5C +5C -20C -20C a a c a
Y0000597 Y0000549 New Y0000655 S1100000 4530 IU per mg Spiramycin I: 87.9%, Spiramycin II: 0.2%, Spiramycin III: 5.3% 95.9% CHClNOS
Spectinomycin hydrochloride Spectinomycin for system suitability Spectinomycin sulphate tetrahydrate Spiramycin
2 1 1 4
100 mg 20 mg 10 mg 200 mg
1 1 1 1
99.7% CH (5,17)-17-hydroxy-17-methylandrostan-3-one Batch 2 is valid until 30 September 2006 99.6% CHNO Plastic additive 19
Y0000381 Y0000332 S1200000 Y0000185 S1250000 S1250010 S1300000 1 1 2 1 1 1
Spirapril hydrochloride monohydrate Spirapril for system suitability Spironolactone Squalane Stanozolol Stanozolol impurity A Starch BRP
1 1 1 1 1 1 3
1 1 1 1 1 1 1
1152 1658 0179,0293,1982, 1983,20702 1766 1766 0688 1630 1568 1568 0350
+5C +5C +5C +5C +5C +5C +5C +5C +5C +5C
a a a a a a a a a a
Y0000408 Stavudine Y0000421 Stavudine for system suitability S1340000 Stearic acid
60 mg 15 mg 100 mg 0.25 ml 125 mg 10 mg 50000 mg 100 mg 10 mg 100 mg
S1350000 Stearyl alcohol
250 mg
100% CHO
+5C
S1400000 Streptomycin sulphate 1 1 100 mg 100 mg 1 1
n/a
100 mg
78 500 IU per ampoule; International standard provided for an interim period
-20C +5C +5C
a a a
S1500000 Succinylsulfathiazole S1600000 Sucrose
S1608100 S1609000 Y0000529 Y0000528 Y0000550 S1700000
Sufentanil - reference spectrum Sufentanil citrate - reference spectrum Sulbactam sodium Sulbactam Sulbactam for peak identification Sulfacetamide sodium
n/a n/a 1 1 1 1
n/a n/a 10 mg 150 mg 20 mg 50 mg
1 1 1 1 1 1
99.7% CHNOS
2130 2130 Yes 0229,0882,2058, 30103,30105,30106, 30107 0702,0753,0801, 0802,0847,0969, 1123,1340,1411 0032,0033,0053, 0485,20702 0357 0177,0178,0187, 0188,0204,0209, 1061,1570 1569 1269 2209 2209 2209 Yes 0107
+5C -20C +5C +5C
l l a b a a For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 0294 0295 0740 0741 1476 0358,1571 0637 0108 0108 0108 0638 1571 0863 0863,1457 0863 +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C Monograph Leaflet Storage
6 December 2006
Order Code S1800000 S1900000 S1950000 S1975000 S1975600 S2000000 S2050000 S2100000 Y0000412 Y0000413 S2150000 S2151000 S2159100 S2155000 S2155010
Reference Standard
Sulfadiazine Sulfadimidine Sulfadoxine Sulfafurazole Sulfaguanidine Sulfamerazine Sulfamethizole Sulfamethoxazole Sulfamethoxazole impurity A Sulfamethoxazole impurity F Sulfamethoxypyridazine Sulfanilamide Sulfapyridine Sulfasalazine Sulfasalazine derivative for resolution
Information Unit Sale Quantity Unit 100 mg 1 100 mg 1 100 mg 1 100 mg 1 60 mg 1 100 mg 1 100 mg 1 50 mg 1 5 mg 1 N-(4-(5-methyl)-isoxazol-3-ylsulphamoyl)phenylacetamide 5 mg 1 4-amino-N-(3-methylisoxazol-5-yl)benznesulphonamide 50 mg 1 100 mg 1 20 mg 1 250 mg 2 99.9 % CHNOS 20 mg 1 2-hydroxy-5-[[4-[[(6-methylpyridin-2-yl)amino]-sulfonyl]phenyl] azo]benzoic acid Extra charges a a g a a a a a a a a a a a a
S2158000 S2159000 S2159010 S2159015 S2160000 S2180000 S2190000 S2191000 S2192000 Y0000530 Y0000531 Y0000532 Y0000022 Y0000025 3 2 1 1 1 2 mg 1000 mg 50 mg 10 mg 1 1 1 1 3 mg 1
Sulfathiazole Sulfinpyrazone Sulfinpyrazone impurity A Sulfinpyrazone impurity B Sulfisomidine Sulindac Sulpiride Sulpiride impurity A Sulpiride impurity B Sultamicillin Sultamicillin tosilate Sultamicillin for peak identification Sumatriptan succinate Sumatriptan impurity C
1 1 2 3 1 2 2 2 1 1 1 1 1 2
100 mg 30 mg 20 mg 20 mg 50 mg 50 mg 100 mg 20 mg 30 mg 10 mg 200 mg 10 mg 50 mg 5 mg
1 1 1 1 1 1 1 1 1 1 1 1 1 1
Yes
+5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C -20C -20C Yes 1573 0248 1574 1574 Yes -20C -20C +5C +5C +5C
a a a a a a a a a a a a c c c c a a a
Y0000026 Sumatriptan impurity mixture
0742 0790 1,2-diphenyl-4-[2-(phenylsulphonyl)ethyl)pyrazolidine-3,5-dione 0790 1,2-diphenyl-4-(2-phenylthioethyl)pyrazolidine-3,5-dione 0790 0639 Contains 0.3% m/m of E-isomer 0864 1045,1348 2-aminomethyl-1-ethylpyrrolidine 1045 methyl 5-sulphamoyl-2-methoxybenzoate 1045 2211 68.5% CHNOS 2212 2211 98.8% CHNOS 1573 [3-[2-(dimethylamino)ethyl]-1-(hydroxymethyl)-1Hindol-5-yl]-N- 1573 methylmethanesulphonamide Batch 2 is valid until 31 December 2006 1573 Batch 1 is valid until 30 June 2006
Y0000027 S2200000 S2400000 S2400004
Sumatriptan for system suitability Suxamethonium chloride Suxibuzone Suxibuzone impurity B
(4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methyl ethyl butanedioate
Catalogue No. 48-2006/4 Batch 1 1 1 1 mg 1 2.6 x10 Cfu per vial See leaflet,0064 Yes +5C See leaflet,0064 Yes +5C f f 1574 +5C Information Unit Sale Quantity Unit 10 mg 1 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-1,2-dihydro-4Hpyrazole-3,5-dione 1 mg 1 6.5 x10 Cfu per vial Monograph Leaflet Storage Extra charges a
6 December 2006
Order Reference Standard Code S2400006 Suxibuzone impurity C
S5000001 Swine erysipelas bacteria, serotyp 1 (for vaccines - vet. use) BRP S5000002 Swine erysipelas bacteria, serotyp 2 (for vaccines - vet. use) BRP T0010000 Talampicillin hydrochloride T0014000 Tamoxifen citrate T0015000 Tamoxifen citrate for performance test New Y0000650 Tamsulosin hydrochloride New Y0000653 Tamsulosin racemate New Y0000651 Tamsulosin impurity D 1 1 2 1 1 1 1 1 1 1 1 1 5 mg 1 5 mg 1 5 mg 1 50 mg 5 mg 1 1 10 mg 1 50 mg 80 mg 50 mg 10 mg 10 mg 10 mg 1 1 1 1 1 1 Yes +5C +5C +5C +5C +5C +5C +5C 0879 0954 0954 0954 0954 +5C +5C +5C +5C +5C 0808,0852 1046 1046 2131 2131 (2R)-N-[2-(2-ethoxyphenoxy)ethyl]-1-(4-methoxyphenyl)propan- 2131 2-amine (2R)-N-[2-(2-ethoxyphenoxy)ethyl]-1-(4-methoxyphenyl)propan- 2131 2-amine
a g a a A a a j a a a a
New Y0000652 Tamsulosin impurity H
T0040000 Temazepam - * psy Y0000344 Temazepam impurity C
Y0000345 Temazepam impurity D
Y0000346 Temazepam impurity F
Y0000347 Temazepam impurity G
(3RS)-7-chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4benzodiazepin-3-yl acetate (3RS)-7-chloro-3-methoxy-1-methyl-5-phenyl-1,3-dihydro-2H1,4-benzodiazepin-2-one (5RS)-7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4benzodiazepine-2,3-dione (5RS)-7-chloro-1,4-methyl-5-phenyl-4,5-dihydro-1H-1,4benzodiazepine-2,3-dione
Yes Yes Yes
New New New New New New
T0040800 Y0000621 Y0000666 Y0000622 Y0000665 Y0000623 Y0000624 Y0000535 T0050000 T0050015 1 1 1 1 250 mg 100 mg 30 mg 250 mg 1 1 1 1
Tenoxicam Terazosin hydrochloride dihydrate Terazosin for system suitability Terazosin impurity A Terazosin impurity E Terazosin impurity L Terazosin impurity N Terbinafine hydrochloride Terbutaline sulphate Terbutaline impurity C
1 1 1 1 1 1 1 1 1 3
100 mg 40 mg 0.5 mg 10 mg 10 mg 10 mg 10 mg 10 mg 100 mg 15 mg
1 1 1 1 1 1 1 1 1 1
1156 2021 2021 2-chloro-6,7-dimethoxyquinazolin-4-amine 2021 2,2'-(piperazine-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine) 2021 1-(furan-2-ylcarbonyl)piperazine 2021 1-[[(2RS)-tetrahydrofuran-2-yl]carbonyl]piperazine 2021 1734 0690 1-(3,5-dihydroxyphenyl)-2-[(1,1-dimethylethyl)amino]-ethanone 0690 ; Batch 2 is valid until 30 April 2006 1270 0955 0955 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(hydroxydiphenylmethyl) piperidin-1-yl]butan-1-one (ketone) 0410,1373
+5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C
a a a a a a a a a g a a a g For extra charges please see 2.2
T0060000 Terconazole T0071000 Terfenadine T0080000 Terfenadine impurity A
T0100000 Testosterone
Catalogue No. 48-2006/4 Batch 2 1 1 1 1 1 1 1 n/a 2 Yes -20C n/a n/a 1 1325 l 0297 1048 1048 1048 1373 1373 1048 1048 0297 See leaflet,20708 +5C +5C +5C -20C +5C +5C +5C +5C Monograph Leaflet Storage
6 December 2006
Order Code T0200000 T0210000 T0240000 T0250000 Y0000342 Y0000343 T0260000 T0300000 Y0000170 T0400000
Reference Standard
Testosterone acetate Testosterone caproate Testosterone decanoate Testosterone enantate Testosterone for impurity D identification Testosterone for system suitability Testosterone isocaproate Testosterone propionate Testosterone propionate - reference spectrum Tetanus vaccine (adsorbed) BRP
Information Unit Sale Quantity Unit 10 mg 1 50 mg 1 25 mg 1 100 mg 1 15 mg 1 15 mg 1 25 mg 1 250 mg 1 n/a 1 11 mg 1 469 IU per ampoule for assays in guinea pig 496 IU per ampoule for assays in mice Extra charges a a a c a a a a l c
T0499000 1,3,4,6-Tetra-O-acetyl-2-O-trifluoromethane-sulphonyl- - ref spectrum T0500000 Tetracaine hydrochloride T0550000 Tetracosactide T0600000 Tetracycline hydrochloride 1 2 2 365 g per vial of pure tetracosactide peptide CHNOS 96.7% CHClNO ; Batch 1 is valid until 31 March 2006 n/a 1 1 1 1 n/a 1 1 1 2 1 10 mg 100 mg 100 mg n/a 125 mg 10 mg 20 mg 10 mg 10 mg 1 1 1 1 1 1 1 1 1 n/a 20 mg 1 1 100 mg 0.365 mg 100 mg 1 2 1
+5C -20C +5C
g c a
Y0000015 Tetrazepam - reference spectrum Y0000008 Tetrazepam impurity C
7-chloro-5-cyclohexyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
0057 0644 0173,0198,0199, 0210,0211,1654 1738 1738
+5C +5C +5C +5C +5C +5C +5C +5C +5C
l a a a a l a a a a a
Y0000460 T0700000 T0800000 Y0000294 Y0000336 Y0000372 Y0000373 Y0000467 Y0000059
Tetryzoline hydrochloride Theobromine Theophylline Theophylline - reference spectrum Thiamazol Thiamazol impurity A Thiamazol impurity C Thiamine hydrochloride Thiamine impurity E
2101 0298 0300,0301 0299,0302 1706 1706 1706 0303 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)- 0303,0531 4-methyl-4-thiazolidine-2-thione
Y0000060 T1100000 Y0000546 Y0000592 Y0000545 Y0000109 T1200000 Y0000150 T1300000
Thiamine nitrate - reference spectrum Thiamphenicol Thioctic acid Thioctic acid for system suitability Thioctic acid containing impurity B Thiomersal Thiopental Thioridazine - reference spectrum Thioridazine hydrochloride
n/a 1 1 1 1 1 1 n/a 1
n/a 125 mg 110 mg 10 mg 30 mg 30 mg 500 mg n/a 50 mg
1 1 1 1 1 1 1 1 1
99.8% CHOS
0531 0109 1648 1648 1648 1625 0212 2005 0586,20303
+5C +5C +5C +5C +5C +5C +5C
l a a a a a a l g For extra charges please see 2.2
Catalogue No. 48-2006/4 Batch Yes Monograph Leaflet Storage
6 December 2006
Reference Standard
Yes
+5C +5C +5C +5C +5C +5C +5C +5C
+5C +5C +5C +5C +5C +5C Yes +5C +5C 0956 +5C
Order Code Y0000541 T1305100 T1305000 T1340000 T1350000 T1410000 Y0000414 Y0000333 Y0000379 Y0000151 Y0000152 Y0000153 T1405000 T1405050 T1410900 T1410910 New Y0000748 New Y0000668 Y0000465 1 2 2 1 1 1 1 1 n/a n/a 1 1 1 1 1 1 n/a 1 1 1 a 0586 1347 1347 0785,1049 0791 0866 1659 1659,1660 1660 2022 0505 2022 1575 1575 1157 1157 1739 1739 0956
Thioridazine for system suitability Thioxanthene Thioxanthone Threonine Thymol Tiabendazole Tiamulin for peak identification Tiamulin hydrogen fumarate Tiamulin - reference spectrum Tianeptine sodium - reference spectrum Tianeptine for system suitability Tianeptine impurity A Tiapride hydrochloride Tiapride N-oxide Tiaprofenic acid Tiaprofenic acid impurity C Tibolone - reference spectrum Tibolone for system suitability Ticarcillin monosodium
Extra charges a a a a a a g g l l a a a a a a l b a
T1420010 Ticarcillin impurity A
Information Unit Sale Quantity Unit 0.21 mg 1 20 mg 1 10 mg 1 50 mg 1 50 mg 1 50 mg 1 10 mg 1 450 mg 1 99.1% CHNOS n/a 1 n/a 1 30 mg 1 20 mg 1 ethyl 7-bromoheptanoate 60 mg 1 20 mg 1 50 mg 1 20 mg 1 ()-2-(5-benzoyl-3-thienyl)propanoic acid n/a 1 10 mg 1 250 mg 1 93.2% CHNNaOS Correction factor 1.054 50 mg 1 89.8%; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(thiophen-3-yl)acetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (decarboxyticarcillin) 6-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine +5C +5C
1-(2-ethylsulphonylethyl)-2-methyl-4-nitroimidazole
91.6% CHNO
T1423000 Ticlopidine hydrochloride T1423025 Ticlopidine impurity F Y0000325 Tilidine hydrochloride hemihydrate - reference spectrum T1450000 Timolol maleate Y0000644 (R)-timolol T1470000 Tinidazole T1471000 Tinidazole impurity B T1490000 Tinzaparin sodium Y0000292 Tioconazole - reference spectrum Y0000282 Tioconazole for system suitability T1500000 Tobramycin Y0000383 All-rac-alpha-tocopherol for peak identification Y0000384 All-rac-alpha-tocopheryl acetate for peak identification T1550000 alpha-Tocopherol T1600000 alpha-Tocopheryl acetate Council of Europe, all rights reserved 2006
3 2 n/a 2 1 1 3 1 n/a 1 2 1 1 5 6
50 mg 10 mg n/a 50 mg 20 mg 100 mg 20 mg 250 mg n/a 50 mg 250 mg 15 mg 15 mg 250 mg 250 mg
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
97.7% CHO; Vitamin E 98.9% CHO
1050 1050 1767 0572 0572 1051 1051 0828 2074 2074 0645 0692 0439 0692,1256,20432 0439,0691,1257 For extra
a a l +5C g Yes +5C g +5C a +5C a +5C a l Yes +5C a +5C a Yes +5C a Yes +5C a +5C a +5C a charges please see 2.2
6 December 2006
Reference Standard
Order Code T1610000 T1700000 Y0000154 T1707000 Y0000461 Y0000462 Y0000155 Y0000156 1 1 1 1 1 1 2 2 Yes 2 1 1 1 20 mg 10 mg 10 mg N-(naphthalen-1-yl)-4,5-dihydro-1H-imidazol-2-amine 75% CHNO; mixture of 1-acetyl-2-[(5,6,7,8-tetrahydronaphthalen-1-yl) amino]-4,5- dihydro-1H-imidazole and N-(4,5-dihydro-1H-imidazol-2-yl)-N-(5,6,7,8- tetrahydronaphthalen-1-yl)acetamide 1 1 1 1681 1597 1597 1597 +5C +5C +5C +5C a a a a 1258,1259 0304 2039 1158 2132 2132 1681 1681 +5C +5C +5C +5C +5C +5C +5C +5C
RRR-alpha-Tocopheryl hydrogen succinate Tolbutamide Tolfenamic acid Tolnaftate Torasemide anhydrous Torasemide for system suitability Tramadol hydrochloride Tramadol impurity A
Y0000157 Y0000072 Y0000065 Y0000066
Tramadol impurity E Tramazoline hydrochloride monohydrate Tramazoline impurity A Tramazoline impurity B
Information Unit Sale Quantity Unit 125 mg 1 98.6% CHO 100 mg 1 100 mg 1 60 mg 1 10 mg 1 0.4 mg 1 75 mg 1 15 mg 1 (1RS,2SR)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol 10 mg 1 (2RS)-2-[(dimethylamino)methyl]cyclohexanone Extra charges a a a a a a a a
Y0000501 Trandolapril Y0000495 Trandolapril impurity C
1 1
10 mg 10 mg
1 1
+5C +5C
a a
Y0000496 Trandolapril impurity D
10 mg
2245 (2S,3aR,7aS)-1-[(2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)pr 2245 opyl]amino]propanoyl]octahydro-1H-indole-2-carboxylic acid (hexahydrotrandolapril) ethyl (2S)-2-[(3S,5aS,9aR,10aS)-3-methyl-1,4-dioxodecahydro 2245 pyrazino[1,2-a]indol-2(1H)-yl]-4-phenylbutanoate (trandolapril diketopiperazine) (4-(aminomethyl) cyclohex-1-enecarboxylic acid) 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ol 1,2,4-triazol-3-amine 0875 0875 1576 1576 1576 0693,1019,1385 1325 1106 1376 0533,0867,1075 0533,0867 1376 9-fluoro-11-16alpha,17,21-tetrahydroxypregn-4-ene-3,20dione (pretriamcinolone)
+5C
T1810000 T1810030 T1820000 T1820002 T1820004 T1850000 T1899000 G0400010 T1899990 T1900000 T1950000 Y0000050 1 1 2 n/a 10 mg 150 mg 30 mg n/a 1 1 1 1
Tranexamic acid Tranexamic acid impurity C Trapidil Trapidil impurity A Trapidil impurity B Tretinoin 3,4,6-Tri-O-acetyl-D-glucal - reference spectrum Triacetin - reference spectrum Triamcinolone Triamcinolone acetonide Triamcinolone hexacetonide Triamcinolone impurity C
3 2 1 1 1 1 n/a n/a 1 3 1 1
50 mg 10 mg 50 mg 20 mg 20 mg 100 mg n/a n/a 150 mg 100 mg 100 mg 10 mg
1 1 1 1 1 1 1 1 1 1 1 1
+5C +5C +5C +5C +5C +5C
+5C +5C +5C +5C 1065 98.9% CHO 1740 3,5,6-tri-O-benzyl-1,2-O-(1-methylethylidene)--D-glucofuranose 1740 1770 +5C +5C -20C
a a a a a a l l a a a a j a c l For extra charges please see 2.2
T1975000 Triazolam - * psy Y0000165 Tribenoside Y0000166 Tribenoside impurity A Y0000330 Tributyl acetylcitrate - reference spectrum Council of Europe, all rights reserved 2006
Catalogue No. 48-2006/4 Batch +5C -20C -20C -20C +5C +5C +5C +5C 1 1 1 1 n/a 1 n/a 1 1 1 1682 1410 1410 1410 1967 0393 1479 0059,20303 1377 1377 Monograph Leaflet Storage
6 December 2006
Order Code Y0000279 T1977990 T1977995 T1978000 Y0000111 T1985000 T1986000 T2000000 T2005000 T2005010
Reference Standard
Tri-n-butyl phosphate Tricaprin Tricaproin Tricaprylin Trichloroacetic acid - reference spectrum Trichlorotrifluoroethane Triethyl citrate - reference spectrum Trifluoperazine hydrochloride Triflusal Triflusal impurity B
Information Unit Sale Quantity Unit 300 l 1 150 mg 1 40 mg 1 225 mg 1 n/a 1 2.5 ml 2 n/a 1 100 mg 1 50 mg 1 25 mg 1 2-hydroxy-4-(trifluoromethyl)benzoic acid; (4-(trifluoromethyl)salicylic acid) Extra charges a c c c l a l a a a 1-phenyl-3-(piperidin-1-yl)propan-1-one +5C +5C -20C
Y0000108 Y0000068 T2009000 Y0000092 Y0000093 T2100000 T2200000 New Y0000684 100% CHNO 3 2 2 1 1 1 1 2 1 1 1 1 1 1 1 1 1 30 mg 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 1 1 (2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone 4-amino-5-(3,4,5-trimethoxybenzyl)pyrimidin-2-ol Batch 1 is valid until 30 April 2007
Trihexyphenidyl hydrochloride Trihexyphenidyl impurity A Trilaurin Trimetazidine dihydrochloride - reference spectrum Trimetazidine for system suitability Trimethadione Trimethoprim Trimethoprim for system suitability
1 1 1 n/a 1 1 1 1
1 1 1 1 1 1 1 1
1626 1626 1410 1741 1741 0440 0060 0060
Yes
+5C +5C +5C +5C +5C +5C +5C +5C -20C -20C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C 2133 +5C
a a c l a a a a a a a g c c a a a g a a g a g g a For extra charges please see 2.2
T2200010 T2200025 New T2450000 T2500000 T2500100 T2501200 T2545000 T2550000 T2580000 Y0000616 Y0000618 T2580300 Y0000429 Y0000432 Y0000431 Y0000430
Trimethoprim impurity B Trimethoprim impurity E Trimethyltetradecylammonium bromide Trimipramine maleate Trimyristin Tristearin Trolamine Trometamol Tropicamide Tropisetron hydrochloride Tropisetron impurity B Tropine Trospium chloride Trospium impurity A Trospium impurity B Trospium impurity C
100 mg 20 mg 1250 mg n/a 50 mg 250 mg 50 mg 0.00075 mg 10 mg 20 mg 200 mg 100 mg 500 mg 100 mg 1000 mg 100 mg 50 mg 40 mg 10 mg 50 mg 10 mg 20 mg 15 mg 5 mg
0060 0060 0378 0534 1410 1410 1577 Batch 1 is valid until 30 September 2006 1053 1159,1197 2102 2102 1308 1798 hydroxydiphenylacetic acid (benzilic acid) 1798 (1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl hydroxydiphenylacetate 1798 (1R,3r,5S)-3-hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyr 1798 rolidinium]
Y0000497 Troxerutin
Catalogue No. 48-2006/4 Batch 2 +5C Information Unit Sale Quantity Unit 100 mg 1 0.707 microkatal per mg Monograph Leaflet Storage Extra charges a
6 December 2006
Order Code T2600000 Trypsin BRP
Reference Standard
T2610000 Tryptophan T2800000 Tubocurarine chloride T2880000 Tylosin 87.75% CHClNO 1035 IU per mg
1 1 1
100 mg 100 mg 150 mg
1 1 1
+5C +5C +5C
a a a
T2880100 Y0000498 T2880200 T2900000 1 1 1 1 5,6-dimethoxy-3-methyl-2-[(all-E)-3,7,11,15,19,23,27,31,35nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl] benzene-1,4-dione (ubiquinone-9) 10 mg 50 mg 10 mg 5 mg 1 1 1 1
Tylosin D Tylosin phosphate for peak identification Tylosin tartrate - reference spectrum Tyrosine
2 1 n/a 1
5 mg 10 mg n/a 50 mg
1 1 1 1
Yes
+5C +5C +5C Yes +5C +5C +5C +5C
a a l a a a a a
T3000000 U0020000 U0020001 U0020008
Tyrothricin Ubidecarenone Ubidecarenone for system suitability Ubidecarenone impurity D
0476,0579,0580, 0694 1272 0305 1273,1274,1661, 20702 1273,1274,1661 1273,1274,1661 1274 0782,0895,1161, 1272,1384 0907,1662 1578 1578 1578
Yes
98.7% CHNOS (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyl-5-hydroxy-4,6,9,10-te tramethyl-1-oxodecahydro-3a,9-propano-3aH-cyclopenta[8]ann ulen-8-yl 2-hydroxyacetate (pleuromulin) 102500 IU per vial
U0100000 U0600000 U0800000 New Y0000583 V0030000 Y0000584 Y0000533 Y0000585 Y0000586
Uracil arabinoside Urea Ursodeoxycholic acid Valerian standardised dry extract Valine Valnemulin hydrochloride Valnemulin hydrogen tartrate Valnemulin for peak identification Valnemulin impurity E
1 2 1 1 1 1 1 1 1
30 mg 100 mg 60 mg 400 mg 50 mg 10 mg 120 mg 10.25 mg 10 mg
1 1 1 1 1 1 1 1 1
0760 0743 1189,1275 0453,1898,1899 0770,0771,0796 2137 2137 2137 2137
Yes
+5C +5C +5C -20C +5C +5C +5C +5C +5C
a a a c a a a a a
Yes
V0033000 V0045000 V0050000 Y0000561 Y0000625 Y0000587 Y0000588 V0100000 V0100018 2 20 mg 1
Valproic acid Vancomycin hydrochloride Vanillin Vecuronium bromide Vecuronium for peak identification Venlafaxine hydrochloride Venlafaxine for system suitability Verapamil hydrochloride Verapamil impurity I
2 2 1 1 1 1 1 1 2
100 mg 100 mg 100 mg 10 mg 10 mg 50 mg 1 mg 100 mg 5 mg
1 1 1 1 1 1 1 1 1
Yes
+5C -20C +5C +5C +5C +5C +5C +5C +5C +5C
a a a g g a a a a a For extra charges please see 2.2
V0100026 Verapamil impurity M
1378 1058,20702 0747 1769 1769 2119 2119 0573 (2)-2-(3,4-dimethoxyphenyl)-2-[2-[[2-(3,4)dimethoxyphenyl)- 0573 ethyl](methyl)amino]ethyl]-3-methylbutanenitrile 5,5'-[[2-(3,4)dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxy 0573 -phenyl)-2-(1-methylethyl)pentanenitrile
Catalogue No. 48-2006/4 Batch 1 1 Yes -20C -20C -20C 1854 0213,0538,1057 +5C -180C Information Unit Sale Quantity Unit 11 mg 1 0.97 mg CHO 1 ml 2 Cell lines (kidney, african green monkey, Cercopithecus aethiops) titration of live measles, mumps and rubella vaccines 5 mg 1 5.01 mg per vial of CHNOS Monograph Leaflet Storage Extra charges a d 4.98 mg per vial of CHNOS 5.11 mg of CHNOS
6 December 2006
Order Code Y0000661 Verbenalin V0180000 VERO cells
Reference Standard
4-O-deacetylvinorelbine
V0300000 V0305000 V0400000 V0405000 V0500000 V0500010 Y0000463 Y0000464 W0100000 X0075000 Y0000158 Y0000159 X0080000 X0100000 X0101000 n/a 4.98 mg n/a 5 mg n/a 40 mg 7 mg 100 mg 125 mg 50 mg 50 mg 500 mg 100 mg 10 mg 2,6-dimethylphenyl isothiocyanate 87.5% CHNS; N-(2,6-dimethylphenyl)-S-methyldithiourea 99.2% CHO N-(2-aminoethyl)-2-(4-1,1-dimethylethyl-2,6-dimethylphenyl) acetamide 100 mg 60 mg 10 mg 10 mg 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1
Vinblastine sulphate Vinblastine sulphate - reference spectrum Vincristine sulphate Vincristine sulphate - reference spectrum Vindesine sulphate Vindesine sulphate - reference spectrum Vinorelbine tartrate Vinorelbine impurity B Warfarin sodium Xylazine hydrochloride Xylazine impurity C Xylazine impurity E Xylitol Xylometazoline hydrochloride Xylometazoline impurity A
4 n/a 4 n/a 2 n/a 1 1 1 1 1 1 1 1 1
0748,0749 0748 0748,0749 0749 1276 1276 2107 2107 0698,0699 1481 1481 1481 1381 0972,1162 1162
-20C -20C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C +5C
c l c l c l c c g a a a a g a a a a a
X0200000 Xylose Z1900000 Zidovudine Z1902000 Zidovudine impurity A
Z1904000 Zidovudine impurity B
1278 99.7% CHNO 1059 1-[(2,5)-5-hydroxymethyl-2,5-dihydro-2-furyl]-5-methyl 1059 pyrimidine-2,4(1,3)-dione 1-(3-chloro-2,3-dideoxy--D-ribofuranosyl)-5-methylpyrimidine- 1059 2,4(1,3)-dione 6-[[6-(acetylamino)hexanoyl]amino]hexanoic acid N,N'-dimethyl-2-[7-methyl-2-(4-methylphenyl)imidazol[1,2-a] pyridin-3-yl]acetamide ; Batch 2 is valid until 31 January 2007 1279 1279 1280 1280
Z2000000 Z2000010 Z2500000 Z2500010
Zinc acexamate Zinc acexamate impurity A Zolpidem tartrate - * psy Zolpidem impurity A
1 1 2 3
50 mg 50 mg 150 mg 10 mg
1 1 1 1
+5C +5C +5C +5C +5C +5C Yes
a a j a
Z3000000 Z3001000 Y0000062 Y0000534 Y0000083
Zopiclone -* psy Zopiclone oxide Zuclopenthixol decanoate - reference spectrum Zuclopenthixol for system suitability Zuclopenthixol impurity B
1 2 n/a 1 1
60 mg 20 mg n/a 0.1 mg 10 mg
1 1 1 1 1
2-chloro-9H-thioxanthen-9-one
1060 1060 1707 1707 1707
-20C +5C
j a l c a
Laboratory Reagents
Catlogo European Pharmacopoeia

Chemical Reference Substances Infrared Reference Spectra Biological Reference Preparations
Lista No. 48
Diciembre 06
REFERENCIA REAGECON 2006
VIDA DEL PRODUCTO EN MESES
ENVASE
PRODUCTO
Reagents as Outlined in Chapter 2

EPPOSO1 6 100ml PRIMARY OPALESCENCE SUSPENSION
Colouration - Prymary Solutions

EPYSO1 EPRSO1 EPBSO1 24 24 24 100ml 100ml 100ml Coloration - Primary Solution Yellow Coloration - Primary Solution Red Coloration - Primary Solution Blue
Standard Solutions
EP703 EP704 EP706 EP705 EP707 HADM1 12 12 12 12 12 24 125ml 125ml 125ml 125ml 125ml 1 litre STANDARD SOLUTION B (Brown) STANDARD SOLUTION BY (Brownish Yellow) STANDARD SOLUTION Y (Yellow) STANDARD SOLUTION GY (Greenish Yellow) STANDARD SOLUTION R (Red) HCl DILUTION MATRIX (10g/l HCl)
Reference Buffer Solutions - All @25C

EP168 EP356 EP378 EP401 EP687 EP741 EP918 24 * * 36 24 24 24 500ml pH BUFFER SOLUTION 1.68 No Longer Available but can be made No Longer Available but can be made pH BUFFER SOLUTION 4.01 pH BUFFER SOLUTION 6.87 pH BUFFER SOLUTION 7.41 pH BUFFER SOLUTION 9.18 .@25C
500ml 500ml 500ml 500ml
.@25C .@25C .@25C .@25C
Conductivity & Resistivity Solutions - @20C

EP1330 EP133 EP266 18 12 12 500ml 500ml 500ml CONDUCTIVITY & RESISTIVITY 1330us/cm CONDUCTIVITY & RESISTIVITY 133 us/cm CONDUCTIVITY & RESISTIVITY 26.6 us/cm .@20C .@20C .@20C
Reagents as Outlined in Chapter 4 (4.11) of Ph. Eur

1000401 1000402 1000501 1002501 1004702 1004703 1005201 1007301 1007302 1009301 1009401 1011601 1012601 1012602 1012701 1012801 1012803 1012901 1015201 1022901 1023100 1023300-A 1023300-B 1031101 1032101 1032102 1037702 1038100 1039101 1039401 1039402 1043101 1043501 24 24 12 12 12 12 24 12 12 24 24 12 24 12 24 24 24 24 12 12 12 12 12 24 12 12 12 24 12 12 12 12 24 1L 1L 1L 1L 1L 1L 1L 100ml 100ml 1L 1L 1L 100ml 100ml 100ml 100ml 100ml 100ml 1L 100ml 1L 500ml 500ml 1L 1L 1L 1L 100ml 100ml 100ml 100ml 1L 1L Acetic acid (30%) Acetic acid, Dilute (12%) Acetic anhydride solution R1 Alcohol, aldehyde-free Ammonia, dilute R1 Ammonia, dilute R2 Ammonium carbonate solution Anisaldehyde solution Anisaldehyde solution R1 Barium chloride solution R1 Barium hydroxide solution Biuret reagent Bromocresol green solution Bromocresol green-methyl red solution Bromocresol purple solution Bromophenol blue solution Bromophenol blue solution R2 Bromothymol Blue solution R1 Calcium sulphate solution Crystal violet solution Cupri-citric solution Cupri-tartaric solution I Cupri-tartaric solution II Dimidium bromide - sulphan blue mixed Diphenylamine solution Diphenylamine solution R1 Ferric ammonium sulphate sol R2 Ferroin Formaldehyde solution Funhsin solution, decolorised Funhsin solution decolorised R1 Holmium perchlorate solution Hodrochloric acid R1
ENVASE
PRODUCTO
1043503 1043504 1045901 1046300 1048001 1048101 1048102 1052101 1053601 1054801 1054802 1055101 1055102 1056700 1056801 1057601 1058201 1058303 1058304 1058305 1058402 1062901 1063601 1063603 1063702 1063703 1065000 1065200 1065801 1065802 1069101 1069201 1069501 1069801 1070001 1070302 1070303 1070501 1070502 1070600 1070602 1070902 1071301 1071600 A+B 1075201 1078301 1078302 1079301 1081401 1081402 1081404 10816005 1083901 1085103 1086804 1089602 1090701 1094201 1102301 1096601 1096602
24 24 12 12 24 12 12 12 12 12 24 12 24 12 24 24 24 12 12 12 24 24 24 24 24 24 6 12 6 6 24 24 12 12 6 12 12 12 24 6 3 24 12 24 24 24 24 24 24 24 24 * 6 12 24 12 12 4 12 24 12
1L 1L 1L 200ml 1L 1 bottle 10g pk of 50 pk of 50 100ml 100ml 100ml 100ml 100ml 100ml 100g 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 500ml 100ml 100ml 100ml 100ml 100ml 100ml 1L 1L 1L 100ml 1L 1L 100ml 125ml 1L 100ml 100ml 1L 125ml 2x 100ml 100ml 1L 1L 1L 1L 1L 1L 500ml 100ml 100ml 1L 1L 100ml 100ml 1L 1L 1L
Hydrochloric acid, dilute Hydrochloric acid, dilute R1 Iodine bromide solution Iodoplatinate reagent Lanthanum nitrate solution Lead acetate cotton Lead acetate paper Mercuric bromide paper Methoxyphenylacetic reagent Methyl orange mixed solution Methyl orange solution Methyl red mixed solution Methyl red solution Molybdovanadic reagent Mordant black 11 triturate Naphtolbenzein solution Nile blue A solution Ninhydrin solution Ninhydrin solution R1 Ninhydrin solution R2 Nitric acid, dilute Perchloric acid solution Phenol red solution Phenol red solution R2 Phenolphthalein solution Phenolphthalein solution R1 Phosphomolybdotungstic reagent phosphotungstic acid solution Picric acid solution Picric acid solution R1 Potassium chloride, 0.1m Potassium chromate solution Potassium dichromate solution Potassium ferrocyanide solution Potassium hydrogen phthalate, 0.2M Potassium hydroxide in alcohol (10% V/V) 0.5M Potassium hydroxide sol, alcoholic Potassium iodide and starch sol. Potassium iodide solution Potassium iodobismuthate solution Potassium iodobismuthate solution R2 Potassium permanganate Solution Potassium pyroantimonate solution Potassium tetraiodomercurate solution, alkaline (A+B) Ruthenium red solution Silver nitrate solution R1 Silver nitrate solution R2 Sodium carbonate solution Sodium hydroxide solution Sodium hydroxide solution dilute Sodium Hydroxide solution strong Sodium hypochlorite solution, strong Sodium sulphide solution Starch solution Sulphuric acid, dilute Thioacetamide solution Thymolphthalein solution Tris(hydroymethyl) aminomethane solution Zinc acetate solution Zinc chloride formic acid solution Zinc chloride solution, iodinated
ENVASE
PRODUCTO
Standard Solutions for Limit Test as Outlined in Chapter 4 (4.1.2) of Ph. Eur
5000200 5000300C 5000500C 5000700 5000800C 5000802C 5000900C 5001000 5001100 5001200C 5001400C 5001600C 5001602C 5001701C 5001800C 5002000C 5002100C 5002200C 5002400C 5002500 5002700C 5002800C 5003100C 5003401C 6 6 12 12 12 12 12 6 12 12 6 6 6 12 12 12 12 12 24 12 12 12 12 6 100ml 100ml 100ml 100ml 100ml 100ml 100ml 1L 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 1L 100ml 100ml 100ml 100ml Aluminium standard solution (200ppm AL) Concentrate to make Ammonium std sol (100ppm NH4) Concentrate to make Arsenic sol. (10ppm As) Conc. to make Cadmium standard sol. (0.1% Cd) Concentrate to make Calcium sol. (400ppm Ca) Conc. to make Calcium sol (100ppm Ca), alcoholic Concentrate to make Chloride sol. (8ppm Cl) Chromium standard sol (100ppm Cr) Copper standard sol. (0.1% Cu) Conc. to make Ferrocyanide solution (100ppm Fe) Conc. to make Fluoride solution (10ppm F) Conc. to make Iron solution (20ppm Fe) Conc. to make Iron solution (8ppm Fe) Concentrate to make Lead sol. (100ppm Pb) Conc to make Magnesium standard sol (100ppm Mg) Conc. to make Nickel solution (10ppm Ni) Conc. to make Nitrate sol. (100ppm NO3) Conc. to make Phosphate solution (5ppm PO4) Conc. to make Potassium standard solution (100ppm K) Selenium standard sol (100ppm Se) Conc. to make Sodium standard sol (200ppm Na) Concentrate to make Sulphate solution (10ppm SO4) Conc. to make Tin standard solution (5ppm Sn) Concentrate to make Zinc solution (100ppm Zn)
Buffer Solutions as Outlined in Chapter 4 (4.1.3) of Ph. Eur

4000100 4000600 4001400 4004800 4008300 4007200 4007300 24 24 24 24 12 24 24 1L 1L 1L 1L 1L 1L 1L Buffered acetone solution Buffer solution PH3.5 Acetate buffer solution PH4.6 Phosphate buffer solution PH7.4 Buffer (phosphate) solution PH9.0 Ammonium chloride buffer PH9.5 Ammonium chloride buffer PH10.0
Volumetric Solutions as Outlined in Chapter 4 (4.2.2) of Ph. Eur

3000100 3000200 3000300 3000500 3000600 3000900 3001100 3008700 3001300 3001500 3001700 3001800 3002100 3008800 3002700 3003100 3003300 3003500 3003900 3004200 3002900 3009100 3004800 3004900 3005000 3005100 3005300 24 12 12 24 12 24 24 12 24 24 24 24 24 12 12 24 24 24 12 12 12 24 24 12 12 12 24 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 0.1M Ammonium and cerium nitrate 0.01M Ammonium and cerium nitrate 0.1M Ammonium and cerium sulphate 0.1M Ammonium thiocyanate 0.1M Barium chloride 0.004M Benzethonium chloride 0.1M Cerium sulphate 1M Cupriethylenediamine hydroxide solution 0.1M Ferric ammonium sulphate 6M Hydrochloric acid 2M Hydrochloric acid 1M Hydrochloric acid 0.1M Hydrochloric acid 0.1M Hydrochloric acid, alcoholic 0.05M Iodine 0.1M Lead nitrate 0.1M Lithium methoxide 0.02M Mercuric nitrate 0.1M Perchloric acid 0.033M Potassium bromate 0.01M Iodine 1.0M Potassium hydroxide 0.1M Potassium hydroxide 0.5M Potassium hydroxide in alcohol (60% V/V) 0.5M Potassium hydroxide, alcoholic 0.1M Potassium hydroxide, alcoholic 0.02M Potassium permanganate
ENVASE
PRODUCTO
3005600 3009300 3005800 3005900 3006300 3006600 3007000 3007100 3007200 3007300 3007800 3008000 3008300 3008400 3008600
24 * 12 24 24 24 12 12 6 24 24 24 12 12 24
1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L 1L
0.1M Silver nitrate 0.001M Silver Nitrate 0.1M Sodium arsenite 0.1M Sodium edetate 1M Sodium hydroxide 0.1M Sodium hydroxide 0.1M Sodium hydroxide, ethanolic 0.1M Sodium methoxide 0.1M Sodium nitrite 0.1M Sodium thiosulphate 0.5M Sulphuric acid 0.05M Sulphuric acid 0.1M Tetrabutylammonium hydroxide 0.1M Tetrabutylammonium hydroxide in 2-propanol 0.1M Zinc sulphate
Conductivity Standards
Conductivity Standard Values @25C Conductivity Premium Values @25C TDS Standard
ENVASE
PRODUCTO
Conductivity Standard Values @25C

CSKC84 CSKCS CSKCL CSKC12880 12 12 18 18 500ml 500ml 500ml 500ml 84 Microsiemens/cm 147 Microsiemens/cm 1413 Microsiemens/cm 12,880 Microsiemens/cm 25C 25C 25C 25C
Conductivity Premium Values @25C

CSKC136 CSKC13 CSKC5 CSKC10 CSKC20 CSKC50 CSKC100 CSKC200 CSKC500 CSKC1000 CSKC5M CSKC10M CSKC20M CSKC50M CSKC100M CSKC150M CSKC200M CSKC300M CSKC350M CSKC450M CSKC500M 3 3 6 6 12 12 12 18 18 18 18 18 18 18 18 18 18 18 18 18 24 6x250ml 250ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 1.30 Microsiemens/cm 1.30 Microsiemens/cm 5 Microsiemens/cm 10 Microsiemens/cm 20 Microsiemens/cm 50 Microsiemens/cm 100 Microsiemens/cm 200 Microsiemens/cm 500 Microsiemens/cm 1,000 Microsiemens/cm 5,000 Microsiemens/cm 10,000 Microsiemens/cm 20,000 Microsiemens/cm 50,000 Microsiemens/cm 100,000 Microsiemens/cm 150,000 Microsiemens/cm 200,000 Microsiemens/cm 300,000 Microsiemens/cm 350,000 Microsiemens/cm 450,000 Microsiemen/cm 500,000 Microsiemens/cm 25C 25C 25C 25C 25C 25C 25C 25C 25C 25C 25C 25C 25C 25C 25C 25C 25C 25C 25C 25C 25C
TDS Standard
CS1382 18 500ml TDS Standard 1382 ppm NaCl 25C
pH Buffer Solutions
Colour Coded Buffers @20C/25C Twin Neck Bottle Format @20C/25C
ENVASE
PRODUCTO
pH Buffers Colour Coded @20C/@25C

10405C 1040C 5040C 10705C 1070C 5070C 11005C 1100C 5100C 1040525C 104025C 504025C 1070525C 107025C 507025C 1100525C 110025C 510025C 36 36 36 24 24 24 24 24 24 36 36 36 24 24 24 24 24 24 500ml 1L 5L 500ml 1L 5L 500ml 1L 5L 500ml 1L 5L 500ml 1L 5L 500ml 1L 5L BUFFER pH4.00 (Red) 0.01 @ 20C BUFFER pH4.00 (Red) 0.01 @ 20C BUFFER pH4.00 (Red) 0.01 @ 20C BUFFER pH7.00 (Yellow) 0.01 @ 20C BUFFER pH7.00 (Yellow) 0.01 @ 20C BUFFER pH7.00 (Yellow) 0.01 @ 20C BUFFER pH10.00 (Blue) 0.01 @ 20C BUFFER pH10.00 (Blue) 0.01 @ 20C BUFFER pH10.00 (Blue) 0.01 @ 20C BUFFER pH4.00 (Red) 0.01 @25C BUFFER pH4.00 (Red) 0.01 @25C BUFFER pH4.00 (Red) 0.01 @25C BUFFER pH7.00 (Yellow) 0.01 @25C BUFFER pH7.00 (Yellow) 0.01 @25C BUFFER pH7.00 (Yellow) 0.01 @25C BUFFER pH10.00 (Blue) 0.01 @25C BUFFER pH10.00 (Blue) 0.01 @25C BUFFER pH10.00 (Blue) 0.01 @25C 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 .@ 20C .@ 20C .@ 20C .@ 20C .@ 20C .@ 20C .@ 20C .@ 20C .@ 20C .@ 25C .@ 25C .@ 25C .@ 25C .@ 25C .@ 25C .@ 25C .@ 25C .@ 25C
pH Buffers Twin Neck Format @20C/25C

10402CTT 10405CTT 1040CTT 10702CTT 10705CTT 1070CTT 11002CTT 11005CTT 1100CTT 1040225CTT 1040525CTT 104025CTT 1070225CTT 1070525CTT 107025CTT 1100225CTT 1100525CTT 110025CTT 36 36 36 24 24 24 24 24 24 36 36 36 24 24 24 24 24 24 250ml 500ml 1L 250ml 500ml 1L 250ml 500ml 1L 250ml 500ml 1L 250ml 500ml 1L 250ml 500ml 1L BUFFER pH4.00 (Red) 0.01 @ 20C BUFFER pH4.00 (Red) 0.01 @ 20C BUFFER pH4.00 (Red) 0.01 @ 20C BUFFER pH7.00 (Yellow) 0.01 @ 20C BUFFER pH7.00 (Yellow) 0.01 @ 20C BUFFER pH7.00 (Yellow) 0.01 @ 20C BUFFER pH10.00 (Blue) 0.01 @ 20C BUFFER pH10.00 (Blue) 0.01 @ 20C BUFFER pH10.00 (Blue) 0.01 @ 20C BUFFER pH4.00 (Red) 0.01 @25C BUFFER pH4.00 (Red) 0.01 @25C BUFFER pH4.00 (Red) 0.01 @25C BUFFER pH7.00 (Yellow) 0.01 @25C BUFFER pH7.00 (Yellow) 0.01 @25C BUFFER pH7.00 (Yellow) 0.01 @25C BUFFER pH10.00 (Blue) 0.01 @25C BUFFER pH10.00 (Blue) 0.01 @25C BUFFER pH10.00 (Blue) 0.01 @25C 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 .@ 20C .@ 20C .@ 20C .@ 20C .@ 20C .@ 20C .@ 20C .@ 20C .@ 20C .@ 25C .@ 25C .@ 25C .@ 25C .@ 25C .@ 25C .@ 25C .@ 25C .@ 25C
Low Ionic Strength Buffers @20C

LS41 LS415 LS69 LS695 24 24 24 24 500ml 5L 500ml 5L BUFFER SOLUTION pH4.10 0.04 BUFFER SOLUTION pH4.10 0.04 BUFFER SOLUTION pH6.96 0.04 BUFFER SOLUTION pH6.96 0.04 0.04 0.04 0.04 0.04
Bag in Box Colour Coded pH Buffers @20C/25C

BPH01 36 5L Buffer pH4.00 (Red) 0.01 @ 20C BPH02 36 10L Buffer pH4.00 (Red) 0.01 @ 20C BPH03 24 5L Buffer pH7.00 (Yellow) 0.01 @ 20C BPH04 24 10L Buffer pH7.00 (Yellow) 0.01 @ 20C BPH05 24 5L Buffer pH10.00 (Blue) 0.01 @ 20C BPH06 24 10L Buffer pH10.00 (Blue) 0.01 @ 20C BPH07 36 5L Buffer pH4.00 (Red) 0.01 @25C BPH08 36 10L Buffer pH4.00 (Red) 0.01 @25C BPH09 24 5L Buffer pH7.00 (Yellow) 0.01 @25C BPH10 24 10L Buffer pH7.00 (Yellow) 0.01 @25C BPH11 24 5L Buffer pH10.00 (Blue) 0.01 @25C BPH12 24 10L Buffer pH10.00 (Blue) 0.01 @25C All other pH values are available at the same prices as above per 5L & 10L cubitainers 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 .@ 20C .@ 20C .@ 20C .@ 20C .@ 20C .@ 20C .@ 25C .@ 25C .@ 25C .@ 25C .@ 25C .@ 25C
Analytical Volumetric Solutions

Ready to use Aqueous Solutions Non Aqueous Titrants
ENVASE
PRODUCTO
Ready to use Aqueous Solutions

CH22005 CH22001 CH21005 CH21001 CH20055 CH20051 CH20105 CH20101 NH20105 NH20101 AS2055 AS2051 AT21W AT21F BACL2105 BACL2101 BACL2055 BACL2051 BACL20055 BACL20051 HY045 HY041 HY0045 HY0041 BR20105 BR20101 CAAC2105 CAAC2101 CACL2055 CACL2051 CACL20025 CACL20021 CACL2001255 CACL2001251 CACL20015 CACL20011 CACL20055 CACL20051 CS2105 CS2101 CS20255 CS20251 CS2015 CS2011 CS20055 CS20051 CUS02055 CUS02051 CUS02015 CUS02011 CUCL2055 CUCL2051 CU201685 CU201681 EDB50510 ED2055 ED2051 EDB20110 ED2015 ED2011 EDB200110 ED20015 ED20011 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 12 12 12 12 12 12 12 12 12 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 2.5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 10L 5L 1L 10L 5L 1L 10L 5L 1L Acetic acid 2.0N 2.0M Acetic acid 2.0N 2.0M Acetic acid 1.0N 1.0M Acetic acid 1.0N 1.0M Acetic acid 0.5N 0.5M Acetic acid 0.5N 0.5M Acetic acid 0.1N 0.1M Acetic acid 0.1N 0.1M Ammonia 0.1N 0.1M Ammonia 0.1N 0.1M Ammonium sulphate 1.0N 0.5M Ammonium sulphate 1.0N 0.5M Ammonium Thiocyanate 1.0N 1.0M Ammonium Thiocyanate 1.0N 1.0M Barium chloride 2.0N 1.0M Barium chloride 2.0N 1.0M Barium chloride 1.0N 0.5M Barium chloride 1.0N 0.5M Barium chloride 0.1N 0.05M Barium chloride 0.1N 0.05M Benzethonium chloride 0.04N 0.04M Benzethonium chloride 0.04N 0.04M Benzethonium chloride 0.004N 0.004M Benzethonium chloride 0.004N 0.004M Bromine (Bromate/bromide) 0.1N 0.05M Bromine (Bromate/bromide) 0.1N 0.05M Calcium acetate 1.0N 1.0M Calcium acetate 1.0N 1.0M Calcium chloride 1.0N 0.5M Calcium chloride 1.0N 0.5M Calcium chloride 0.04N 0.02M Calcium chloride 0.04N 0.02M Calcium chloride 0.025N 0.0125M Calcium chloride 0.025N 0.0125M Calcium chloride 0.02N 0.01M Calcium chloride 0.02N 0.01M Calcium chloride 0.01N 0.005M Calcium chloride 0.01N 0.005M Cerium IV sulphate 1.0N 1.0M Cerium IV sulphate 1.0N 1.0M Cerium IV sulphate 0.2N 0.2M Cerium IV sulphate 0.2N 0.2M Cerium IV sulphate 0.1N 0.1M Cerium IV sulphate 0.1N 0.1M Cerium IV sulphate 0.05N 0.05M Cerium IV sulphate 0.05N 0.05M Copper II sulphate 0.5N 0.5M Copper II sulphate 0.5N 0.5M Copper II sulphate 0.1N 0.1M Copper II sulphate 0.1N 0.1M Copper II Chloride 0.5N 0.5M Copper II Chloride 0.5N 0.5M Cupric solution 0.168N 0.168M Cupric solution 0.168N 0.168M EDTA (Disodium salt) 1.0N 0.5M EDTA (Disodium salt) 1.0N 0.5M EDTA (Disodium salt) 1.0N 0.5M EDTA (Disodium salt) 0.2N 0.1M EDTA (Disodium salt) 0.2N 0.1M EDTA (Disodium salt) 0.2N 0.1M EDTA (Disodium salt) 0.02N 0.01M EDTA (Disodium salt) 0.02N 0.01M EDTA (Disodium salt) 0.02N 0.01M
ENVASE
PRODUCTO
HB25010 H25005 H25001 HB235710 H23575 H23571 HB22010 H22005 H22001 H218025 H21805 HB21010 H21005 H21001 HB20510 H20505 H20501 HB2035710 H203575 H203571 HB202510 H20255 H20251 HB20210 H20205 H20201 HB20110 H20105 H20101 HB200510 H20055 H20051 HB20035710 H2003575 H2003571 HB200210 H20025 H20021 HF20055 HF20051 I2050W I2050F I2005W I2005F I20023F FES2025 FES2021 FECL215 FECL211 PBA2055 PBA2051 PBA20055 PBA20051 PBNO2055 PBNO2051 MG2015 MG2011 MG20015 MG20011 MGSO2015 MGS2011 MNCL2055 MNCL2051 MNCL20055
24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 12 12 12 12 12 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24
10L 5L 1L 10L 5L 1L 10L 5L 1L 25L 5L 10L 5L 1L 10L 5L 1L 10L 5L 1L 10L 5L 1L 10L 5L 1L 10L 5L 1L 10L 5L 1L 10L 5L 1L 10L 5L 1L 5L 1L 2.5L 1L 2.5L 1L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L
Hydrochloric Acid 5.0N 5.0M Hydrochloric Acid 5.0N 5.0M Hydrochloric Acid 5.0N 5.0M Hydrochloric Acid 3.57N 3.57M Hydrochloric Acid 3.57N 3.57M Hydrochloric Acid 3.57N 3.57M Hydrochloric Acid 2.0N 2.0M Hydrochloric Acid 2.0N 2.0M Hydrochloric Acid 2.0N 2.0M Hydrochloric Acid 1.8N 1.8M Hydrochloric Acid 1.8N 1.8M Hydrochloric Acid 1.0N 1.0M Hydrochloric Acid 1.0N 1.0M Hydrochloric Acid 1.0N 1.0M Hydrochloric Acid 0.5N 0.5M Hydrochloric Acid 0.5N 0.5M Hydrochloric Acid 0.5N 0.5M Hydrochoric Acid 0.357N 0.357M Hydrochoric Acid 0.357N 0.357M Hydrochoric Acid 0.357N 0.357M Hydrochoric Acid 0.25N 0.25M Hydrochoric Acid 0.25N 0.25M Hydrochoric Acid 0.25N 0.25M Hydrochoric Acid 0.2N 0.2M Hydrochoric Acid 0.2N 0.2M Hydrochoric Acid 0.2N 0.2M Hydrochoric Acid 0.1N 0.1M Hydrochoric Acid 0.1N 0.1M Hydrochoric Acid 0.1N 0.1M Hydrochoric Acid 0.05N 0.05M Hydrochoric Acid 0.05N 0.05M Hydrochoric Acid 0.05N 0.05M Hydrochoric Acid 0.0357N 0.0357M Hydrochoric Acid 0.0357N 0.0357M Hydrochoric Acid 0.0357N 0.0357M Hydrochoric Acid 0.02N 0.02M Hydrochoric Acid 0.02N 0.02M Hydrochoric Acid 0.02N 0.02M Hydrofluoric Acid 0.05N 0.05M Hydrofluoric Acid 0.05N 0.05M Iodine 1.0N 0.5M Iodine 1.0N 0.5M Iodine 0.1N 0.05M Iodine 0.1N 0.05M Iodine 0.0473N 0.02365M Iron (II) Sulphate 0.2N 0.2M Iron (II) Sulphate 0.2N 0.2M Iron (III) Chloride 1.0N 1.0M Iron (III) Chloride 1.0N 1.0M Lead (II) Acetate 1.0N 0.5M Lead (II) Acetate 1.0N 0.5M Lead (II) Acetate 0.1N 0.05M Lead (II) Acetate 0.1N 0.05M Lead (II) Nitrate 1.0N 0.5M Lead (II) Nitrate 1.0N 0.5M Magnesium Chloride 0.2N 0.1M Magnesium Chloride 0.2N 0.1M Magnesium Chloride 0.02N 0.01M Magnesium Chloride 0.02N 0.01M Magnesium Sulphate 0.1N 0.1M Magnesium Sulphate 0.1N 0.1M Manganese (II) Chloride 0.5N 0.5M Manganese (II) Chloride 0.5N 0.5M Manganese (II) Chloride 0.05N 0.05M
ENVASE
PRODUCTO
MNCL20051 HGN2015 HGN2011 HGN20015 HGN20011 HGN200055 HGN200051 NICL2055 NICL2051 NICL20055 NICL20051 NOB280010 NO28005 NO28001 NOB240010 NO24005 NO24001 NOB220010 NO22005 NO22001 NOB210010 NO21005 NO21001 NOB20110 NO20105 NO20101 NOB200210 NO20025 NO20021 OA2055 OA2051 OA20055 OA20051 OA200255 OA200251 P2050F P2050H P2010W P2010F P2010H KB20016W KB20016F KCL2105 KCL2101 KCL2025 KCL2021 KC2016W KC2016F KC20041W KC20041F KC20016W KC20016F KC2002W KC2002F KFE2015 KFE2011 PHP2015 PHP2011 KOHB2110 KOH21005 KOH21001 KOHB20110 KOH20105 KOH20101
24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 12 12 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24
1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 10L 5L 1L 10L 5L 1L 10L 5L 1L 10L 5L 1L 10L 5L 1L 10L 5L 1L 5L 1L 5L 1L 5L 1L 1L 500ml 2.5L 1L 500ml 2.5L 1L 5L 1L 5L 1L 2.5L 1L 2.5L 1L 2.5L 1L 2.5L 1L 5L 1L 5L 1L 10L 5L 1L 10L 5L 1L
Manganese (II) Chloride 0.05N 0.05M Mercury (I) Nitrate 0.1N 0.1M Mercury (I) Nitrate 0.1N 0.1M Mercury (II) Nitrate 0.02N 0.01M Mercury (II) Nitrate 0.02N 0.01M Mercury (ll) Nitrate 0.01N 0.005M Mercury (ll) Nitrate 0.01N 0.005M Nickle (II) Chloride 0.5N 0.5M Nickle (II) Chloride 0.5N 0.5M Nickle (II) Chloride 0.05N 0.05M Nickle (II) Chloride 0.05N 0.05M Nitric Acid 8.0N 8.0M Nitric Acid 8.0N 8.0M Nitric Acid 8.0N 8.0M Nitric Acid 4.0N 4.0M Nitric Acid 4.0N 4.0M Nitric Acid 4.0N 4.0M Nitric Acid 2.0N 2.0M Nitric Acid 2.0N 2.0M Nitric Acid 2.0N 2.0M Nitric Acid 1.0N 1.0M Nitric Acid 1.0N 1.0M Nitric Acid 1.0N 1.0M Nitric Acid 0.1N 0.1M Nitric Acid 0.1N 0.1M Nitric Acid 0.1N 0.1M Nitric Acid 0.02N 0.02M Nitric Acid 0.02N 0.02M Nitric Acid 0.02N 0.02M Oxalic Acid 1.0N 0.5M Oxalic Acid 1.0N 0.5M Oxalic Acid 0.1N 0.05M Oxalic Acid 0.1N 0.05M Oxalic Acid 0.05N 0.025M Oxalic Acid 0.05N 0.025M Perchloric Acid in Acetic Acid 0.5N 0.5M Perchloric Acid in Acetic Acid 0.5N 0.5M Perchloric Acid in Acetic Acid 0.1N 0.1M Perchloric Acid in Acetic Acid 0.1N 0.1M Perchloric Acid in Acetic Acid 0.1N 0.1M Potassium Bromate/Bromide 0.1N 0.0167M Potassium Bromate/Bromide 0.1N 0.0167M Potassium Chloride 1.0N 1.0M Potassium Chloride 1.0N 1.0M Potassium Chloride 0.2N 0.2M Potassium Chloride 0.2N 0.2M Potassium Dichromate 1.0N 0.167M Potassium Dichromate 1.0N 0.167M Potassium Dichromate 0.25N 0.041M Potassium Dichromate 0.25N 0.041M Potassium Dichromate 0.1N 0.0167M Potassium Dichromate 0.1N 0.0167M Potassium Dichromate 0.125N 0.0208M Potassium Dichromate 0.125N 0.0208M Potassium Ferricyanide 0.1N 0.1M Potassium Ferricyanide 0.1N 0.1M Potassium Hydrogen Phythalate 0.1N 0.1M Potassium Hydrogen Phythalate 0.1N 0.1M Potassium Hydroxide 1.0N 1.0M Potassium Hydroxide 1.0N 1.0M Potassium Hydroxide 1.0N 1.0M Potassium Hydroxide 0.1N 0.1M Potassium Hydroxide 0.1N 0.1M Potassium Hydroxide 0.1N 0.1M
ENVASE
PRODUCTO
KOHB205010 KOH20505 KOH20501 KOHB200510 KOH20055 KOH20051 PII2002W PII2002H P12005W PI20025W PI20016W PI2008W K12305 K12301 KI2105 KI2101 KI2015 KI2011 KO20055 KO20051 PP2020W PP2020F PP2002W PP2002F PP2001W PP2001F KT210W KT210F KT201W KT201F KT2005W KT2005F KT2002W KT2002F N21000W N21000F N21000H N201709W N20100W N20100F N20100H N20085W N20050W N20028W N20025F N20020W N20020F N20014W SA2005W SC20505 SC20501 SC20055 SC20051 NACL2015 NACL2011 NACL20055 NACL20051 SB250010 S25005 S25001 SB235710 S23575 S23571 SB220010
24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 12 12 12 12 12 12 24 24 24 24 24 24 24 24 24
10L 5L 1L 10L 5L 1L 2.5L 500ml 2.5L 2.5L 2.5L 2.5L 5L 1L 5L 1L 5L 1L 5L 1L 2.5L 1L 2.5L 1L 2.5L 1L 2.5L 1L 2.5L 1L 2.5L 1L 2.5L 1L 2.5L 1L 500ml 2.5L 2.5L 1L 500ml 2.5L 2.5L 2.5L 1L 2.5L 1L 2.5L 2.5l 5L 1L 5L 1L 5L 1L 5L 1L 10L 5L 1L 10L 5L 1L 10L
Potassium Hydroxide 0.5N 0.5M Potassium Hydroxide 0.5N 0.5M Potassium Hydroxide 0.5N 0.5M Potassium Hydroxide 0.05N 0.05M Potassium Hydroxide 0.05N 0.05M Potassium Hydroxide 0.05N 0.05M Potassium Iodate/Iodide 0.02N 0.00333M Potassium Iodate/Iodide 0.02N 0.00333M Potassium Iodate 0.3N 0.05M Potassium Iodate 0.15N 0.025M Potassium Iodate 0.1N 0.01667M Potassium Iodate 0.008833N 0.0147M Potassium Iodide 3.0N 3.0M Potassium Iodide 3.0N 3.0M Potassium Iodide 1.0N 1.0M Potassium Iodide 1.0N 1.0M Potassium Iodide 0.1N 0.1M Potassium Iodide 0.1N 0.1m di-Potassium Oxalate 0.1N 0.05M di-Potassium Oxalate 0.1N 0.05M Potassium Permanganate 1.0N 0.2M Potassium Permanganate 1.0N 0.2M Potassium Permanganate 0.1N 0.02M Potassium Permanganate 0.1N 0.02M Potassium Permanganate 0.05N 0.01M Potassium Permanganate 0.05N 0.01M Potassium Thiocyanate 1.0N 1.0M Potassium Thiocyanate 1.0N 1.0M Potassium Thiocyanate 0.1N 0.1M Potassium Thiocyanate 0.1N 0.1M Potassium Thiocyanate 0.05N 0.05M Potassium Thiocyanate 0.05N 0.05M Potassium Thiocyanate 0.02N 0.02M Potassium Thiocyanate 0.02N 0.02M Silver Nitrate 1.0N 1.0M Silver Nitrate 1.0N 1.0M Silver Nitrate 1.0N 1.0M Silver Nitrate 0.1709N 0.1709M Silver Nitrate 0.1N 0.1M Silver Nitrate 0.1N 0.1M Silver Nitrate 0.1N 0.1M Silver Nitrate 0.085N 0.085M Silver Nitrate 0.05N 0.05M Silver Nitrate 0.0282N 0.0282M Silver Nitrate 0.025N 0.025M Silver Nitrate 0.02N 0.02M Silver Nitrate 0.02N 0.02M Silver Nitrate 0.0141N 0.0141M Sodium Arsenite 0.1N 0.5M Sodium Carbonate 1.0N 0.5M Sodium Carbonate 1.0N 0.5M Sodium Carbonate 0.1N 0.05M Sodium Carbonate 0.1N 0.05M Sodium Chloride 0.1N 0.1M Sodium Chloride 0.1N 0.1M Sodium Chloride 0.05N 0.05M Sodium Chloride 0.05N 0.05M Sodium Hydroxide 5.0N 5.0M Sodium Hydroxide 5.0N 5.0M Sodium Hydroxide 5.0N 5.0M Sodium Hydroxide 3.57N 3.57M Sodium Hydroxide 3.57N 3.57M Sodium Hydroxide 3.57N 3.57M Sodium Hydroxide 2.0N 2.0M
ENVASE
PRODUCTO
S22005 S22001 S212025 SB212010 SB21205 SB210010 S21005 S21001 S20625 S2065 SB205010 S20505 S20501 S2035465 S2035461 S203135 S203131 S20255 S20251 SB202010 S20205 S20201 S20115 S20111 S20105 S20101 SB20110 S20025 S20021 S21005LC S21001LC S20505LC S20501LC S20105LC S20101LC NANO055 NANO051 NAT21005 NAT21001 NAT20105 NAT20101 TB210010 T21005 T21001 TB201010 T20105 T20101 T2005515 T2005511 T20055 T20051 TB200110 T20015 T20011 SUB250010 SU25005 SU25001 SUB225010 SU22505 SU22501 SUB210010 SU21005 SU21001 SU20925
24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 12 12 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24
5L 1L 25L 10L 5L 10L 5L 1L 25L 5L 10L 5L 1L 5L 1L 5L 1L 5L 1L 10L 5L 1L 5L 1L 5L 1L 10L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 10L 5L 1L 10L 5L 1L 5L 1L 5L 1L 10L 5L 1L 10L 5L 1L 10L 5L 1L 10L 5L 1L 25L
Sodium Hydroxide 2.0N 2.0M Sodium Hydroxide 2.0N 2.0M Sodium Hydroxide 1.2N 1.2M Sodium Hydroxide 1.2N 1.2M Sodium Hydroxide 1.2N 1.2M Sodium Hydroxide 1.0N 1.0M Sodium Hydroxide 1.0N 1.0M Sodium Hydroxide 1.0N 1.0M Sodium Hydroxide 0.6N 0.6M Sodium Hydroxide 0.6N 0.6M Sodium Hydroxide 0.5N 0.5M Sodium Hydroxide 0.5N 0.5M Sodium Hydroxide 0.5N 0.5M Sodium Hydroxide 0.35465N 0.35465M Sodium Hydroxide 0.35465N 0.35465M Sodium Hydroxide 0.313N 0.313M Sodium Hydroxide 0.313N 0.313M Sodium Hydroxide 0.25N 0.25M Sodium Hydroxide 0.25N 0.25M Sodium Hydroxide 0.2N 0.2M Sodium Hydroxide 0.2N 0.2M Sodium Hydroxide 0.2N 0.2M Sodium Hydroxide 0.111N 0.111M Sodium Hydroxide 0.111N 0.111M Sodium Hydroxide 0.1N 0.1M Sodium Hydroxide 0.1N 0.1M Sodium Hydroxide 0.1N 0.1M Sodium Hydroxide 0.02N 0.02M Sodium Hydroxide 0.02N 0.02M Sodium Hydroxide (Low in carbonate) 1.0N 1.0M Sodium Hydroxide (Low in carbonate) 1.0N 1.0M Sodium Hydroxide (Low in carbonate) 0.5N 0.5M Sodium Hydroxide (Low in carbonate) 0.5N 0.5M Sodium Hydroxide (Low in carbonate) 0.1N 0.1M Sodium Hydroxide (Low in carbonate) 0.1N 0.1M Sodium Nitrite 0.5N 0.5M Sodium Nitrite 0.5N 0.5M Sodium Thiocyanate 1.0N 1.0M Sodium Thiocyanate 1.0N 1.0M Sodium Thiocyanate 0.1N 0.1M Sodium Thiocyanate 0.1N 0.1M Sodium Thiosulphate 1.0N 1.0M Sodium Thiosulphate 1.0N 1.0M Sodium Thiosulphate 1.0N 1.0M Sodium Thiosulphate 0.1N 0.1M Sodium Thiosulphate 0.1N 0.1M Sodium Thiosulphate 0.1N 0.1M Sodium Thiosulphate 0.0551N 0.0551M Sodium Thiosulphate 0.0551N 0.0551M Sodium Thiosulphate 0.05N 0.05M Sodium Thiosulphate 0.05N 0.05M Sodium Thiosulphate 0.01N 0.01M Sodium Thiosulphate 0.01N 0.01M Sodium Thiosulphate 0.01N 0.01M Sulphuric Acid 10.0N 5.0M Sulphuric Acid 10.0N 5.0M Sulphuric Acid 10.0N 5.0M Sulphuric Acid 5.0N 2.5M Sulphuric Acid 5.0N 2.5M Sulphuric Acid 5.0N 2.5M Sulphuric Acid 2.0N 1.0M Sulphuric Acid 2.0N 1.0M Sulphuric Acid 2.0N 1.0M Sulphuric Acid 1.8N 0.9M
ENVASE
PRODUCTO
SU2095 SUB205010 SU20505 SU20501 SU203195 SU203191 SUB202510 SU20255 SU20251 SU20135 SU20131 SU2012755 SU2012751 SU20105 SU20101 SU20055 SU20051 SU20015 SU20011 SU2004165 SU2004161 ZNCL20105 ZNCL20101 ZNCL20505 ZNCL20501 ZNSO00505 ZNSO00501 ZNSO0105 ZS011
24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24
5L 10L 5L 1L 5L 1L 10L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L 5L 1L
Sulphuric Acid 1.8N 0.9M Sulphuric Acid 1.0N 0.5M Sulphuric Acid 1.0N 0.5M Sulphuric Acid 1.0N 0.5M Sulphuric Acid 0.638N 0.319M Sulphuric Acid 0.638N 0.319M Sulphuric Acid 0.5N 0.25M Sulphuric Acid 0.5N 0.25M Sulphuric Acid 0.5N 0.25M Sulphuric Acid 0.26N 0.13M Sulphuric Acid 0.26N 0.13M Sulphuric Acid 0.255N 0.1275M Sulphuric Acid 0.255N 0.1275M Sulphuric Acid 0.2N 0.1M Sulphuric Acid 0.2N 0.1M Sulphuric Acid 0.1N 0.05M Sulphuric Acid 0.1N 0.05M Sulphuric Acid 0.02N 0.01M Sulphuric Acid 0.02N 0.01M Sulphuric Acid 0.0832N 0.0416M Sulphuric Acid 0.0832N 0.0416M Zinc Chloride 0.1N 0.01M Zinc Chloride 0.1N 0.01M Zinc Chloride 0.5N 0.5M Zinc Chloride 0.5N 0.5M Zinc Sulphate 0.05N 0.05M Zinc Sulphate 0.05N 0.05M Zinc Sulphate 0.1N 0.1M Zinc Sulphate 0.1N 0.1M
Non Aqueous Titrants

MH2050 MD2050 PM2005 TB010H TB050H 12 24 12 12 * 2.5L 2.5L 500ml 500ml 0.5N Methanolic HCI 0.5N Morpholine in Methanol 0.1N Potassium Methoxide
0.1N Tetra n Butyl Ammonium Hydroxide in 50/50 Methanol/Propan-2-ol
0.5N Tetra n Butyl Ammonium 500ml Hydroxide in 50/50 methanol / Propan-2-ol 0.02N Tetra N Butyl Ammonium Hydroxide in 50/50 Methanol/Propan-2-ol TB002H 12 500ml ETKOH1F 12 1L 1.0N Potassium Hydroxide in Ethanol ETKOH1W 12 2.5L 1.0N Potassium Hydroxide in Ethanol ETKOH05F 12 1L 0.5N Potassium Hydroxide in Ethanol ETKOHO5W 12 2.5L 0.5N Potassium Hydroxide in Ethanol ETKOH01F 12 1L 0.1N Potassium Hydroxide in Ethanol ETKOH01W 12 2.5L 0.1N Potassium Hydroxide in Ethanol MKOH1F 12 1L 1.0N Potassium Hydroxide in Methanol 12 2.5L 1.0N Potassium Hydroxide in Methanol MKOH1W MKOH205F 12 1L 0.5N Potassium Hydroxide in Methanol 12 2.5L 0.5N Potassium Hydroxide in Methanol MKOH205W MKOH01F 12 1L 0.1N Potassium Hydroxide in Methanol 12 2.5L 0.1N Potassium Hydroxide in Methanol MKOH01W 24 500ml 0.1 Lithium Methoxide in Toluene/Methanol LIM2015 P2010H 24 500ml 0.1N Perchloric Acid in Acetic Acid 24 2.5L 0.1N Perchloric Acid in Acetic Acid P2010W 12 2.5L 0.1N Perchloric Acid in 1.4 Dioxan PD201W MN2010F 24 1L 0.1N Silver Nitrate in Methanol MN2010H 24 500ml 0.1N Silver Nitrate in Methanol MN2001OF 24 1L 0.01N Silver Nitrate in Methanol MN2001OH 24 500ml 0.01N Silver Nitrate in Methanol Reagecon has recently revised the packaging of this range and they are now supplied in glass or plastic ampoules and each ampolue is supplied in its own box. The packaging is now the same as that of Merck (Titrisol ), Prolab (Normadose TM) and JT Baker (Dilut-it). Full instructions for use are printed on the box, additionally shelf-life has been extended. All solutions will make 1 Litre.
Inorganic Spectroscopy Standards

Atomic Absorbtion Standards
ENVASE
PRODUCTO
Atomic Absorption Standards

AAAIH AAAIM AASbH AASbM AAAsH AAAsM AAAsVH AAAsVM AABaH AABaM AABeH AABeM AABiH AABiM AAB-H AAB-M AACdH AACdM AACaH AACaM AACsH AACsM AACrH AACrM AACoH AACoM AACuH AACuM AAGdH AAGdM AAGaH AAGaM AAAuH AAAuM AAInH AAInM AAIrH AAIrM AAFeH AAFeM AALaH AALaM AAPbH AAPbM AALiH AALiM AAMgH AAMgM AAMnH AAMnM AAHgH AAHgM AAMoH AAMoM AANiH AANiM AAPdH AAPdM AAP-H AAP-M AAPtH AAPtM 36 36 24 24 36 12 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 * * 36 36 36 36 36 36 * * 36 36 36 36 36 36 24 * 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml ALUMINIUM 1M HNO3 1,000ppm ALUMINIUM 1M HNO3 10,000ppm ANTIMONY H2O 1,000ppm ANTIMONY H2O 10,000ppm ARSENIC (III) 1M HCI 1,000ppm ARSENIC (III) 1M HCI 10,000ppm ARSENIC (V) 1M HNO3 1,000ppm ARSENIC (V) 1M HNO3 10,000ppm BARIUM 1M HNO3 1,000ppm BARIUM 1M HNO3 10,000ppm BERYLLIUM 1M HCI 1,000ppm BERYLLIUM 1M HCI 10,000ppm BISMUTH 1M HNO3 1,000ppm BISMUTH 1M HNO3 10,000ppm BORON H2O 1,000ppm BORON H2O 10,000ppm CADMIUM 1M HNO3 1,000ppm CADMIUM 1M HNO3 10,000ppm CALCIUM 1M HNO3 1,000ppm CALCIUM 1M HNO3 10,000ppm CESIUM 1M HNO3 1,000ppm CESIUM 1M HNO3 10,000ppm CHROMIUM 1M HNO3 1,000ppm CHROMIUM 1M HNO3 10,000ppm COBALT 1M HNO3 1,000ppm COBALT 1M HNO3 10,000ppm COPPER 1M HNO3 1,000ppm COPPER 1M HNO3 10,000ppm GADOLINIUM 1M HCI 1,000ppm GADOLINIUM 1M HCI 10,000ppm GALLIUM 1M HCL 1,000ppm GALLIUM 1M HCL 10,000ppm GOLD 2M HCI 1,000ppm GOLD 2M HCI 10,000ppm INDIUM 1M HNO3 1,000ppm INDIUM 1M HNO3 10,000ppm IRIDIUM 10% HCL 1,000ppm IRIDIUM 10%HCL 10,000ppm IRON 1M HNO3 1,000ppm IRON 1M HNO3 10,000ppm LANTHANUM 1M HNO3 1,000ppm LANTHANUM 1M HNO3 10,000ppm LEAD 1M HNO3 1,000ppm LEAD 1M HNO3 10,000ppm LITHIUM 1M HNO3 1,000ppm LITHIUM 1M HNO3 10,000ppm MAGNESIUM 1M HNO3 1,000ppm MAGNESIUM 1M HNO3 10,000ppm MANGANESE 1M HCI 1,000ppm MANGANESE 1M HCI 10,000ppm MERCURY 1M HNO3 1,000ppm MERCURY 1M HNO3 10,000ppm MOLYBDENUM 1M HNO3 1,000ppm MOLYBDENUM 1M HNO3 10,000ppm NICKEL 1M HNO3 1,000ppm NICKEL 1M HNO3 10,000ppm PALLADIUM 1M HCI 1,000ppm PALLADIUM 1M HCI 10,000ppm PHOSPHORUS H2O 1,000ppm PHOSPHORUS H2O 10,000ppm PLATINUM 1M HCI 1,000ppm PLATINUM 1M HCI 10,000ppm
ENVASE
PRODUCTO
AAK-H AAK-M AARhH AARhM AASeH AASeM AASiH AASIM AAAgH AAAgM AANaH AANaM AASrH AASrM AAS-H AAS-M AATeH AATeM AATlH AATlM AATtH AATtM AASnH AASnM AATiH AATiM AAW-H AAW-M AAUH AAUM AAV-H AAV-M AAZnH AAZnM AAZrH AAZrM
36 36 36 36 36 36 24 24 36 36 36 36 36 36 36 36 36 36 36 36 24 24 36 36 36 36 36 36 36 36 36 36 36 36 36 36
500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml
POTASSIUM 1M HNO3 1,000ppm POTASSIUM 1M HNO3 10,000ppm RHODIUM 1M HNO3 1,000ppm RHODIUM 1M HNO3 10,000ppm SELENIUM 1M HNO3 1,000ppm SELENIUM 1M HNO3 10,000ppm SILICON H2O 1,000ppm SILICON H2O 10,000ppm SILVER 1M HNO3 1,000ppm SILVER 1M HNO3 10,000ppm SODIUM 1M HNO3 1,000ppm SODIUM 1M HNO3 10,000ppm STRONTIUM 1M HNO3 1,000ppm STRONTIUM 1M HNO3 10,000ppm SULPHUR H2O 1,000ppm SULPHUR H2O 10,000ppm TELLURIUM 1M HCI 1,000ppm TELLURIUM 1M HCI 10,000ppm THALLIUM 1M HNO3 1,000ppm THALLIUM 1M HNO3 10,000ppm THORIUM 1M HNO3 1,000ppm THORIUM 1M HNO3 10,000ppm TIN 1M HCI 1,000ppm TIN 1M HCI 10,000ppm TITANIUM H2O 1,000ppm TITANIUM H2O 10,000ppm TUNGSTEN H2O 1,000ppm TUNGSTEN H2O 10,000ppm URANIUM 1M HNO3 1,000ppm URANIUM 1M HNO3 10,000ppm VANADIUM 1M HNO3 1,000ppm VANADIUM 1M HNO3 10,000ppm ZINC 1M HNO3 1,000ppm ZINC 1M HNO3 10,000ppm ZIRCONIUM 1M HCI 1,000ppm ZIRCONIUM 1M HCI 10,000ppm
Standards and Calibrators

Ion Chromatography Anion Standards Ion Chromatography Cation Standards Mixed Anion & Cations Standards Spectrophotometric Optical Standards
ENVASE
PRODUCTO
Ion Chromatography Anion Standards

ICAS35 ICAT35 ICAS01 ICAT01 ICAS02 ICAT02 ICAS29 ICAT29 ICAS03 ICAT03 ICAS34 ICAT34 ICAS40 ICAT40 ICAS04 ICAT04 ICAS11 ICAS13 ICAT13 ICAS05 ICAT05 ICAS12 ICAT12 ICAS06 ICAT06 ICAS36 ICAT36 12 * 24 24 24 12 12 12 24 24 12 * 24 24 24 12 12 12 12 24 12 24 12 12 12 12 * 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml Acetate 1mg/ml (1,000ppm) Acetate- OB on Syspro but can be made 0.2mg/ml (200ppm) Bromide 1mg/ml (1,000ppm) Bromide 0.2mg/ml (200ppm) Chloride 1mg/ml (1,000ppm) Chloride 0.2mg/ml (200ppm) Chromate 1mg/ml (1,000ppm) Chromate 0.2mg/ml (200ppm) Fluoride 1mg/ml (1,000ppm) Fluoride 0.2mg/ml (200ppm) Formate 1mg/ml (1,000ppm) Formate 0.2mg/ml (200ppm) Iodide 1mg/ml (1,000ppm) Iodide- can be made 0.2mg/ml (200ppm) Nitrate 1mg/ml (1,000ppm) Nitrate 0.2mg/ml (200ppm) Nitrite 1mg/ml (1,000ppm) Oxalate 1mg/ml (1,000ppm) Oxalate 0.2mg/ml (200ppm) Phosphate 1mg/ml (1,000ppm) Phosphate 0.2mg/ml (200ppm) Silica 1mg/ml (1,000ppm) Silica 0.2mg/ml (200ppm) Sulphate 1mg/ml (1,000ppm) Sulphate 0.2mg/ml (200ppm) Tartrate 1mg/ml (1,000ppm) Tartrate- Can be made 0.2mg/ml (200ppm)
Ion Chromatography Cation Standards

ICCS06 ICCT06 ICCS01 ICCT01 ICCS44 ICCT44 ICCS08 ICCT08 ICCS91 ICCT91 ICCS12 ICCT12 ICCS02 ICCT02 ICCS07 ICCT07 ICCS11 ICCT11 ICCS03 ICCT03 ICCS92 ICCT92 ICCS04 ICCT04 ICCS43 ICCT43 12 12 24 12 24 * 24 12 * * 24 12 12 12 24 12 24 12 24 12 12 * 12 12 24 * 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml Aluminium 1mg/ml 1000ppm Aluminium 0.2mg/ml 200ppm Ammonium 1mg/ml 1000ppm Ammonium 0.2mg/ml 200ppm Barium 1mg/ml 1000ppm Barium- can be made 0.2mg/ml 200ppm Calcium 1mg/ml 1000ppm Calcium 0.2mg/ml 200ppm Caesium- can be made 1mg/ml 1000ppm Caesium- can be made 0.2mg/ml 200ppm Iron 1mg/ml 1000ppm Iron 0.2mg/ml 200ppm Lithium 1mg/ml (1000ppm) Lithium 0.2mg/ml (200ppm) Magnesium 1mg/ml (1000ppm) Magnesium 0.2mg/ml (200ppm) Manganese 1mg/ml (1000ppm) Manganese 0.2mg/ml (200ppm) Potassium 1mg/ml (1000ppm) Potassium 0.2mg/ml (200ppm) Rubidium- can be made 1mg/ml (1000ppm) Rubidium- can be made 0.2mg/ml (200ppm) Sodium 1mg/ml (1000ppm) Sodium 0.2mg/ml (200ppm) Strontium 1mg/ml (1000ppm) Strontium- can be made 0.2mg/ml (200ppm)
ENVASE
PRODUCTO
Mixed Anion & Cations Standards

ICAS501 ICA-DX-711 12 100ml 100ml Mixed Anion Standard - contains Fluoride 100ppm, chloride 100ppm Nitrate 200ppm, Phosphate 200ppm, and Sulphate 200ppm Combined Seven Anion Standard-I: contains Fluoride 20mg/L, Chloride 30mg/L, Nitrite 100mg/L, bromide 100mg/L, nitrate 100mg/L phosphate 150mg/L, and sulfate 150mg/L- can be made Combined Seven Anion Standard-II: contains Fluoride 20mg/L, chloride 100mg/L, nitrite 100mg/L, bromide 100mg/L, nitrate 100ml/L phosphate 200mg/L and sulphate 100mg/L Combined Five Anion Standard - contains Fluoride 20mg/L, chloride 30mg/L, nitrate 100mg/L, phosphate 150mg/L and sulfate 150mg/L- can be made Mixed Cation Standard - contains sodium 500ppm, calcium 500ppm magnesium 200ppm and potassium 200ppm Combined Six Cation Standard-I: contains lithium 50mg/L, sodium 200mg/L, ammonium 400mg/L, potassium 200mg/L, magnesium 200mg/L and calcium 1000mg/L Combined Six Cation Standard-II: contains lithium 50mg/L, sodium 200mg/L, ammonium 250mg/L, potassium 500mg/L, magnesium 250mg/L and calcium 500mg/L- can be made
ICA-DX-721
100ml
ICA-DX-51
100ml
ICCS401 ICC-DX-611
12
100ml 100ml
ICC-DX-621
100ml
Spectrophotometric Optical Photometric Standards

OPS1 OPS2 OPS3 OPS4 OPS5 OPS6 OPS7 OPS8 OPS20 OPS30 OPSB 12 12 12 12 12 12 12 12 12 12 12 125ml 125ml 125ml 125ml 125ml 125ml 125ml 125ml 125ml 125ml 125ml Spectro Photometric Std 1.0 Spectro Photometric Std 2.0 Spectro Photometric Std 3.0 Spectro Photometric Std 4.0 Spectro Photometric Std 5.0 Spectro Photometric Std 6.0 Spectro Photometric Std 7.0 Spectro Photometric Std 8.0 Spectro Photometric Std 20.0 Spectro Photometric Std 30.0 BACKGROUND SOLUTION
Electrode Care and Maintenance

Care and Maintenance Kit Filling Solutions Cleaning Solutions Storage Solutions
ENVASE
PRODUCTO
Care & Maintenance Kit

RCMK1 * REAGECARE pH Electrode Care & Maintenance Kit
Filling Solutions
EFS3 EFS35 EFS4 EFS381 LKCL EFS3AC EFS3AC5 EFS4AC EFSPS EFS2AS EFSO1AS EFSKNO EFSLICL EFSLIET EFSLIGA EFSDO 36 36 36 36 36 24 24 24 * * 24 24 36 24 * 24 100ml 500ml 100ml 100ml 100ml 100ml 500ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 100ml 3mol/litre Potassium chloride (KCI), free from Silver ion 3mol/litre Potassium chloride (KCI), free from Silver ion 4mol/litre Potassium chloride (KCI), free from Silver ion 3.8mol/litre Potassium chloride (KCI), free from Silver ion Saturated Potassium (KCI), free from Silver ion 3mol/litre Potassium chloride (KCI), saturated with AgCl 3mol/litre Potassium chloride (KCI), saturated with AgCl 4mol/litre Potassium chloride (KCI), saturated with AgCl Saturated Potassium Sulphate K2SO4) Double junction bridge sol. 2M/Litre Ammonium sulphate(NH4)2 SO4 0.1mol/Litre Ammonuim Sulphate (NH4)2 SO4 Double junction bridge sol; 10% w/v Potassium Nitrate Non-aqueous filling solution; 1mol/litre Lithium chloride (LiCl), developed in Isopropanol Non-aqueous filling solution; 1mol/litre Lithium chloride (LiCl), dissolved in ethanol Non-aqueous filling solution; 1mol/litre lithium chloride (LiCl), dissolved in galcial acetic acid Dissolved Oxygen Electrolyte
Cleaning Solutions
ECS IECS5 OECS ERS 12 18 12 24 500ml 500ml 500ml 100ml Electrode cleaning solution (Pepsin/hydrochloric acid) for removal of proteins Inorganic Electrode Cleaning Solution (Thiourea/hydrochloric acid); for removal of sulphide Organic Electrode Cleaning Solution Electrode Regeneration Solution
Storage Solutions
ESS5 ESS01 24 24 500ml 1L pH Electrode Storage Solution pH Electrode Storage Solution
Certificados
de
de Anlisis
Ejemplos
Catlogo de Publicaciones EP
6th Edition European Pharmacopoeia
Edition Book and CD-ROM
5th Edition European Pharmacopoeia

Edition Printed Version Edition CD-ROM Version Edition Online Version
6th Edition Book and CD-ROM

Ref Ttulos
pheur2008-2SE pheur2008-2SF pheur2008E pheur2008F CD60-62-001E CD60-62-001F CD60-62-001B
Book Subscription 6th Edition 2008 (includes Volumes 6.0-6.2) - English. Book Subscription 6th Edition 2008 (includes Volumes 6.0-6.2) - French. Book 6th Edition 2008 - Vol 6.0 English. Book 6th Edition 2008 - Vol 6.0 French. CATALOGUE PRICE 380 CD-ROM Subscription 6th Edition 2008 (includes Volumes 6.0-6.2) - English. CD-ROM Subscription 6th Edition 2008 (includes Volumes 6.0-6.2) - French. CD-ROM Subscription 6th Edition 2008 (includes Volumes 6.0-6.2) - Bilingual.
5th Edition Printed Version

Ref Ttulos
pheur2007-3SE pheur2007-3SF pheur2006-3SE pheur2006-3SF pheur2005-2SE pheur2005-2SF pheur2005E pheur2005F pheur05-5.1E pheur05-5.1F pheur05-5.2E pheur05-5.2F pheur06-5.3E pheur06-5.3F pheur06-5.4E pheur06-5.4F pheur06-5.5E pheur06-5.5F pheur07-5.6E pheur07-5.6F pheur07-5.7E pheur07-5.7F pheur07-5.8E pheur07-5.8F
Book Subscription 5th Edition 2007 (Supp. 5.6, 5.7 & 5.8) - English Book Subscription 5th Editon 2007 (Supp. 5.6, 5.7 & 5.8) - French Book Subscription 5th Edition 2006 (Supp. 5.3, 5.4 & 5.5) - English Book Subscription 5th Edition 2006 (Supp. 5.3, 5.4 & 5.5) - French Book Subscription 5th Edition 2005 (up to 5.2) - English Book Subscription 5th Edition 2005 (up to 5.2) - French Book Vol 5.0 - 5th Edition 2005 - English Book Vol 5.0 - 5th Edition 2005 - French Book Vol 5.1 - 5th Edition 2005 - English Book Vol 5.1 - 5th Edition 2005 - French Book Vol. 5.2 - 5th Edition 2005 English Book Vol 5.2 - 5th Edition 2005 - French Book Vol. 5.3 - 5th Edition 2006 - English Book Vol. 5.3 - 5th Edition 2006 - French Book Vol. 5.4 - 5th Edition 2006 - English Book Vol 5.4 - 5th Edition 2006 - French Book Vol. 5.5 - 5th Edition 2006 - English Book Vol. 5.5 - 5th Edition 2006 - French Book Vol 5.6 - 5th Edition 2007 - English Book Vol. 5.6 - 5th Edition 2007 - French Book Vol. 5.7 - 5th Edition 2007 - English Book Vol. 5.7 - 5th Edition 2007 - French Book Vol. 5.8 - 5th Edition 2007 - English Book Vol. 5.8 - 5th Edition 2007 - French
5th Edition CD-ROM Version

Ref Ttulos
CD56-58-001B CD56-58-001E CD56-58-001F CD56-58-001BU CD56-58-001EU CD56-58-001FU
CD-ROM Subscription 5th Edition 2007 (up to Supp. 5.8) - Bilingual - NEW subscriber CD-ROM Subscription 5th Edition 2007 (up to Supp. 5.8) - English - NEW subscriber CD-ROM Subscription 5th Edition 2007 (up to Supp. 5.8) - French - NEW subscriber CD-ROM Subscription 5th Edition 2007 (incl. 5.6, 5.7 & 5.8) - Bilingual - Existing subscriber CD-ROM Subscription 5th Edition 2007 (incl. 5.6, 5.7 & 5.8) - English - Existing subscriber CD-ROM Subscription 5th Edition 2007 (incl. 5.6, 5.7 & 5.8) - French - Existing subscriber
5th Edition Online Version

Ref Ttulos
ON56-58-001B
ONLINE Subscription 5th Edition 2007 (Supp. 5.6 - 5.8) - Trilingual

EP48

Загружено:

Сведения о документе

Исходное описание:

Авторское право

Доступные форматы

Поделиться этим документом

Поделиться или встроить документ

Параметры публикации

Этот документ был вам полезен?

Это неприемлемый материал?

Авторское право:

Доступные форматы

EP48

Загружено:

Авторское право:

Доступные форматы

DICIEMBRE 2006

Catlogo Farmacopea Europea 2006

European Pharmacopoeia - Catalogue, December 2006

European Pharmacopoeia - Catalogue, December 2006

Catalogue No. 48-2006/4 Batch Monograph Leaflet Storage

Y0000127 Acebutolol impurity C Y0000128 Acebutolol impurity I

90.9% CHNOS; N,N'-diacetyl-L-cystine N,-diacetyl-L-cysteine

20 mg 50 mg 10 mg 100 mg 50 mg 50 mg 10 mg 10 mg 30 mg 10 mg 100 mg 125 mg 200 mg 1 ml 75 mg 15 mg

A0349000 Allantoin A0350000 Allopurinol New A0350010 Allopurinol impurity A

A0350020 Allopurinol impurity B A0350030 Allopurinol impurity C

10 mg 20 mg 10 mg 25 mg n/a 125 mg 100 mg 50 mg 5 mg 5 mg 0.125 mg 10 mg 100 mg 125 mg n/a 100 mg 200 mg 10 mg

A0365900 Amikacin sulphate A0370000 Amiloride hydrochloride

a a For extra charges please see 2.2

Council of Europe, all rights reserved 2006

Order Code Y0000020 Y0000173 A0420000 A0460000 A0496000 A0496005

A0496020 Aminoglutethimide impurity D

A0560000 5-Amino-2,4,6-tri-iodo-N-methylisophthalamic acid A0575000 Amiodarone hydrochloride Y0000129 Amiodarone impurity D

Y0000130 A0590000 A0590002 A0590004

Amiodarone impurity E Amisulpride Amisulpride impurity A Amisulpride impurity B

n/a 3 n/a n/a n/a 1

n/a 150 mg n/a

0464 1491 2081 2082

+5C +5C +5C

Y0000005 Amphotericin B A1000000 Ampicillin (anhydrous) 2 150 mg 1

960 IU per mg 98.0% CHNOS

-20C +5C +5C

A1100000 Ampicillin trihydrate

A1200000 A1210000 Y0000172 A1220000 A1230000

+5C +5C +5C +5C

a a l a a For extra charges please see 2.2

Council of Europe, all rights reserved 2006

Arginine aspartate Arginine hydrochloride Articaine hydrochloride Articaine impurity A

Y0000081 Articaine impurity E

A1300000 A1315000 Y0000305 A1320000 A1321000

Yes Yes Yes

+5C +5C +5C +5C +5C +5C +5C +5C Yes

1-benzoyl-2-[(4RS)-1-methylhexahydro-1H-azepin-4-yl]diazane 4-(4-chlorobenzyl)phthalazin-1(2H)-one 3-(4-chlorobenzilidene)isobenzofuran-1(3H)-one 93.2% CHNO

Yes 6-demethylazithromycin 3-deoxyazithromycin

a a a a f f f a l a a a a a a a a a a a a For extra charges please see 2.2

Council of Europe, all rights reserved 2006

B0070000 B0100000 B0200000 B0200050 B0250000 B0300000 Y0000295 B0305000

Y0000351 Y0000352 Y0000469 B0400000 Y0000564 Y0000044 Y0000043 B0470000 1 1 1 2

B0477000 B0477010 B0490000 B0500000

Benserazide hydrochloride Benserazide impurity A Benzarone Benzathine benzylpenicillin

n/a 100 mg 50 mg 40 mg 50 mg n/a 10 mg 50 mg 200 mg

+5C +5C +5C +5C +5C +5C

l a a a a l a a a a a a For extra charges please see 2.2

B0950000 Betadex Y0000391 Betahistine dihydrochloride B0990000 Betahistine mesilate

Council of Europe, all rights reserved 2006

Order Code B1000000 Betamethasone

+5C +5C +5C +5C -20C

Y0000434 Boldine B1142000 Bordetella pertussis mouse antiserum BRP

60 mg 10 mg 100 mg 10 mg 30 mg 5 mg 100 mg 60 mg 100 mg 10 mg 10 mg

j j a a g g a a a j a f a For extra charges please see 2.2

B1155000 Brucella melitensis Rev. 1 strain BRP - * Biotox B1157300 Budesonide

Council of Europe, all rights reserved 2006

B1158000 Y0000309 Y0000310 B1160000 Y0000088 New Y0000089

4.92 mg per vial of CHNO

n/a n/a 1 n/a 1 1 1 1 1 3 1

n/a n/a 4.92 mg n/a 0.5 mg 5 mg 2 mg 50 mg 50 mg 50 mg 50 mg

1 3 1 n/a n/a 1 n/a 7

100 mg 100 mg 5 mg n/a n/a 5 mg n/a 0.98 mg

+5C -20C -20C -20C -20C